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ABSTRACT  
 
 
 
Coxsackievirus B5 (CBV5) is a positive sense, single-stranded RNA virus 
belonging to the Enterovirus genus of the Picornaviridae family. It can cause 
many serious diseases, including viral myocarditis (which can lead on to dilated 
cardiomyopathy), aseptic meningitis, and pancreatitis. The structure and cell cycle 
of CBV5 is typical of a picornavirus.  
 
Viral RNA is detected by Toll-like receptors (TLRs) and retinoic acid inducible 
gene-I (RIG-I)-like receptors (RLRs). The RLR family, consisting of RIG-I, 
MDA5 (melanoma differentiation-associated gene 5), and LGP2, are pattern 
recognition receptors that detect a range of different viruses. RIG-I and MDA5 are 
homologous cytoplasmic proteins containing an N-terminal region with two 
caspase activation and recruitment domains (CARDs), a central SF2 type 
DExD/H-box RNA helicase domain, and a C-terminal repressor domain (RD). 
Once a viral ligand has been detected and bound by RIG-I and MDA5, both signal 
downstream through their CARDs to activate IRF3/7 and NF-κB indirectly, via 
the protein intermediate IPS-1 (IFN-β promoter stimulator 1), and initiate an 
immune response.  
 
RIG-I and MDA5 contribute to antiviral signalling in different ways depending on 
the virus involved. MDA5 has been shown to be critical for Picornaviridae 
detection, whilst RIG-I can detect a wide variety of different viruses and pathogen 
associated molecular patterns.  
 
II 
 
Results presented here show the expression levels of both are upregulated in 
response to CBV5 infection in human cardiac cells, with MDA5 expression levels 
being slightly greater than RIG-I. However, in Huh cells, RIG-I expression levels 
are greater than those of MDA5, indicating that it plays a role in CBV5 sensing. 
The presence of both phospho-IκB (corresponding to NF-κB activation) and IRF3 
is detected in both cardiac cells and Huh cells in response to CBV5, and IFN-β 
production is also greatly upregulated. RIG-I and MDA5 colocalise with the 
adaptor protein IPS-1 in response to CBV5 infection, again indicating the 
synergistic response by the two RLRs, and both RLRs form homodimers in the 
cytoplasm. Overall, this suggest that both MDA5 and RIG-I act synergistically to 
detect CBV5 and initiate a downstream immune response, although MDA5 
appears to be the marginally stronger sensor. 
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Chapter 1  
INTRODUCTION  
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The immune system is a wonder of the human body. It constantly protects us 
against millions of invading pathogens, ranging from viruses to bacteria, from 
fungi to parasitic worms. It does this every moment of every day, ceaselessly 
defending the body from diseases. Viruses are responsible for some of the most 
serious and deadly diseases in the world. Found in almost every ecosystem on 
Earth, there are millions of different types of viruses [Breitbart et al., 2008]. Due 
to their enormous diversity and potential infectivity, the field of virology is vitally 
important. The structure of the virus, the life cycle, the diseases caused, how they 
infect the body, and the innate and adaptive immune response, among other things, 
are all being studied by virologists, in the hope to combat these most successful of 
predators.  
 
1.1 Picornaviridae  
 
The Picornaviridae family (picornaviruses) are important human and animal 
pathogens, which cause a wide range of illnesses. The name comes from pico, 
meaning small, and RNA, referring to their genome, so a picornavirus is literally a 
small RNA virus.  
 
Picornaviruses are group IV viruses (they contain single-stranded, positive sense 
genomes between 7.2 - 9kb long), of the order Picornavirales. Five families are 
within this order: Dicistroviridae, Iflaviridae, Marnaviridae, Picornaviridae, and 
Secoviridae [Le Gall et al., 2008]. The Picornaviridae family can be further 
subdivided into 12 distinct genera: Aphthovirus, Avihepatovirus, Cardiovirus, 
Enterovirus, Erbovirus, Hepatovirus, Kobuvirus, Parechovirus, Sapelovirus, 
Senecavirus, Teschovirus, and Tremovirus [NCBI Taxonomy Browser, URL].  
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Type B Coxsackieviruses (CBVs) belong to the Enterovirus genus, and the 
Human enterovirus B species. The Enterovirus genus consists of 10 species: 
Bovine enterovirus, Human enterovirus A, Human enterovirus B, Human 
enterovirus C, Human enterovirus D, Human rhinovirus A, Human rhinovirus B, 
Human rhinovirus C, Porcine enterovirus B, and Simian enterovirus A, 
accounting for over 265 serotypes of virus [Picornaviridae, Enteroviruses, URL]. 
Within the Human enterovirus B species, there are 60 serotypically distinct 
viruses, including Type B enteroviruses, echoviruses, and CBVs.  
 
There are six different serotypes of CBVs, B1 – B6 (and serotypes A1 to A24 for 
Type A Coxsackieviruses), which cause both acute and chronic diseases. The 
virus enters the body through the gastrointestinal tract, and is mainly transmitted 
via the faecal-oral route, respiratory aerosols, and direct contact with secretions 
from an infected person. Infants, young children, and immunocompromised 
individuals are the most susceptible to infection, with illnesses usually lasting 
between two days and two weeks, occurring during the summer months between 
June and October [Strikas et al., 1986]. Symptoms usually include fever, 
headache, sore throat, malaise, gastrointestinal distress, and muscle and chest pain. 
Rashes and blisters can also occur.  Bornholm disease is typical of CBV infection 
[Brown, 1973]. The most serious diseases caused by CBV5 include viral 
myocarditis (which can lead on to dilated cardiomyopathy, DCM), aseptic 
meningitis, and pancreatitis.  
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Viral myocarditis is an inflammatory disease of the myocardium characterised by 
leukocyte infiltrate and necrosis of the myocytes [Bohn and Benson, 2002]. 
Although it is a rare disease, the mortality rate in newborns is approximately 75%, 
decreasing in older infants and children to between 10-25% [Bengtsson and 
Lamberger, 1966; English et al., 2004]. Some patients can develop chronic 
myocarditis, whilst myocardial destruction can lead on to DCM. DCM is 
characterised by dilation and impaired contraction of the left or both ventricles of 
the heart, and is the major reason for cardiac transplantation in Europe and the 
USA [Manolio et al., 1992].  
 
Aseptic meningitis is characterised by serious inflammation of the layers lining 
the brain (the meninges), and is not caused by pyogenic bacteria. Enteroviruses 
are the most common cause of aseptic meningitis, with CBV5 and echovirus 6, 9, 
and 30 more likely to cause meningitis outbreaks, whilst coxsackievirus A9, 
CBV3, and CBV4 are mostly endemic [Lee and Davies, 2007]. Pancreatitis is the 
inflammation of the pancreas. Gallstones and heavy alcohol use cause the 
majority of cases of pancreatitis, but CBV infection has been shown to play a role 
as well [Huber and Ramsingh, 2004].  
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1.2 Coxsackievirus B5 Structure  
 
CBV5 consists of a non-enveloped icosahedral capsid enclosing a naked single-
stranded, positive sense, polyadenylated RNA genome, 7402 nucleotides long, 
encoding a 2185 amino acid long polyprotein [Zhang et al., 1993].  
 
The virus capsid of CBV5 is arranged the same as for all picornaviruses. It is 
composed of 60 icosahedral subunits (12 pentagon-shaped pentamers of five 
protomers), each of which is composed of one copy of viral protein (VP) 1, VP2, 
VP3, and VP4. Interactions between VP1, VP2, and VP3 form the shell, whilst the 
smaller VP4 lies on the inner surface of the protein shell. The structure of the 
capsid can be seen in Figure 1.1.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1: Capsid structure of a Picornaviridae virion. VP1, VP2, and VP3 
form the outer shell, with VP4 lying on the inner surface. Together, they make up 
a single protomer of the capsid [Viral Zone, Picornaviridae, URL].  
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The 160S (sedimentary) spherical capsid (approximately 30nm in diameter) lacks 
a lipid envelope, making infectivity insensitive to solvents. It can also resist low 
pH, thereby enabling it to pass through the stomach and infect the intestine. 
Although VP1, VP2, and VP3 have no sequence homology, they do share a 
similar corrugated topology. The prominent star-shaped plateau (called the mesa) 
at the fivefold axis of symmetry is surrounded by a deep depression (called a 
canyon). The canyon is the receptor binding site of CBV5 virions. VP1, VP2, and 
VP3, approximately 35 kDa each, are folded into eight-stranded antiparallel β-
sheet structures, termed a β-barrel jelly roll [Rossmann et al., 1985]. VP1 is 
located at the 12 fivefold axes, whereas VP2 and VP3 are located at the quasi-
sixfold axes [UniProtKB, Q03053, URL]. Although as yet unsolved for CBV5, 
the β-barrel jelly roll structure of CBV3 has been determined to a resolution of 3.5 
Ångstroms [Muckelbauer et al., 1995], as can be seen in Figure 1.2.  
 
 
 
 
 
 
 
 
 
 
Figure 1.2: β-barrel jelly roll structure of CBV3. VP1 is shown in blue, VP2 in 
red, VP3 in green, and VP4 in yellow. VP1, VP2, and VP3 are each folded into 
eight-stranded antiparallel β -sheets with a jelly-roll topology [ViperDB, URL].  
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Underneath the canyon floor, within the core of the VP1 β-barrel, is a 
hydrophobic pocket, occupied by a fatty acid ‘pocket factor’, which is thought to 
mediate the stability of the capsid and is released before uncoating [Airaksinen, 
2000; Smyth and Martin, 2002]. The CBV5 genome exhibits the same gene 
organisation as other enterovirus genomes, and can be seen in Figure 1.3.  
 
 
 
 
 
 
Figure 1.3: Genome organisation of an enterovirus. A 5’ UTR containing an 
IRES is followed by a single open reading frame (ORF) divided into three regions, 
and ends with a short 3’ UTR with a poly(A) tract. P1, P2, and P3 are the 
products of the initial proteolytic cleavages of the viral polyprotein. Abbreviations: 
VP, viral protein; UTR, untranslated region; IRES, internal ribosome entry site; 
VPg, viral protein genome-linked [Viral Zone, Enterovirus, URL].  
 
 
The enterovirus genome consists of a single open reading frame (ORF) encoding a 
polyprotein. At the 5’ end is long (~600-1300 nucleotides) and highly structured 
untranslated region (UTR). This 5’ UTR contains a cloverleaf secondary structure 
termed a Type I internal ribosome entry site (IRES), as well as a covalently linked 
22 – 24 amino acid long VPg region (viral protein genome-linked) in place of a 
 
 
8 
 
methylated nucleotide cap structure. The shorter 3’ UTR (~50-100 nucleotides) 
contains a pseudoknot secondary structure and a short poly(A) tract, which is 
essential for virus infectivity [Spector and Baltimore, 1974]. The 5’ UTR is 
involved in the initiation of translation, with VPg acting as the protein primer of 
RNA synthesis [Pelletier and Sonenberg, 1988; Jang et al., 1988], whilst the 3’ 
UTR is important in initiating the synthesis of negative-strand RNA [Rohll et al., 
1995], and may have a role in increasing the efficiency of viral replication and 
determining tissue tropism [Brown et al., 2004].  
 
During translation, the ORF encoding the single viral polyprotein is 
proteolytically cleaved into the three precursor proteins P1, P2, and P3. These are 
further cleaved into the structural proteins VP1 to VP4 (from P1), and seven non-
structural proteins (2A to 2C and 3A to 3D), involved in protein processing and 
genome replication. Each protein has a specific function in viral replication, and 
many of the intermediate cleavage products are also functional, as detailed later.  
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1.3 Picornavirus Replication Cycle  
 
The picornavirus replication cycle takes place entirely within the cytoplasm of the 
cell, and can even occur in enucleated cells [Pollack and Goldman, 1973; Bossart 
and Bienz, 1979]. The replication cycle can be divided into eight main stages: 
attachment, uncoating, translation, protein processing, negative (-) sense RNA 
synthesis, positive (+) sense RNA synthesis, assembly, and release. Figure 1.4 
provides an overview of the picornavirus replication cycle, with the eight most 
significant stages highlighted.  
 
The picornavirus replication cycle occurs rapidly, with the cycle generally being 
completed within 5-10 hours of infection. Table 1.1 outlines the kinetics of the 
picornavirus replication cycle.  
 
Table 1.1: Kinetics of the picornavirus replication cycle.  
Time after infection Event 
~1-2 hours Sharp decrease in host cell macromolecular synthesis  
~2-3 hours Start of viral protein synthesis, vacuolation of cytoplasm  
~3-4 hours Permeabilisation of plasma membrane  
~4-6 hours Virus assembly in cytoplasm  
~6-10 hours Cell lysis and release of virions  
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Figure 1.4: Replication cycle of a picornavirus. The virion attaches to its specific 
receptor (1) and uncoats, releasing its viral RNA into the cytoplasm (2). The viral 
RNA is then translated into a polyprotein using the host machinery (3). Cleavage 
of the polyprotein into structural (P1) and non-structural (P2 and P3) regions 
then occurs (4). The positive (+) sense viral RNA is used as a template to 
synthesise complementary negative (-) sense RNA (5), from which large amounts 
of (+) sense RNA can then be synthesised (6). Cleavage of P1 into VP0, VP1, and 
VP3 occurs simultaneously, resulting in a procapsid, which is packaged with the 
viral (+) sense RNA (7). VP0 is cleaved, and the mature virion is released from 
the cell (8) [modified from MicrobiologyBytes, URL].  
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1.3.1 Attachment  
 
The first step in the picornavirus replication cycle is the attachment of the virion 
to specific host cell receptors. The attachment phase is the determinant of tissue 
tropism, as viruses can only infect cells that have particular cell surface receptors. 
Picornaviruses use a wide range of cell surface molecules for cellular receptors, 
and certain viruses can bind to several different receptors. CBV5 has been shown 
to have many cell surface binding receptors, with the two most common being 
coxsackievirus-adenovirus receptor (CAR), a member of the immunoglobulin (Ig) 
superfamily [Bergelson et al., 1997a], and decay accelerating factor (DAF / CD55) 
[Bergelson et al., 1995; Shafren et al., 1995]. A further five cell surface receptors, 
found on the surface of human cardiac cells, have also been shown to interact with 
CBV5 [Orthopoulos et al., 2004]. 
 
CAR is a 46 kDa transmembrane protein, consisting of 365 amino acids with a 
short leader, a 222 amino acid extracellular domain, a membrane-spanning helical 
domain, and a 107 amino acid intracellular domain [Bergelson et al., 1997b]. 
Analysis of the CAR amino acid sequence suggests that the extracellular domain 
consists of two Ig-like domains (Ig V-like and Ig C2-like), as can be seen in 
Figure 1.5.  
 
DAF is a 70 kDa glycosylphosphatidylinositol (GPI)-anchored protein found on 
most cell surfaces that regulates the complement system on the cell surface. It 
prevents the assembly or promotes the disassembly of the C3-convertase of the 
alternative complement pathway, thereby blocking the formation of the membrane 
attack complex. It consists of four short consensus repeat (SCR) domains 
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followed by a heavily O-glycosylated serine and threonine-rich domain, attached 
to the cell membrane by a GPI anchor [Nicholson-Weller and Wang, 1994], as 
seen in Figure 1.6.  
 
The precise mechanism of CBV5 attachment is yet to be elucidated, with the most 
likely theory currently being the “canyon hypothesis” [Rossmann et al., 2002]. 
The canyon, which surrounds the fivefold axis of symmetry, contains deeply 
buried, conserved amino acid residues that bind the amino terminal domains of 
CAR and DAF. The residues outside the canyon are hyper-variable and vulnerable 
to attack by antibodies [Petrella et al., 2002; Rossmann et al., 2002], which are 
too large to penetrate deep into the canyon, thereby allowing the virus to escape 
the host immune surveillance.  
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Figure 1.5: General representation of CAR structure, depicting the two Ig-like 
domains Ig V-like (starting at the amino terminus and ending near residue 120) 
and Ig C2-like (found approximately between residues 124 to 210) [Carson, 
2001].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6: Diagrammatic structure of decay accelerating factor (DAF). The 
green ellipses represent the four short consensus repeat (SCR) domains. The 
yellow spheres are O-linked and the orange spheres are N-linked carbohydrate 
moieties. DAF is attached to the cell membrane via a glycosylphosphatidylinositol 
(GPI) anchor [He et al., 2002].  
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1.3.2 Uncoating  
 
The uncoating stage of the picornavirus replication cycle is even less well 
understood than the attachment phase. For a virus to survive and infect new hosts, 
the viral capsid must be stable and strong enough to protect the viral genome 
during transmission between hosts, whilst at the same time, upon receiving the 
appropriate signal, it must be able to dissociate or alter its conformation 
sufficiently to allow the genome to be released into the host cell’s cytoplasm.  
 
After binding to the receptor, the picornavirus capsid undergoes a permanent 
structural rearrangement inside a clathrin-coated pit. The main characterisation of 
this is the loss of VP4 [Crowell and Philipson, 1971] and the shift from a 160S 
particle to a 135S particle. The 135S particles, also known as altered, or A 
particles, contain the viral RNA, but have lost VP4. These A particles also have 
the hydrophobic N-terminus of VP1 exposed externally, which has an increased 
affinity for the cellular membrane [Fricks and Hogle, 1990]. This exposed N-
terminus of VP1 inserts into the cell membrane, forming a channel in the fivefold 
axis mesa, through which the viral RNA can travel into the cytoplasm [Smyth and 
Martin, 2002; Tosteson and Chow, 1997], as shown in Figure 1.7.  
 
 
 
15 
 
 
 
 
 
Figure 1.7: Uncoating of a picornavirus. A potential mechanism for transferring 
viral RNA across the cell membrane. VP1, VP2, VP3, and VP4 are coloured cyan, 
yellow, red, and green, respectively. In the crystal structure of the virion (upper 
right), the beta-tube of VP3 (red) forms a plug at the fivefold axis that separates 
the virus interior from the outer surface. Attachment of the 160S particle (upper 
left) to the virus receptor (three gray circles) triggers conversion to the 135S form 
(lower left). Upon conversion, cell attachment is mediated by externalised VP4 
(green tubes) and the N-termini of VP1 (blue tubes). The N-termini emerge from 
the bottom of the canyon and extend along the sides of the fivefold axis mesa 
towards the apex. Once the N-terminal helices of VP1 have inserted into the 
membrane, they rearrange to form a pore (lower right). To permit the RNA 
(purple tube) to pass through the pore into the cytoplasm, it would be necessary 
for the VP3 beta-tube (red rectangle) to shift on its 40-residue tether (red tube) 
and for the VP1 barrels to splay farther apart [modified from Belnap et al., 2000].  
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1.3.3 Translation  
 
Once in the cytoplasm, the viral RNA is translated into a polyprotein using the 
host cell’s translational machinery, via a mechanism of cap-independent 
translation known as internal ribosome entry [Jang et al., 1998; Pelletier et al., 
1988]. During viral infection, the host cell machinery is rapidly shut down, to 
allow the viral gene expression to initiate and persist. This is possible due to the 
two different translation initiation mechanisms involved: The host cell uses a cap-
dependent mechanism; whilst picornaviruses use a cap-independent mechanism 
(Figure 1.8).  
 
In cap-dependent translation initiation, the eIF4E component of the cap binding 
complex (eIF4F) interacts with the cap structure covalently linked to the 5’ end of 
the mRNA. The 40S ribosomal subunit, complexed with eIF2-Met-tRNA-GTP, 
eIF3, and eIF1A, gets recruited to the mRNA and scans along it until the start 
codon is reached. The 60S ribosomal subunit then joins the complex, initiation 
factors are released, and translation begins [Bedard and Semler, 2004].  
 
Picornavirus RNA genomes utilise the cap-independent translation initiation 
mechanism, as they do not have a 7-methyl G cap structure found at the 5’ end of 
their genome. Instead, they contain a VPg region and a Type I IRES within a long, 
highly structured 5’ UTR, which contains several, non-authentic start codons that 
potentially preclude a scanning ribosome [Racaniello and Baltimore, 1981], and is 
where viral translation initiates. To ensure the host cell machinery switches from 
cellular to viral processes, the viral proteinases 2A and 3C cleave several cellular 
proteins, including eIF4G, causing a rapid shut off of cap-dependent translation 
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[Kräusslich et al., 1987]. Poly(A)-binding protein (PABP) cleavage by 2A has 
also been shown to inhibit host cell translation [Kerekatte et al., 1999].  
 
The IRES elements are divided into three groups, Type I, Type II, and Type III, 
based on sequence similarity and structure homology [Wimmer et al., 1993; 
Borman et al., 1997], with CBVs containing Type I IRESs. The 5’ UTR of CBV 
RNA is predicted to contain six major stem-loop structures upstream of the 
translation start site, and the IRES is located within the region between stem-loops 
II and V (Figure 1.8) [Martinez-Salas and Fernandez-Miragall, 2004; Pelletier et 
al., 1988]. The stem-loop IV structure has been shown to be important for 
translation [Trono et al., 1988] and cellular protein binding [Gamarnik and 
Andino, 2000], such as by poly(rC) binding protein (PCBP2), which interacts with 
the IRES and is necessary for efficient translation [Blyn et al., 1997; Walter et al., 
1999; Sean et al., 2009]. 
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Figure 1.8: The mechanisms of cap-dependent and cap-independent translation 
initiation. Panel A shows the steps of translation initiation for canonical cap-
dependent translation. The characteristics of picornavirus RNA and the cleavage 
events during an infection that prevent cap-dependent translation of viral RNA 
are highlighted in red in Panel B. Although the mechanism of cap-independent 
translation of picornaviruses is not fully understood, the predicted steps of 
picornavirus translation initiation are highlighted [modified from Bedard and 
Semler, 2004].  
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1.3.4 Protein Processing  
 
Once translated, the viral polyprotein gets proteolytically cleaved into precursor 
and mature viral proteins (Figure 1.3). The primary cleavage event is mediated by 
the viral cysteine proteinase 2A, which cleaves the polyprotein at the junction 
between P1 and P2. This self-cleavage occurs in cis, resulting in the structural P1 
precursor and the nascent non-structural P2-P3 protein [Toyoda et al., 1986]. 
Translation slows down markedly if P1 is not removed from the nascent chain, 
and further processing is unlikely to occur [Nicklin et al., 1987]. The 2A 
proteinase also cleaves the eIF4G component of the cap binding complex, causing 
a rapid shutdown of host cell translation [Kräusslich et al., 1987]. Secondary 
cleavage events are carried out in trans by the viral cysteine proteinase 3C, and its 
precursor 3CD, both of which process key replication proteins within the P2 and 
P3 regions.  
 
Each of the viral proteins involved in RNA replication has a specific function, 
with some proteins having multiple roles to play. The P1 region encodes for the 
four structural capsid proteins, VP1 to VP4. It is initially cleaved into VP1, VP3, 
and VP0 [Jore et al., 1988], then during maturation, VP0 is cleaved into VP2 and 
VP4 in a final processing step [Basavappa et al., 1994].  
 
The proteins from the P2 region of the polypeptide (2A, 2B, and 2C) are involved 
in protein processing, host cell membrane rearrangement, and RNA replication. 
The viral cysteine proteinase 2A plays a vital role in the initial processing events, 
as mentioned above, and has also been shown to function in RNA replication [Li 
et al., 2001]. 2B affects membrane integrity, resulting in an increase in 
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permeability, which is important for virion release during the late stages of 
infection [van Kuppeveld et al., 1997; Doedens and Kirkegaard, 1995], whilst 2C, 
and its precursor protein 2BC, induce structural rearrangements of intracellular 
membranes and are involved in the formation of viral-induced cytoplasmic 
vesicles [Cho et al., 1994; Echeverri and Dasqupta, 1995].  
 
The P3 proteins (3A, 3B, 3C, 3D, and their precursors) are crucial for immune 
response interference and viral RNA replication. 3A inhibits both transport 
between the endoplasmic reticulum and the Golgi apparatus [Doedens et al., 
1997], and major histocompatibility complex (MHC) Class I-dependent antigen 
presentation [Deitz et al., 2000]. 3B (also called VPg), is the protein primer 
covalently linked to the 5’ end of both positive- and negative-strand RNAs. 3AB 
is involved in RNA replication [Giachetti et al., 1992] and membrane association 
of RNA replication complexes [Towner et al., 1996], and it also stimulates the 
activity of 3D [Paul et al., 1994] and the self-cleavage of 3CD [Molla et al., 1994]. 
The viral cysteine proteinase 3C, as well as carrying out secondary cleavage 
events, binds to the cloverleaf RNA structure called stem-loop I (Figure 1.8) 
along with its precursor 3CD, influencing viral genome replication [Bell et al., 
1999; Zell et al., 2002]. Protein 3D, known as the viral RNA-dependent RNA 
polymerase 3D
pol
, is responsible for VPg uridylylation and RNA chain elongation 
during viral RNA synthesis [Kerkvliet et al., 2010]. It is an error-prone 
polymerase, integrating 1-2 nucleotides per replication of each viral template, 
resulting in an increased mutation frequency and evolution rate, potentially 
enhancing the fitness of the picornavirus population.  
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1.3.5 Negative (-) and Positive (+) Sense RNA Synthesis  
 
Picornaviruses contain single-stranded, positive sense RNA genomes, and use a 
unique mechanism to replicate themselves, involving several different RNA-
protein and protein-protein interactions. The positive sense viral RNA strand, as 
well as serving as a template for protein synthesis, is used as a template to 
synthesise complementary negative sense RNA strands with poly(U) tails, which 
are in turn used to synthesise large amounts of positive sense RNA genomes. This 
occurs near the smooth endoplasmic reticulum in the host cell [Mosser et al., 1972; 
Schlegel et al., 1996]. These positive sense RNA strands can then be packaged 
into virions, or act as templates for subsequent rounds of cap-independent 
translation for the synthesis of more viral proteins.  
 
3D
pol
 is an essential protein involved in this synthesis process. As well as 
catalysing chain elongation during viral RNA synthesis, it also generates the 
protein primer, VPg-pU-pU, in a process called VPg uridylylation [Paul et al., 
1998]. 3D
pol
 covalently couples uridine nucleotides to a conserved tyrosine 
residue in the VPg protein, located at the 5’ end of both positive and negative 
sense viral RNA. The cis-acting replication element (CRE), a sequence within the 
coding region of the picornavirus genomic RNA, serves as a template for VPg 
uridylylation by 3D
pol
, and is stimulated by the binding of 3AB and 3CD [Molla et 
al., 1994; Rieder et al., 2000; Pathak et al., 2008]. Following on from VPg 
uridylylation, the viral 3’ poly(A) tract acts as the initiation site for negative sense 
RNA synthesis. A double-stranded RNA intermediate, termed the replicative form, 
is produced first, which brings the CRE in proximity of VPg uridylylation and 
initiation. The new negative sense RNA strands are then used as templates for 
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multiple initiation events to produce large quantities of positive sense viral RNA 
strands.  
 
Positive sense RNA synthesis is dependent upon the uridylylation of VPg, which 
occurs at the CRE of the RNA [Murray and Barton, 2003], and thus, positive 
sense RNA initiation occurs at the 3’ end of the negative sense replicative form. A 
single negative sense RNA strand can serve as a template for the production of 
several positive sense RNA genomes, with a ratio of positive to negative viral 
RNA strands being between 40:1 and 70:1 [Novak and Kirkegaard, 1991].  
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1.3.6 Assembly and Release  
 
Virion assembly begins when the P1 precursor protein is cleaved by the proteinase 
3CD into the capsid 5S protomer, consisting of one each of VP0, VP1, and VP3 
(Figures 1.3 and 1.4). Five of these protomers then assemble to form the 14S 
pentamer [Palmenberg, 1982], followed by twelve pentamers associating together 
to form the 73S procapsid.  
 
Newly synthesised positive sense RNA is encapsidated within the procapsid, 
forming a 155S provirion. This is a highly specific process, resulting in only 
positive sense RNA strands being packaged [Novak and Kirkegaard, 1991], and it 
has been suggested that glutathione, or a glutathione-dependent process, is 
required for efficient encapsidation of viral RNA to produce infectious virions 
[Smith and Dawson, 2006]. During RNA encapsidation, VP0 is cleaved into VP2 
and VP4. This process is called the maturation cleavage, and it locks the 
assembled capsid into a stable, mature, 155S virion. Maturation cleavage does not 
involve the action of either of the proteinases 2A or 3C, since the VP0 scissile 
bond is located in the interior of empty and mature virions, and is therefore 
inaccessible to viral or host proteinases. When VP0 is cleaved, an ordered N-
terminal network containing an interlocking seven-stranded β-sheet formed by 
capsid residues from adjacent pentamers is established, resulting in an increase in 
particle stability and the acquisition of infectivity [Basavappa et al., 1994]. Once 
the virions have been assembled, they are released from the cell via cell lysis. The 
steps involved in picornavirus virion assembly can be seen in Figure 1.9.  
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Figure 1.9: Picornavirus virion assembly. Precursor proteins (VP0, VP3, and 
VP1) associate to form 5S protomers, which then assemble to form 14S pentamers. 
Twelve of these assemble to form the 73S procapsid into which virion RNA is 
incorporated. Final cleavage of VP0 into VP2 and VP4 takes place to form the 
mature virus particle [modified from Wagner et al., 2008].  
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1.4 Innate Immunity and Toll-like Receptors  
 
All living organisms are constantly exposed to invasive microorganisms present in 
the environment that need to be detected and dealt with effectively to ensure 
survival. Invading pathogens initiate an immune response in the host via two main 
branches of immunity: innate (non-specific) immunity and adaptive (antigen 
specific; also known as acquired) immunity. The adaptive immune response, 
present only in vertebrates, is mediated by B and T cells. This response is very 
specific, as both B cells (antibody producing) and T cells (killer and helper) 
express highly diverse antigen receptors, generated through DNA rearrangement, 
which enable them to detect and respond to a wide range of potential antigens. 
This provides life-long immunological memory, but can take weeks or months to 
establish sufficient levels of immunity. On the other hand, innate immunity, 
present in almost all multicellular organisms, is the first line of defence against 
pathogens, and responds rapidly to invading microbes.  
 
Innate immune cells, such as macrophages and dendritic cells (DCs), express a 
class of immune-sensor molecules termed pattern recognition receptors (PRRs). 
Proposed over 20 years ago [Janeway, 1989], PRRs, which can distinguish self 
from non-self, recognise certain microbial components, termed pathogen-
associated molecular patterns (PAMPs), and initiate an appropriate immune 
response. PAMPs are highly conserved structures that are usually essential for 
microbial survival or pathogenicity, and entire classes of pathogens share these 
invariant structures. Recognition of PAMPs by PRRs leads to the rapid activation 
of latent transcription factors to stimulate the expression of antimicrobial genes 
and the production of type I interferons (IFN). Type I IFNs (consisting of multiple 
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IFN-α isoforms, a single IFN- β one, and other members, including IFN-ε, -κ, and 
-ω) are pleiotropic cytokines that mediate induction of the innate immune 
response, as well as the subsequent development of the adaptive immune response 
[Akira and Takeuchi, 2007]. They induce maturation of DCs by increasing the 
expression of costimulatory molecules (such as CD80, CD86, and CD40), and 
they also increase antigen presentation via MHC class I, which facilitates cross-
presentation of the viral antigens. As well as this, type I IFNs also mediate 
induction of antigen-specific CD8
+
 T cell responses and chemokines, which 
results in stimulation and recruitment of lymphocytes and monocytes to inflamed 
sites. To fully induce an antimicrobial state, type I IFNs also upregulate hundreds 
of effector molecules that directly influence protein synthesis, cell growth, and 
survival [Kawai and Akira, 2006]. Type I IFNs are transcriptionally upregulated 
through the coordinated activation of latent transcription factors, including nuclear 
factor-κB (NF-κB), activating transcription factor 2-c-Jun (ATF2-c-Jun), mitogen-
activated protein kinases (MAPKs), IFN Regulatory Factor 3 (IRF3), and IRF7.  
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1.4.1 Toll-like Receptors  
 
The Toll-like receptors (TLRs) are an important class of PPRs that have been 
shown to recognise an increasingly diverse set of pathogens, leading to the 
activation of the innate and adaptive immune response. TLRs were originally 
identified based on their sequence homology with the Toll receptor in Drosophila, 
which is essential in controlling dorsoventral polarity during embryogenesis, and 
also plays a critical role in the fly’s innate immune response to fungal pathogens 
[Lemaitre et al., 1996; Medzhitov et al., 1997; Rock et al., 1998]. The amino acid 
sequence of the Toll receptor in Drosophila and the cytoplasmic portion of the 
mammalian interleukin-1 receptor (IL-1R) is highly conserved [Gay and Keith, 
1991], and is termed the Toll/IL-1R (TIR) domain, with activation of IL-1R 
signalling pathways activating NF-κB, a transcription factor homologous to 
Drosophila Dorsal [Belvin and Anderson, 1996].  
 
Upon the discovery of Drosophila Toll homologues, a whole family of TLRs has 
since been identified. Currently, there are 13 members within the TLR family: 
TLR1 – TLR9 are conserved in both human and mice; TLR10 is functional only 
in humans; whilst TLR11 – TLR13 are present only in mice [Medzhitov et al., 
1997; Rock et al., 1998; Takeuchi et al., 1999; Chuang and Ulevitch, 2000; Du et 
al., 2000; Tabeta et al., 2004; Zhang et al., 2004]. Each TLR recognises a 
particular PAMP, and initiates the appropriate downstream signalling to activate 
the innate and adaptive immune response. The ligand for TLR4 was the first 
identified, and found to be lipopolysaccharide (LPS), a cell-wall component 
mainly found in Gram-negative bacteria [Hoshino et al., 1999]. Other bacterial 
lipoprotein moieties are recognised by TLR1, TLR2, and TLR6. TLR1 and TLR2 
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form a heterodimer and recognise several triacyl lipopeptides (including 
Pam3CSK4) [Takeuchi et al., 2002], whilst TLR2 and TLR6 can form another 
heterodimer and recognise diacyl lipopeptides (such as MALP-2) [Takeuchi et al., 
2001]. TLR2 is essential for the recognition of lipoteichoic acid (LTA) from 
Gram-positive bacteria, and peptidoglycan, lipoarabinomannan, porins, GPI-
anchored proteins and Hemagglutinin proteins from bacteria, viruses, and 
parasites [Akira et al., 2006]. TLR9 is responsible for the recognition of 
unmethylated CpG DNA [Wagner, 2002], DNA from DNA viruses, and 
hemozoin [Coban et al., 2005]. TLR3 recognises polyinosinic: polycytidylic acid 
(Poly I:C), a synthetic double-stranded RNA (dsRNA) analogue, and dsRNA from 
Reovirus and rotaviruses [Akira et al., 2006]. Single-stranded RNA (ssRNA), on 
the other hand, is recognised by TLR7/8 [Diebold et al., 2004]. Finally, TLR5 
recognises flagellin, a component of bacterial flagella [Hayashi et al., 2001], and 
TLR11 recognises a parasite-derived profilin-like protein [Yarovinsky et al., 
2005]. Table 1.2 shows which microbial component from which species is 
detected by which TLR(s).  
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Table 1.2: TLR recognition of microbial components [modified from Akira et al., 
2006].  
 
 
Microbial Components  Species  TLR Usage 
Bacteria    
LPS  
Diacyl lipopeptides 
Triacyl lipopeptides  
LTA  
PG 
Porins 
Lipoarabinomannan  
Flagellin  
CpG DNA  
ND 
Gram-negative bacteria  
Mycoplasma  
Bacteria and mycobacteria  
Group B Streptococcus  
Gram-positive bacteria  
Neisseria  
Mycobacteria  
Flagellated bacteria  
Bacteria and mycobacteria  
Uropathogenic bacteria  
TLR4 
TLR6/ TLR2 
TLR1/ TLR2 
TLR6/ TLR2 
TLR2 
TLR2 
TLR2 
TLR5 
TLR9 
TLR11 
Fungus   
Zymosan 
Phospholipomannan 
Mannan 
Glucuronoxylomannan 
Saccharomyces cerevisiae 
Candida albicans 
Candida albicans  
Cryptococcus neoformans 
TLR6/ TLR2 
TLR2 
TLR4 
TLR2 and TLR4 
Parasites   
tGPI-mutin 
Glycoinositolphospholipids  
Hemozoin 
Profilin-like molecule 
Trypanosoma 
Trypanosoma 
Plasmodium  
Toxoplasma gondii 
TLR2 
TLR4 
TLR9 
TLR11 
Viruses   
DNA  
dsRNA 
ssRNA 
Envelope proteins  
Hemagglutinin protein 
ND 
Viruses  
Viruses  
RNA viruses  
RSV, MMTV  
Measles virus  
HCMV, HSV1 
TLR9 
TLR3 
TLR7 and TLR8 
TLR4 
TLR2 
TLR2 
Host   
Heat-shock protein 60, 70 
Fibrinogen 
 TLR4 
TLR4 
ND = Not Determined   
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1.4.2 Toll-like Receptor Structure  
 
The members of the TLR family are Type I transmembrane proteins consisting of 
three major domains: a leucine rich extracellular domain; a transmembrane 
domain; and a cytoplasmic TIR domain (Figure 1.10). The extracellular domain 
contains a leucine rich repeat (LRR), composed of 19-25 tandem copies of the 
“xLxxLxLxx” motif, 24-29 amino acids in length, in a horseshoe-like structure 
[Akira et al., 2006; Jin and Lee, 2008]. All TLRs form hetero- and homodimers, 
facilitating dimerisation of the TIR domain to activate intracellular signalling. 
Some TLRs require additional proteins to be bound to them to be fully functional. 
TLR4 is tightly bound to MD-2 on the cell surface, a molecule that confers 
responsiveness to LPS [Shimazu et al., 1999]. CD14 and LPS-binding protein 
(LBP) are also involved in LPS recognition by TLR4, as CD14 transfers the LBP-
LPS complex to TLR4/MD-2 to induce cellular activation [Kitchens, 2000]. TLR2 
heterodimerises with TLR1 and TLR6, as well as non-TLR receptors such as 
CD36 or Dectin-1, to enable recognition of various TLR2 ligands [Gantner et al., 
2003; Hoebe et al., 2005]. The crystal structures of TLR3 [Choe et al., 2005], 
TLR4 [Kim et al., 2007], and TLR1, TLR2, and TLR6 [Jin et al., 2007; Kang et 
al., 2009], with or without their ligands, have been elucidated. The TLRs can be 
separated into intracellular and extracellular members, as shown in Figure 1.10.  
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Figure 1.10: TLR localisation. TLR1, TLR2, TLR4, TLR5, TLR6, and TLR11 
recognise their ligands on the cell surface, whilst TLR3, TLR7, TLR8, and TLR9 
are located intracellularly, in endosomes and lysosomes [Yamamoto and Takeda, 
2010].  
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1.4.3 Toll-like Receptor Signalling Pathways 
 
Once TLRs have recognised their PAMP, they signal downstream, through their 
TIR domains, via two different pathways: the MyD88-dependent pathway (all 
TLRs except TLR3); and the MyD88-independent (TRIF-dependent) pathway 
(TLR3 and TLR4) (Figure 1.11). MyD88 (Myeloid differentiation primary 
response gene 88) is a member of the family of cytoplasmic TIR domain-
containing adaptor molecules, which also includes TIRAP (TIR-containing 
adaptor protein, also known as Mal; MyD88-adaptor like), TRIF (TIR-domain-
containing adapter-inducing IFN-β), and TRAM (TRIF-related adaptor molecule). 
The TIR domain of TLRs selectively recruits specific TIR domain-containing 
adaptors, thereby generating signalling specificity for each TLR [Yamamoto et al., 
2004].  
 
MyD88, a master adaptor molecule, is used by all TLRs except TLR3, and is also 
utilised by all IL-1R family members [Akira et al., 2006]. Mal/TIRAP interacts 
with MyD88 through the TIR domain, and selectively participates in TLR2- and 
TLR4-mediated MyD88-dependent signalling pathways [Yamamoto et al., 2002]. 
In the MyD88-dependent pathway, MyD88, through a homophilic interaction of 
the death domain, interacts with IL-1R-associated kinase (IRAK) 4 [Li et al., 
2002]. IRAK4, via IRAK1, regulates the activity of tumour necrosis factor (TNF) 
receptor-associated factor (TRAF) 6, a RING finger-containing E3 ligase, which 
is involved in lysine 63 (K63)-linked ubiquitination-mediated signalling. TRAF6, 
catalysed by the E2 ubiquitin conjugating enzyme complex Ubc13 and UEV1A, 
activates the TAK1 – TABs complex [Adhikari et al., 2007]. This complex 
activates the IKK (IκB kinase) complex of NEMO (NF-κB essential modulator), 
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IKK-α, and IKK-β, which in turn phosphorylates IκB, tabbing it for ubiquitination 
and targeting it to the proteosome for degradation, thereby releasing NF-κB and 
allowing it to translocate to the nucleus [Karin and Ben-Neriah, 2000].  
 
The TRIF-dependent pathway induces the expression of Type I IFN, and is only 
utilised by TLR3 and TLR4. TRIF is bound to TLR3 through the TIR domain, but 
TLR4 requires TRAM to activate TRIF-dependent signalling [Yamamoto et al., 
2003a; Yamamoto et al., 2003b]. TRIF signals to TRAF3, which activates the 
IKK complex of TRAF-associated NF-κB activator (TANK)-binding kinase 1 
(TBK1) and IKKε. This complex activates the signal-dependent phosphorylation 
of IRF3 and IRF7, causing homo- or heterodimerisation, nuclear translocation, 
and assembly onto the IFN-β enhancer, assisted by CBP/p300 (CREB binding 
protein) [Fitzgerald et al., 2003; Sharma et al., 2003].  
 
Depending on which pathway is used, the latent transcription factors NF-κB, 
ATF2-c-Jun, MAPKs, IRF3, or IRF7 are activated, resulting in the upregulation 
of Type I IFNs, leading on to inflammation, immune regulation, survival, and 
proliferation [Yamamoto and Takeda, 2010]. The two different signalling 
pathways can be seen in Figure 1.11.  
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Figure 1.11: TLR signalling pathway. Each TLR recognises its specific PAMP, 
then signals via the MyD88- or TRIF-dependent pathway, leading to the 
activation of the latent transcription factors NF-κB, ATF2-c-Jun, MAPKs, IRF3, 
and IRF7, resulting in the upregulation of Type I IFNs [Cell Signaling 
Technology, URL].  
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1.4.4 Virus Recognition by Toll-like Receptors 
 
Although a lot of study has gone into how TLRs detect bacteria, several TLRs are 
also important for the recognition of different viruses. TLR2 and TLR4, located 
on the cell surface, recognise viral envelope glycoproteins on virions, whilst the 
intracellular TLRs (TLR3, TLR7, TLR8, and TLR9), recognise viral nucleic acids. 
A wide range of viruses are detected by these TLRs, and Figure 1.12 shows which 
TLRs interact with which viruses [Takeda and Akira, 2005; Akira et al., 2006; 
Finberg et al., 2007; Xagorari and Chlichlia, 2008]. 
 
 
Figure 1.12: Virus interactions with TLRs. Innate immune activation by viruses 
is triggered by transmembrane TLRs both on the cell surface (TLR2 and TLR4) 
and within endosomal/ER intracellular compartments (TLR9, TLR7/8 and TLR3). 
TLRs activate type I IFN and inflammatory cytokine production via IRF and NF-
κB. The TLRs have a cytoplasmic signalling motif, the TIR domain, which is 
essential for activation of shared downstream adapters (MyD88, Mal/TIRAP, 
TRAM, and TRIF) and activation of intracellular signal transducing proteins 
including IRAK/IKKαβγ and TBK-1/IKKε/IRF3 signalling cascades [modified 
from Finberg et al, 2007].  
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1.4.4.1 TLR2  
 
TLR2 has been shown to interact with many different viruses. TLR2 recognises 
the human cytomegalovirus (HCMV) (a dsRNA virus) envelope glycoproteins B 
and H [Boehme et al., 2006; Compton et al., 2003], leading to NF-κB activation 
and the induction of inflammatory cytokines. It is also a receptor in natural killer 
(NK) cells for murine CMV (MCMV) [Szomolanyi-Tsuda et al., 2006]. The 
hemagglutinin protein of measles virus stimulates the production of cytokines via 
TLR2 [Bieback et al., 2002], and the innate immune recognition of vaccinia virus 
is also mediated by TLR2 [Zhu et al., 2007]. TLR2 is activated in human 
monocytes and macrophages in response to Varicella-zoster virus (VZV) [Wang 
et al., 2005], and plays an important role in infections with Herpes Simplex Virus 
(HSV) Type 1, shown using both transfected cell lines and knockout mice [Kurt-
Jones et al., 2004], and in DCs, along with TLR9 [Sato et al., 2006]. Furthermore, 
infectious and UV-inactivated Epstein-Barr virus (EBV) virions lead to the 
activation of NF-κB through TLR2 [Gaudreault et al., 2007].  
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1.4.4.2 TLR3 
 
The role of TLR3 in the antiviral response has not yet been fully elucidated. TLR3 
recognises dsRNA, and its synthetic analogue Poly I:C, leading to the activation 
of NF-κB and the production of Type 1 IFNs [Alexopoulou et al., 2001] in vitro, 
but results are less clear in vivo [Edelmann et al., 2004]. TLR3 plays a role in 
rhinoviral infections in human bronchial epithelial cells [Hewson et al., 2005], in 
respiratory syncytial virus (RSV) in epithelial cells, mediating inflammatory 
cytokine and chemokine production [Rudd et al., 2005], in influenza A virus in 
human lung epithelial cells [Le Goffic et al., 2007], and in MCMV-induced Type 
1 IFN production [Tabeta et al., 2004]. Hepatitis B virus (HBV) has been shown 
to be recognised by TLR3, notably the 3’ CCACCA motif of tRNAAla (UGC) 
[Wang et al., 2006], and hepatitis C virus (HCV) suppresses TLR3 expression, 
thereby being responsible for the persistence of the virus in chronic HCV 
infection [Sato et al., 2007]. Interestingly, TLR3 seems to benefit the 
pathogenesis of West Nile virus (WNV), an ssRNA flavivirus. The dsRNA 
replication intermediate leads to a TLR3-dependent inflammatory response that 
disrupts the blood-brain barrier and mediates entry and penetration of WNV into 
the brain, causing lethal encephalitis [Wang et al., 2004].  
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1.4.4.3 TLR4 
 
The main PAMP of TLR4 is bacterial LPS, but it has been shown to interact with 
several different viruses as well. Using TLR4-deficient mice, it was found that 
TLR4 is involved in the innate immune response to RSV, through an interaction 
with the viral envelope fusion protein [Kurt-Jones et al., 2000; Haynes et al., 
2001]. Mouse mammary tumour virus (MMTV, a retrovirus) stimulates a TLR4 
response, inducing the maturation of bone marrow-derived DCs and the 
upregulation of CD71 (the MMTV entry receptor) on these cells [Burzyn et al., 
2004]. LPS can induce the reactivation of latent MCMV via TLR4 signalling in 
immunocompetent mice [Cook et al., 2006]. The HBV surface antigen (HBVsAg) 
is recognised by several TLRs, including TLR4 [Isogawa et al., 2005], whilst the 
HCV lipo-Viro-particle from chronically infected patients interferes with TLR4 
signalling in DCs [Agaugué et al., 2007]. TLR4 has also been shown to be 
involved in the pathogenesis of CBV3-induced myocarditis [Fairweather et al., 
2003], and can mediate CBV4-induced cytokine production in human pancreatic 
cells [Triantafilou and Triantafilou, 2004].  
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1.4.4.4 TLR7 and TLR8 
 
TLR7 and TLR8, located within endosomal compartments, are the primary 
detectors of viral ssRNA within the cytoplasm. TLR7 and TLR8 within 
plasmacytoid DCs (pDCs) recognise Vesicular stomatitis virus (VSV) [Lund et al., 
2004] and influenza virus [Diebold et al., 2004]. Murine TLR7 and human TLR8 
have also been implicated in sensing guanosine- and uridine-rich ssRNA 
oligonucleotides derived from human immunodeficiency virus-1 (HIV-1), 
stimulating DCs and macrophages to secrete IFN-α and pro-inflammatory 
cytokines [Heil et al., 2004]. TLR7 also recognises HSV in human corneal 
epithelial cells [Li et al., 2006]. TLR8, and to a lesser degree TLR7, mediates the 
CBV-induced inflammatory response in human cardiac cells [Triantafilou et al., 
2005a], and both are involved in the sensing of Sendai virus (SeV) [Melchjorsen 
et al., 2005] and human parechovirus 1 [Triantafilou et al., 2005b].  
 
1.4.4.5 TLR9 
 
TLR9 recognises unmethylated CpG DNA in bacteria, and these motifs are also 
found within several viruses. HSV1 and HSV2 both activate pDCs and DCs to 
produce Type 1 IFNs through TLR9 [Ashkar et al., 2003; Krug et al., 2004; Lund 
et al., 2003; Sato et al., 2006], and TLR9 also mediates the recognition of MCMV 
[Tabeta et al., 2004]. In addition, the recognition of adenovirus in pDCs is 
mediated by TLR9 and is dependent upon MyD88 [Zhu et al., 2007], but 
infectivity alone by adenoviruses is not sufficient for TLR9 activation, which are 
regulated by the specific receptor entry pathway of the virus [Iacobelli-Martinez 
and Nemerow, 2007]. TLR9 has also been shown to be involved with HIV in 
pDCs [Mandl et al., 2008].  
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1.4.5 Viral Modulation of Toll-like Receptor Signalling Pathways  
 
All viruses modulate TLR and other PAMP-induced signal transduction pathways, 
either by activating the PRRs, or suppressing them or their pathways. Figure 1.13 
provides an overview of this battle between virus and host. TLR8 and TLR7 have 
been shown to mediate the CBV-induced inflammatory response in human cardiac 
cells [Triantafilou et al., 2005a], though it remains to be found if and where 
CBV5 modulates the TLR signalling pathway.  
 
Figure 1.13: Modulation of TLR and other PAMP-induced signal transduction 
pathways by virus infection. Red line indicates suppression by virus. Blue line 
indicates activation by virus. Parenthesises denote viral proteins or nucleic acids 
[Yokota et al., 2010].  
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1.5 Innate Immunity and RIG-I-like Receptors  
 
Along with the TLRs, several new TLR-independent PRRs have been discovered, 
including the retinoic acid inducible gene-I (RIG-I)-like receptor (RLR) family. 
There are three known members: RIG-I (also known as DDX58) [Yoneyama et al., 
2004], melanoma differentiation-associated gene 5 (MDA5, also known as IFIH1 
or Helicard) [Kang et al., 2002], and laboratory of genetics and physiology 2 
(LGP2, also known as DHX58) [Rotherfusser et al., 2005].  
 
1.5.1 RIG-I, MDA5, and LGP2 Structures  
 
RIG-I and MDA5 are homologous proteins (925 amino acids long and 1025 
amino acids long, respectively) that detect cytoplasmic viral RNA during viral 
replication [Wilkins and Gale, 2010]. They belong to the superfamily 2 (SF2) 
helicases, and share seven conserved ‘helicase motifs’ that mediate ATP and 
nucleic acid binding [Gorbalenya et al., 1988]. MDA5 is distributed throughout 
the cytoplasm, whereas RIG-I appears to colocalise with F-actin, and is therefore 
associated with the cytoskeleton [Mukherjee et al., 2009]. Both RIG-I and MDA5 
contain an N-terminal region with two caspase activation and recruitment domains 
(CARDs), a central SF2 type DExD/H-box RNA helicase domain, and a C-
terminal repressor domain (RD) [Takeuchi and Akira, 2007]. MDA5 and RIG-I 
exhibit 23% and 35% amino acid identities in their N-terminal CARD and their 
RNA helicase domains, respectively [Yoneyama et al., 2005]. The third RLR, 
LGP2, is 678 amino acids long, and harbours a DExD/H-box RNA helicase 
domain (which shows 31% and 41% amino acid identities to the RNA helicase 
domains of RIG-I and MDA5, respectively) and a C-terminal RD, but lacks any 
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CARDs [Yoneyama et al., 2005]. The representative structures of RIG-I, MDA5, 
and LGP2 can be seen in Figure 1.14.   
 
 
 
 
 
 
 
 
 
 
Figure 1.14: Representative structures of the RLRs. The position of each CARD 
and the DExD/H-box helicase is shown. Amino acid positions are indicated 
[modified from Wilkins and Gale, 2010].  
 
 
1.5.2 CARDs and RLR Dimerisation  
 
CARDs are members of the proapoptotic death domain fold family, which 
includes death domains, death effector domains, and pyrin domains, and are 
composed of six antiparallel α helices [Park et al., 2007]. They are implicated in 
homophilic interactions (CARD-CARD interactions) that facilitate cell death 
pathways [Lin et al., 2006], and lead to downstream signalling to activate IRF3/7 
and NF-κB. The internal DExD/H-box RNA helicase domain has ATPase activity 
that is activated by ligand binding. This is necessary for signalling, but does not 
appear to be required for RNA binding [Yoneyama et al., 2005; Takahasi et al., 
2008]. The C-terminal RD of RIG-I contains a zinc-binding site, which is 
important for controlling RIG-I-mediated IFN responses [Saito et al., 2007]. 
Research has shown that the C-terminal RD of RIG-I is vital for the binding of 
uncapped 5’-triphosphate single-stranded RNA (5’-pppRNA), as it contains a 
partially buried invariant lysine residue that is ideally located to interact with 
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phosphate. RIG-I has two states; an inactive (closed) one and an active (open) one. 
In the inactive state, the CARDs and the helicase domain are repressed by RD. 
Once viral RNA binds to the RD, a conformational change occurs, converting 
RIG-I to the active state. This results in the dimerisation of RIG-I and the 
initiation of downstream signalling via the CARDs. Without the RD, RIG-I 
constitutively activates downstream signalling, whilst overexpression of the RD 
inhibits the antiviral response [Cui et al., 2008]. The proposed model for 5’-
pppRNA activation of RIG-I by ligand-induced dimer formation of RD can be 
seen in Figure 1.15.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.15: RIG-I dimerisation. Proposed model for 5’-triphosphate RNA (gray 
with red phosphates) activation of RIG-I by ligand-induced dimer formation of the 
repressor domain (RD, yellow with magenta zinc iron). In the inactive state, the 
RD represses the CARDs and the Helicase domain of RIG-I. Binding of 5’-
triphosphate RNA induces a conformational change, resulting in the dimerisation 
of RIG-I and activation of downstream signalling [modified from Cui et al., 2008].  
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1.5.3 IPS-1 
 
After binding a viral ligand, RIG-I and MDA5 both signal downstream through 
their CARDs to activate IRF3/7 and NF-κB indirectly, via the protein intermediate 
IFN-β Promoter Stimulator 1 (IPS-1 [Kawai et al., 2005], also known as MAVS 
(Mitochondrial Antiviral Signalling protein) [Seth et al., 2005], VISA (Virus 
Induced Signalling Adaptor) [Xu et al., 2005], and Cardif (CARD adaptor 
inducing IFN-β) [Meylan et al., 2005], listed in order of the acceptance dates of 
their respective publications, and herein referred to as IPS-1). IPS-1 is the 
essential adaptor in both RIG-I and MDA5 signalling that mediates effective 
responses against a variety of RNA viruses [Kumar et al., 2006; Sun et al., 2006]. 
IPS-1 is 540 amino acids in length, anchored to the mitochondrial outer 
membrane by means of a short hydrophobic C-terminal region (amino acids 514-
535, see Figure 1.16) [Seth et al., 2005]. Although anchored there, it moves into a 
detergent-resistant mitochondrial fraction upon viral infection. The location of 
IPS-1 suggests a link between recognition of viral infection, development of 
innate immunity, and mitochondrial function [Hiscott et al., 2006]. IPS-1 contains 
a single N-terminal CARD-like domain (CLD), homologous to the CARDs of 
RIG-I and MDA5, a proline-rich region, and a C-terminal effector domain. The 
crystal structure of the N-terminal CLD of IPS-1 has been determined to 2.1 
Angstrom resolution [Potter et al., 2008]. Its structure is typical of that of a 
member of the death domain superfamily, comprising of a six-helix bundle. It has 
an asymmetric charge distribution, and shares 25% and 20% sequence homology 
with the N-terminal CARDs of MDA5 and RIG-I, respectively. The structure of 
IPS-1 is represented in Figure 1.16.  
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Figure 1.16: Representative structure of IPS-1. The position of each significant 
area is shown. TRAF3 not shown. Abbreviations: T2, TRAF2 binding motif; T6, 
TRAF6 binding motif; PRR, proline-rich region; TM, mitochondrial 
transmembrane domain. Amino acid positions are indicated [modified from 
Johnson and Gale, 2006].  
 
 
1.5.4 Host Response to Viral Infection  
 
RIG-I and MDA5, activated by ligand RNA, interact with IPS-1 via CARD-
CARD interactions, which induces the recruitment of downstream signalling 
molecules, as seen in Figure 1.17. TRAF family members are important in this 
signalling cascade. TRAF3 interacts directly with the TRAF-interacting motif in 
the proline-rich region of IPS-1, as do TRAF2 and TRAF6 [Xu et al., 2005; 
Oganesyan et al., 2006; Saha et al., 2006]. These TRAF proteins signal 
downstream, via two pathways, to the protein kinase inhibitor of NF-κB (IκB) 
kinase (IKK) family members, to activate the transcription factors IRF3/7 and NF-
κB.  
 
The first pathway signals via the canonical IKK complex of IKK-α, IKK-β, and 
the regulatory subunit NEMO. This complex phosphorylates IκB, the inhibitor of 
NF-κB, on serines 32 and 36. Phospho-IκB is then ubiquitinated and targeted to 
the proteosome for degradation, releasing NF-κB, thereby allowing it to 
translocate to the nucleus [Karin and Ben-Neriah, 2000]. The second pathway 
signals via the non-canonical IKK complex of TBK1 and IKKε. This complex 
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activates the signal-dependent phosphorylation of IRF3 and IRF7, causing homo- 
or heterodimerisation, nuclear translocation, and assembly onto the IFN-β 
enhancer, assisted by CBP/p300 [Fitzgerald et al., 2003; Sharma et al., 2003]. 
TRAF3 interaction with IPS-1 is essential for the recruitment of both IKK 
complexes, whilst TRAF2 and TRAF6 are more important for NF-κB activation. 
Crosstalk between the two IKK complexes has been suggested, as NEMO also 
plays a role in TBK-1/IKKε-mediated activation of IRFs [Zhao et al., 2007]. The 
C-terminal effector domain of IPS-1 interacts with Fas-associated death domain 
(FADD) and receptor interacting protein 1 (RIP1), both death domain-containing 
proteins. They facilitate NF-κB activation via the interaction and activation of 
caspase-8 and caspase-10 [Takahashi et al., 2006].  
 
Once in the nucleus, IRF3/7 and NF-κB transcriptionally upregulate type I IFNs 
(IFN- α/β), which then signal through the IFN-α/β receptor and the Jak-STAT 
pathway to drive interferon stimulated gene (ISG) expression and an innate 
immune response. ISGs can function to trigger apoptosis of infected cells, directly 
inhibit viral infection, and they can also play a role in modulating the adaptive 
immune response [Lei et al., 2009; Yoneyama and Fujita, 2009]. The overall RLR 
signalling pathway can be seen in Figure 1.17.  
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Figure 1.17: The RLR signalling pathway showing RIG-I bound to ligand RNA 
and signalling downstream to IRF3 and NF-κB to induce IFN-α/β production 
from a virus-infected cell. IFN-α/β is then shown signalling through the IFN-α/β 
receptor and the Jak-STAT pathway to drive interferon stimulated gene (ISG) 
expression and an innate immune response [Wilkins and Gale, 2010].  
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1.5.5 Viral Evasion of Host Recognition  
 
To counter the host response to viral infection, several viruses have evolved 
strategies to inhibit the innate signalling events leading to IFN production. 
Perhaps the best characterised evasion method is performed by HCV, an 
infectious agent that mainly infects human hepatocytes. HCV NS3/4A (non-
structural 3/4A) is a multifunctional protein harbouring serine protease activity, 
and has been shown to impair both RIG-I and TLR3 signalling [Foy et al., 2005; 
Li et al., 2005a]. It does this by cleaving the C-terminal region of IPS-1 at Cys508, 
thereby disrupting the RIG-I-dependent signalling process by dislodging IPS-1 
from the mitochondrial outer membrane [Li et al., 2005b; Loo et al., 2006], and 
cleaving TRIF at Cys372, resulting in its inability to recruit TBK1 [Li et al., 
2005a]. Similar mechanisms are seen in GB virus B (a member of the Flaviviridae 
family) [Chen et al., 2007], and the 3ABC protease of hepatitis A virus (a member 
of the Picornaviridae family), which cleaves IPS-1 at Q428 [Yang et al., 2007].  
 
The NS1 protein of influenza A virus has been shown to inhibit RIG-I signalling 
through direct interaction with RIG-I [Mibayashi et al., 2007], while the V 
proteins of different paramyxoviruses, including SeV, bind to and inhibit MDA5-
dependent type 1 IFN production [Andrejeva et al., 2004]. Another technique is 
the viral-directed removal of 5’-ppp from the RNA nucleic acid of Hantaan, 
Crimean-Congo hemorrhagic fever, and Borna disease viruses to evade RIG-I 
detection [Habjan et al., 2008]. The Vaccinia virus-encoded A46R protein 
contains a TIR domain that can inhibit TRIF-mediated IRF3 activation, thereby 
preventing one pathway of TLR3 signalling [Stack et al., 2005]. Understanding 
these evasion techniques will allow scientists to combat viruses more effectively.  
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1.5.6 RLR Ligands  
 
RIG-I and MDA5 contribute to antiviral signalling in different ways depending on 
the virus involved [Kato et al., 2006; Loo et al., 2008]. Despite their structural 
similarities, they show a preferential recognition for different viruses, which may 
be due to the amino acid sequences of the DExD/H-box RNA helicase domains of 
RIG-I and MDA5 being only approximately 35% identical, leading to genetic 
diversity and thus different specificities for distinct RNA conformations [Gitlin et 
al., 2006].  
 
1.5.6.1 RIG-I Ligands  
 
RIG-I preferentially detects a number of both positive and negative stranded 
viruses, including: HCV; RSV and related paramyxoviruses; VSV; and influenza 
A virus [Kato et al., 2006; Loo et al., 2008]. Both RIG-I and MDA5 appear to 
respond to reoviruses, WNV, and Dengue virus [Fredericksen and Gale, 2006], as 
well as measles virus [Ikegame et al., 2010]. RIG-I has been shown to be required 
for the detection of uncapped 5’-ppp RNA [Hornung et al., 2006]. This enables 
RIG-I to distinguish between host (self) and viral (non-self) RNA, as host RNA is 
either capped or post-translationally modified to remove the 5’-triphosphate. RIG-
I has been reported to detect both dsRNA [Yoneyama et al., 2004] and 5’-ppp 
ssRNA [Pichlmair et al., 2006], though some form of double-strandedness may be 
required [Schmidt et al., 2009]. RIG-I can also recognise particular sequences or 
motifs within viral RNA, such as uridine and adenosine-rich 3’-sequences in 5’-
ppp ssRNA (found within HCV and other viruses) [Saito et al., 2008; Uzri and 
Gehrke, 2009], or short double-stranded blunt-end 5’-pppRNA [Schlee and 
Hartmann, 2010]. Table 1.3 lists putative RIG-I ligands.  
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Table 1.3: Putative RIG-I ligands generated by enzymatic polymerisation or 
cleavage. Due to the use of enzymatic polymerisation, the RNA molecules in the 
table are not molecularly defined, and additional RNA molecules may be present 
[modified from Schlee and Hartmann, 2010].  
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In addition to these, cleavage products produced by the host endonuclease RNase 
L during virus infection are recognised by RIG-I, which can amplify the RLR 
antiviral response [Malathi et al., 2007]. Finally, RIG-I is responsible for binding 
short dsRNA viral transcripts, less than 1kb in length [Kato et al., 2008]. Despite 
all this research, there is still debate as to what the RIG-I ligand is, with 
suggestions that negative sense virus genomic RNA, generated by viral replication, 
constitutes the major trigger for RIG-I, whilst the other types of RNA mentioned 
above do not substantially contribute to IFN induction [Rehwinkel et al., 2010]. 
Figure 1.18 provides an overview of putative RIG-I ligands.  
 
 
Figure 1.18: Putative RIG-I ligands. RIG-I has been reported to be triggered 
experimentally by a variety of RNA agonists. 5′-ppp–bearing RNAs are shown in 
green, RNAs without 5′-ppps in blue, and RNAs that may have different 5′-end 
characteristics in orange. An antagonist is shown in black. Activated RIG-I 
promotes the induction of interferons and other pro-inflammatory cytokines via 
the mitochondrial adaptor IPS-1 (bold red arrows). IPS-1-dependent induction of 
pro-interleukin-1b allows it to be processed into mature interleukin-1b by the 
inflammasome, which can be directly activated by RIG-I in an IPS-1-independent 
manner [modified from Rehwinkel and Reis e Sousa, 2010].  
 
IPS-1 
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1.5.6.2 MDA5 Ligands  
 
MDA5 has been shown to be critical for Picornaviridae detection, such as 
encephalomyocarditis virus (EMCV) and Theiler’s virus. This is thought to be due 
to the VPg region at the 5’ end of the viral genome. This VPg region blocks the 
5’-triphosphate required for RIG-I recognition, but still allows for MDA5 to bind 
to it [Gitlin et al., 2006; Kato et al., 2006; Pichlmair et al., 2006]. MDA5 is also 
triggered by reoviruses [Loo et al., 2008] some flaviviruses [Fredericksen et al., 
2008], paramyxoviruses [Gitlin et al., 2010], and norovirus [McCartney et al., 
2008]. In addition, MDA5 and IPS-1 are crucial in mediating Type 1 IFN 
responses to CBV3, with the absence of the MDA5-IPS-1 pathway leading to 
increased mortality in mice after CBV3 infection [Wang et al., 2010; Hühn et al., 
2010]. MDA5 has also been shown to be essential for Poly I:C-induced IFN 
production [Kato et al., 2006; Loo et al., 2008]. Whilst RIG-I is required for the 
detection of short dsRNA, MDA5 preferentially binds long dsRNA products 
(greater than 1-2kb in length) [Kato et al., 2008].  
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1.5.6.3 LGP2 Ligands  
 
In vitro studies suggest that LGP2 acts as a negative regulator of the RIG-I- and 
MDA5-mediated antiviral response, as its overexpression inhibits virus-induced 
IRF3 and NF-κB activation. One possible explanation for this is that LGP2 
sequesters dsRNA away from RIG-I and MDA5, thereby preventing activation of 
the antiviral signal [Rothenfusser et al., 2005]. A second model is that LGP2, via 
its RD, inhibits dimerisation of RIG-I and its interaction with IPS-1 [Saito et al., 
2007], whilst a third possibility is that LGP2 competes with IKKε for recruitment 
to IPS-1 [Komuro and Horvath, 2006]. Structural analyses of the RD of LGP2 
have also shown that LGP2 can bind to the termini of dsRNA more strongly than 
MDA5 [Li et al., 2009; Pippig et al., 2009; Takahasi et al., 2009]. However, in 
vivo data suggests that LGP2 can act as a positive regulator of RIG-I- and MDA5-
mediated antiviral responses, via its ATPase domain [Venkataraman et al., 2007; 
Satoh et al., 2010].  
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1.6 Project Aims  
 
Despite the wealth of research on hunting the RLR ligands, the precise PAMPs 
recognised by each RLR are, as yet, still undetermined. This project aims to 
enhance the current knowledge on whether the RNA helicase RIG-I or MDA5 is 
the primary detector of CBV5. First of all, the extent of RIG-I and MDA5 
involvement in CBV5 infection of cardiac cells was investigated. One of the most 
serious diseases caused by CBV5 is viral myocarditis, which can lead on to 
dilated cardiomyopathy, and thus cardiac cells were chosen to work on. To further 
elucidate the role of RIG-I and MDA5 in CBV5 sensing, Huh cells were used, as 
Huh 7.5.1 cells have a RIG-I mutation that leads to a defect in IFN production. 
RIG-I has been proposed to dimerise in response to viral ligands, so whether 
dimerisation between RIG-I, MDA5, and LGP2 occurred after CBV5 infection 
was observed using immunoprecipitation experiments. Finally, the interaction and 
colocalisation between RIG-I and MDA5 with IPS-1 (an adaptor protein essential 
for downstream signalling) was examined using confocal microscopy.  
 
Understanding whether RIG-I or MDA5 is the primary detector of CBV5 will 
help in the development of novel therapeutic approaches for not only viral 
myocarditis, but other diseases caused by CBV5 as well.  
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Chapter 2 
MATERIALS AND METHODS  
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2.1 Materials  
 
2.1.1 Antibodies  
 
 Donkey Anti-Goat IgG (H+L) TRITC (Rhodamine), purchased from 
Jackson Immuno Labs 705-025-003  
 
 IRF-3 (FL-425) Rabbit Polyclonal IgG, purchased from Santa Cruz 
Biotechnology sc-9082 
 
 LGP2 Goat pAb to DHX58, purchased from Abcam ab82151  
 
 LGP2 (H-159) Rabbit Polyclonal IgG, purchased from Santa Cruz 
Biotechnology sc-134667  
 
 MAVS (T-20) Goat Polyclonal IgG, purchased from Santa Cruz 
Biotechnology sc-70096  
 
 MDA5 (C-16) Goat Polyclonal IgG, purchased from Santa Cruz 
Biotechnology sc-48031  
 
 MDA5 (H-61) Rabbit Polyclonal IgG, purchased from Santa Cruz 
Biotechnology sc-134513  
 
 Phospho-IkappaBalpha (Ser32) (14D4) Rabbit mAb, purchased from Cell 
Signaling Technology #2859L  
 
 Rabbit Anti-Goat Polyclonal Immunoglobulins FITC, purchased from 
DAKO F0250  
 
 RIG-I (C-15) Goat Polyclonal IgG, purchased from Santa Cruz 
Biotechnology sc-48929  
 
 
 
57 
 
 RIG-I (H-300) Rabbit Polyclonal IgG, purchased from Santa Cruz 
Biotechnology sc-98911 
 
 Streptavidin-HRP conjugate, purchased from Amersham Biosciences 
1058765  
 
 Swine Anti-Rabbit Polyclonal Immunoglobulins FITC, purchased from 
DAKO F0205  
 
 Swine Anti-Rabbit Polyclonal Immunoglobulins HRP, purchased from 
DAKO P0217 
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2.2 Tissue Culture  
 
The following basic tissue culture techniques were used on all the cell lines 
utilised throughout the project. All tissue culture (TC) was performed in a 
Microflow Class 2 laminar flow hood in a sterile environment. Aqueous Virkon 
was used to clean the work area before use, and to clean all the equipment before 
placing it inside the cabinet, to ensure sterility. A lab coat and disposable gloves 
and shoes were worn. 25cm
2 
Nunclon
TM
 ∆ Surface Flasks and Nunc Falcon tubes 
were used throughout.  
 
2.2.1 Cell Lines  
 
2.2.1.1 Human Cardiac Cell Line 
 
Human Cardiac (Girardi) cell line (ECACC – European Collection of Animal Cell 
Cultures), maintained in 1g/L Glucose Dulbecco’s Modified Eagle’s Medium 
(DMEM), containing GlutaMAX, 10% heat-inactivated Foetal Calf Serum (FCS), 
and 1% non-essential amino acids (Invitrogen (UK)).  
 
2.2.1.2 Huh 7.5 and Huh 7.5.1 Cell Lines  
 
Human Hepatocellular (Huh) 7.5 cell line (Kindly donated by Dr Chisari, Scripps 
Research Institute, USA), maintained in 4.5g/L glucose DMEM, containing 
GlutaMAX, 10% heat-inactivated FCS, and 1% non-essential amino acids 
(Invitrogen (UK)).  
Huh 7.5.1 cell line (Kindly donated by Dr Chisari, Scripps Research Institute, 
USA), maintained in 4.5g/L glucose DMEM, containing GlutaMAX, 10% heat-
inactivated FCS, and 1% non-essential amino acids (Invitrogen (UK)). They 
contain a RIG-I mutation that leads to a defect in IFN production.  
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2.2.1.3 LLC Cell Line  
 
LLC (Lewis Lung Carcinoma) cell line (ATCC – American Type Culture 
Collection), maintained in 1g/L DMEM, containing GlutaMAX, 10% heat-
inactivated FCS, and 1% non-essential amino acids (Invitrogen (UK)). The LLC 
cell line are monkey cells that nearly all viruses are able to propagate on, as they 
are a very robust cell line.  
 
2.2.2 Thawing Cells  
 
The vial of cells was carefully removed from liquid nitrogen. As soon as they 
were fully defrosted, the cells were added to 10ml of their appropriate growth 
medium in a 15ml Falcon tube. This was then centrifuged at 12,000 rpm for 5 
minutes at room temperature (RT), after which the supernatant was aspirated off. 
5ml growth medium was added, the cells were resuspended, and finally added to a 
flask and incubated at 37
o
C 5% CO2.  
 
2.2.3 Propagating Cells  
 
Cells have a limited lifespan before they start dying, and thus need propagating to 
ensure their survival. Fresh growth medium provides new nutrients for the cells, 
as well as foetal calf serum (FCS; a growth factor) and MEM non-essential amino 
acids (Sigma). Cells need propagating when they become confluent and cover 
over 90% of the bottom of the flask. Propagating cells involves splitting down 
their total number, thereby allowing them the space and nutrients to divide and 
expand back up again. This way, certain cell lines can be maintained indefinitely, 
though after a certain number of passages, the overall quality of the cell line 
decreases.  
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2.2.3.1 Adherent Cell Lines  
 
Cardiac, Huh 7.5, Huh 7.5.1, and LLC cell lines (adherent cell lines) were 
propagated by first removing the supernatant, and then washing the cells with 2ml 
1X PBS to remove any remaining dead cells. The cells were then incubated with 
2ml of trypsin-EDTA solution (1X, Sigma) (a serine protease, which hydrolyses 
the proteins adhering the cells to the flask bottom), until they could be tapped off 
the bottom of the flask. After the cells were in suspension, 2ml of the appropriate 
growth medium was added, to neutralise the trypsin. The cells were then split 
evenly into separate flasks, and fresh medium was added (to a total of 4ml). The 
flasks were then incubated at 37
o
C 5% CO2. In some cases, cell lines only 
required maintaining, rather than propagating. The process is the same, but instead 
of neutralising the trypsin with medium, 1ml of trypsin was removed, 3ml of fresh 
growth medium was added, and the flask incubated at 37
o
C 5% CO2.  
 
2.2.4 Freezing Cells  
 
Healthy cells are frozen in liquid nitrogen (-196
o
C) for long-term cryo-storage. To 
protect the cells from freezing damage due to ice formation, they are frozen in 
freezing medium (10% Dimethyl sulfoxide (DMSO) in FCS), with the DMSO 
acting as a cryoprotectant.  
 
To freeze adherent cell lines, the cells were washed, trypsonised, and neutralised 
as per propagating them, and then combined into a 15ml Falcon tube and 
centrifuged at 12,000 rpm for 5 minutes at RT. The supernatant was aspirated off, 
and 1ml per flask of cells of freezing medium was added (i.e. if two flasks of cells 
were being frozen, 2ml of freezing medium was added) and the cells resuspended. 
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In under 10 minutes, the cells were added to labelled cryotubes (Nunc) and stored 
at -80
o
C, allowing the cells to be cooled at a rate of 1-3
o
C per minute. After 24 
hours, they were added to liquid nitrogen for long-term cryo-storage.  
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2.3 Coxsackievirus B5 (CBV5)  
 
2.3.1 Propagating CBV5 
 
A prototype strain of CBV5 (Faulkner strain) was obtained from the ATCC, and 
propagated on LLC cells. 100µl CBV5 was added to a flask of 1.5ml LLC cells 
and incubated at 37
o
C 5% CO2 for approximately 24 hours. Once all the cells had 
been killed, the flasks were freeze-thawed three times, to break open the cells and 
release the virus. The LLC-CBV5 was then transferred to 50ml Falcon tubes and 
centrifuged at 12,000 rpm for 5 minutes at RT. The supernatant containing the 
virions was then added to fresh 50ml Falcon tubes and frozen at -80
o
C.  
 
2.3.2 Purifying CBV5 using a Sucrose Density Gradient  
 
CBV5 was purified using a sucrose gradient purification procedure. The sucrose 
gradients were prepared in 40ml Beckmann SW28 ultra-centrifuge tubes. The 
sucrose solutions were layered into the tubes in the following order (with the 
boundary between them marked): 7ml 60% sucrose in PBS; 6ml 30% sucrose in 
PBS; and 3ml 10% sucrose in PBS. 15ml CBV5 was gently loaded onto the 
gradient, and the tubes were centrifuged at 25,000 rpm for 90 minutes at 4
o
C. 
CBV5 bands at the interface between 30% and 60% sucrose. The top layers of 
sucrose were carefully removed, and the purified CBV5 was pipetted into 15ml 
Falcon tubes and frozen at -80
o
C.  
 
2.3.3 Isolating Single-Stranded RNA (ssRNA) from Purified CBV5  
 
In TC, 300µl of purified CBV5 was added to sterile Eppendorfs. Each Eppendorf 
will end up containing 80µl ssRNA, enough for two indirect immunofluorescence 
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stimulations of 40µl each. From this point on, all work was performed in a fume 
hood with sterile Eppendorfs and tips, to ensure the purity of the ssRNA.  
 
2µl vanadyl ribonuclease complex (an RNase inhibitor, which stops the 
breakdown of RNA) was added to each Eppendorf, followed by 300µl ultrapure 
phenol (the bottom layer). Phenol dissolves any proteins present. After vortexing 
for 5-10 seconds, the Eppendorfs were centrifuged at 13,000 rpm for 10 minutes 
at RT. The upper layer was then transferred to new Eppendorfs. 300µl chloroform 
/ isoamyl alcohol (chloroform dissolves lipids present, and isoamyl alcohol 
ensures deactivation of RNase) was added to each Eppendorf, followed by another 
round of vortexing and centrifugation. The upper layer was again transferred into 
new Eppendorfs. 15µl (1/20
th
) sodium acetate 2M pH 6.5 and 750µl (2.5x vol) of 
95% ethanol (both reduce co-precipitation of contaminants) were added, mixed, 
and the Eppendorfs were then frozen at -80
o
C for at least 60 minutes. Afterwards, 
the Eppendorfs (straight from the freezer) were centrifuged at 13,000 rpm for 30 
minutes at RT. The excess supernatant was removed, the Eppendorfs were 
centrifuged at 13,000 rpm for a further minute, and the remaining supernatant was 
removed, leaving just a pellet of ssRNA. 80µl sterile water (ddH2O), or LAL 
water, was added to each Eppendorf, and the ssRNA was frozen at -80
o
C.  
 
2.3.4 Preparing UV-Inactivated CBV5  
 
UV-inactivated CBV5 (UV-CBV5) was prepared by shining UV light upon vials 
of CBV5 for 30-45 minutes. To test to see if the UV had destroyed the RNA of 
the CBV5, cardiac cells were stimulated with UV-CBV5 for 24 hours. The UV-
CBV5 should have very little effect upon the cells.  
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2.4 Immunofluorescence  
 
Immunofluorescence is a technique whereby an antigen present within or on a cell 
can be detected using a specific antibody conjugated to a fluorophore (fluorescent 
molecule), with the amount of fluorescence emitted equating to the amount of 
antigen present. Fluorophores absorb light (energy) of a specific wavelength and 
re-emit energy of a different but specific wavelength. The most commonly used 
fluorophore is FITC (fluorescein isothiocyanate), which has an excitation 
wavelength of 495nm (cyan) and an emission wavelength of 519nm (green). 
Another commonly used fluorophore is TRITC (tetramethylrhodamine 
isothiocyanate), which has an excitation wavelength of 547nm (green) and an 
emission wavelength of 572nm (yellow). There are two major types of 
immunofluorescence: primary (direct) and secondary (indirect).  
 
2.4.1 Direct Immunofluorescence  
 
Direct immunofluorescence utilises a single antigen-specific antibody directly 
conjugated to a fluorophore (Figure 2.1). A specific antigen will be detected by 
the antibody, and the fluorophore it is attached to can subsequently be detected via 
microscopy or flow cytometry.  
 
 
 
 
 
 
 
 
 
 
Figure 2.1: Direct immunofluorescence. An antigen-specific fluorescently-
conjugated antibody binds directly to the antigen.  
 
 
Cell with antigen 
Antigen-specific fluorescently-
conjugated antibody   
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2.4.2 Indirect Immunofluorescence  
 
Indirect immunofluorescence involves two antibodies: an unlabelled primary 
antibody specific for the antigen of interest; and a fluorescently-conjugated 
secondary antibody specific for the primary antibody (Figure 2.2). The structure 
of an antibody makes this possible, as it has two regions: an Fc region (fragment 
crystallisable region); and an Fab region (fragment antigen-binding region). The 
Fab region contains variable sections that determine which antigen is bound, 
whilst the Fc region is constant in a class of the same species. Antibodies can be 
designed in such a way that they contain the same Fc region but different Fab 
regions. In this way, primary antibodies with the same Fc region can be used to 
detect various antigens (due to differing Fab regions), and still be detected by a 
single fluorescently-conjugated secondary antibody specific for the Fc region of 
the primary antibody.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2: Indirect immunofluorescence. An antigen-specific primary antibody 
binds to the antigen, and is itself bound by a fluorescently-conjugated secondary 
antibody specific to it.  
 
 
 
Cell with antigen 
Antigen-specific primary antibody  
Fluorescently-
conjugated secondary 
antibody  
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2.5 Flow Cytometry  
 
Flow cytometry is a powerful technique used to analyse cellular characteristics of 
individual cells in a heterogeneous population. In this project, cells were 
fluorescently tagged via indirect immunofluorescence and passed through the 
Becton Dickinson (BD) Fluorescence-Activated Cell Sorting (FACSCalibur
TM
) 
system (Figure 2.3).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3: BD FACSCalibur
TM
 flow cytometer [BD, URL].  
 
 
2.5.1 Principles of Flow Cytometry  
 
A flow cytometer works by passing thousand of cells per second through one or 
more laser beams, scattering the light onto detectors. The cells must be passed 
through the laser beams in single file to get accurate readings, and this is achieved 
using hydrodynamic focusing. The sample of cells merges with a flowing stream 
of sheath fluid and gets funnelled into a smaller orifice, compressing the cells to 
roughly one cell in diameter. When the laser strikes a cell, two forms of scattered 
light occur: forward scatter (FSC), which is the amount of light that is scattered in 
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the forward direction, quantifies a cell’s size; and side scatter (SSC), which is the 
rest of the light collected on a detector located 90
o
 from the laser beam, shows the 
granularity of a cell. Fluorescence can also be detected. Lasers excite the 
fluorophores, and the subsequent fluorescent emission travels along the same 
route as the SSC signal. The light is directed through a series of filters and mirrors, 
so that the appropriate wavelengths are delivered to the correct detector. All the 
data is recorded and accessed using the BD CellQuest software.  
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2.6 Determining RIG-I and MDA5 Expression Levels  
 
Indirect immunofluorescence followed by flow cytometry was used to investigate 
the expression levels of RIG-I and MDA5 before and after stimulation with either 
CBV5, UV-CBV5, polyinosinic: polycytidylic acid (Poly I:C, a synthetic double-
stranded (dsRNA) analogue), or ssRNA, at 0 hour (unstimulated), 1 hour, 2 hour, 
4 hour, and 6 hour time points. Each experiment was performed three separate 
times. The data of all three experiments were averaged to get the final results 
(error bars show standard deviation (SD) over all experiments).   
 
Healthy, confluent cells (>90% confluency) were stimulated with either 100µl 
CBV5, 100µl UV-CBV5, 40µl ssRNA, or 50µl Poly I:C, and incubated for 1, 2, 4, 
or 6 hours. Three flasks were needed per stimulation per time point.  
 
At each time point, 2ml of the supernatant was added to two screwtop Eppendorfs 
and frozen at -20
o
C, for use in the Cytometric Bead Array assay. The rest of the 
supernatant was discarded, and the cells were quickly washed with 4% 
Paraformaldehyde (PFA). 1ml X2 SDS-PAGE Reducing Sample Buffer was 
added to one flask and placed on a rocking table for 1 hour, then transferred to an 
Eppendorf and frozen at -20
o
C, for use in discontinuous SDS-PAGE. The other 
two flasks were fixed with 2.5ml 4% PFA for 15 minutes (4% PFA is used as a 
fixative, by cross-linking proteins, mainly the residues of the amino acid lysine, to 
lend rigidity to the cells and prevent further biochemical reactions), the cells were 
then scraped off and 1ml was transferred to five Eppendorfs (to provide one 
negative control sample, two MDA5 samples, and two RIG-I samples).  
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After centrifuging at 13,000 rpm for 2 minutes at RT, the supernatant was 
aspirated off and the cells were resuspended in 1ml PBS / 0.02%(w/v) Bovine 
Serum Albumin (BSA) / 0.02%(w/v) Saponin / 0.02%(w/v) Sodium Azide (NaN3). 
BSA is used as a carrier protein to antibodies and as a general protein blocking 
agent. The amphipathic nature of Saponin makes it act as a surfactant, enhancing 
the penetration of proteins through the cell membrane. NaN3 prevents the 
internalisation of surface antigens, which could produce a loss of fluorescent 
intensity. The cells were then centrifuged and the supernatant aspirated off again, 
followed by resuspension in 100µl PBS / BSA / Saponin / NaN3, and incubation 
with 2µl of primary antibody (MDA5 (C-16) Goat pAb or RIG-I (C-15) Goat pAb) 
for one hour or greater at RT.  
 
After incubation in primary antibody, the cells were washed and resuspended in 
100µl PBS / BSA / Saponin / NaN3, followed by incubation with 2µl of secondary 
antibody (pAb Rabbit anti-Goat FITC) for 45 – 60 minutes in the dark (to prevent 
photobleaching) at RT. The cells were then washed twice in PBS / BSA / Saponin 
/ NaN3, then resuspended in 500µl PBS and transferred to flow tubes and run on 
the FACSCalibur
TM
. 10,000 cells not gated were analysed for each sample.  
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2.7 Phospho-IκB and IRF3 Detection  
 
2.7.1 SDS-PAGE  
 
SDS-PAGE (Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis) is a 
technique used to electrophoretically separate proteins according to their 
Molecular Weight (MW). There are two types of SDS-PAGE; continuous and 
discontinuous.  
 
2.7.1.1 Continuous SDS-PAGE  
 
In continuous SDS-PAGE, the identity and concentration of the buffer solutions 
are the same in both the gel and the tank. This type of SDS-PAGE is easy to 
prepare and gives adequate resolutions for electrophoresis of DNA and RNA, but 
for proteins, where a higher resolution is often needed, discontinuous SDS-PAGE 
is typically used.  
 
2.7.1.2 Discontinuous SDS-PAGE  
 
Discontinuous SDS-PAGE utilises a different buffer for the tank and the gels, and 
the gel itself is split into two parts: the upper stacking gel and the lower resolving 
gel. The 4% stacking gel has a large pore size (low percentage) and low pH (6.8), 
whilst the 10% resolving gel has smaller pores and a higher pH (8.8). The protein 
samples are stacked into very thin, sharp zones at the interface between the 
stacking gel and resolving gel, and are then separated according to their MW as 
they pass through the resolving gel. Both gels contain chloride (Cl
-
) ions as the 
mobile anion, whilst the running buffer (pH 8.8) has glycine as its anion. When 
electrophoresis starts, both Cl
-
 and glycinate ions migrate through the stacking gel. 
The smaller, strongly charged Cl
-
 ions move faster than the glycinate ions. Due to 
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the low pH in the stacking gel compared to the running buffer, the equilibrium 
favours the zero net charge zwitterionic form of glycine. The faster Cl
-
 ions leave 
behind an area of unbalanced, positive counter ions in their wake, creating a steep 
voltage gradient (the Kohlrausch discontinuity) that pulls the glycinate ions along, 
resulting in two fronts moving at the same speed. The protein sample molecules, 
having an intermediate mobility, are carried along between these two fronts 
through the large pores of the stacking gel, and deposited in a focused narrow 
band on top of the resolving gel. When the Kohlrausch discontinuity enters the 
resolving gel, the pH increases, ionising the glycine and increasing its mobility. 
The faster running glycinate ions dissipate the discontinuity and run past the 
protein samples, allowing them to separate themselves through the resolving gel 
[National Diagnostics, URL].  
 
2.7.1.3 Discontinuous SDS-PAGE Preparation 
 
In this project, discontinuous SDS-PAGE followed by western blotting was used 
to detect the presence of phospho-IκB and IRF3 in the cells’ lysate. As explained 
in the introduction, IκB is an inhibitory protein that regulates NF-κB. RIG-I and 
MDA5, activated by ligand RNA, interact with IPS-1 via CARD-CARD 
interactions, which induces the recruitment of downstream signalling molecules. 
This results in IκB being released from the NF-κB complex and getting 
phosphorylated, marking it for ubiquitination and degradation by proteosomes, 
and leads to the activation of NF-κB and IRF3/7. Figure 2.4 shows the basic setup 
of the apparatus used for discontinuous SDS-PAGE.  
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Figure 2.4: Apparatus used for SDS-PAGE. A 1mm glass spacer plate and a 
shorter glass plate are sandwiched together and placed in the holder, forming the 
cassette. Water is used to test for leaks. A 1mm comb is placed in, and a mark is 
made approximately 5-10mm below the teeth of the comb, to indicate where the 
boundary between the resolving gel and the stacking gel should be [modified from 
The Biotechnology Project at MATC, URL].  
 
 
Once the apparatus was set up, 10% resolving gel was poured in between the glass 
plates up to the mark made previously. 10% Ammonium Persulphate (APS) and 
Tetramethylethylenediamine (TEMED) were only added once the gel was ready 
to be poured, as they catalyse the polymerisation of the acrylamide gel. A thin 
strip of saturated isobutanol (top layer) was added to the surface of the resolving 
gel, to remove any bubbles and even it out, and the gel was then left for 
approximately 45-60 minutes to polymerise. Once the resolving gel was set, the 
isobutanol was washed off with dH2O, and 4% stacking gel was added all the way 
to the top of the cassette (again, 10% APS and TEMED were added once the gel 
Stacking Gel 
Resolving Gel 
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was ready to be poured). A comb was inserted at this stage to create the wells, and 
the stacking gel was left to polymerise for 45-60 minutes.  
 
Once set, the plates were unclipped from the casting stand and slid into a U-
shaped gasket electrode assembly, short plate facing inwards, and placed into a 
tank. Approximately 1 inch (1/3 of the height of the plates) of running buffer was 
added to the tank and filled between the plates.  
 
2.7.1.4 Sample Preparation for SDS-PAGE 
 
To prepare the samples for running on the gel, X2 SDS-PAGE Reducing Sample 
Buffer was added to cells that had been incubated with CBV5, UV-CBV5, ssRNA, 
or Poly I:C for 0, 1, 2, 4, or 6 hours. The SDS in the reducing sample buffer is an 
anionic surfactant which both denatures secondary and non-disulphide-linked 
tertiary structures in proteins, and places a negative charge onto each protein in 
proportion to its mass. This ensures that each protein is linear and separated only 
by its MW. The β-mercaptoethanol present further denatures proteins by cleaving 
their disulphide bonds, thereby disrupting the tertiary and quaternary structure of 
them. The glycerol helps preserve the proteins at low temperatures, and weighs 
down the samples when loading them into the wells. The Tris present acts as a 
buffer (Tris has an effective pH range between 7.0 and 9.2). The addition of 
Bromophenol Blue allows the samples to be visualised as they pass through the 
gel.  
 
100µl of each sample was added to separate Eppendorfs and boiled for 10 minutes, 
along with biotinylated SDS-PAGE standards (2µl + 40µl X2 SDS-PAGE 
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Reducing Sample Buffer), to help denature the proteins further. The standards are 
a mixture of biotinylated proteins with consistent molecular weights, allowing for 
accurate molecular weight determination of immune detected proteins. 40µl of the 
samples (10µl of standards) were then loaded into the wells, and the apparatus 
was run at a constant voltage of 200V for 45 minutes, or until the blue dye ran off 
the bottom of the gel.  
 
2.7.2 Western Blot 
 
Western blotting is a technique used to transfer the proteins that have been 
separated by SDS-PAGE onto a nitrocellulose membrane, and then probe them 
with antibodies for further analysis. Using the electroblotting method, a sandwich 
of the gel (with the stacking gel trimmed off) and the nitrocellulose membrane 
was compressed in a cassette between two layers of blotting paper and pads pre-
soaked in transfer buffer. The gel holder cassette was then placed into a tank 
transfer system together with an ice block, and the tank filled with transfer buffer. 
A constant current of 210mA was applied for 60 minutes, electrophoretically 
transferring the proteins from the gel to the membrane. The principle of western 
blotting can be seen in Figure 2.5.  
 
2.7.2.1 Blocking and Primary Antibody Incubation  
 
After the transfer was complete, the membrane was washed in 0.1% PBS-Tween. 
All washes and incubations were performed at RT on a rocking table, to ensure 
the membrane was fully covered, and the membrane was never left out to dry. At 
this stage, Ponceau S. dye could be added (for 5-15 minutes) to check if the 
transfer worked. Ponceau S. is a red stain that rapidly detects protein bands on 
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membranes, and is easily reversed by multiple washes with 0.1% PBS-Tween. 
The membrane was then blocked for 60 minutes using 5% blocking reagent, and 
washed twice for 15 minutes with 0.1% PBS-Tween. The blocking reagent blocks 
any remaining hydrophobic binding sites, preventing the binding of the primary 
antibody to the membrane itself and thereby reducing background signal. The 
membrane was incubated for 60 minutes with a 1:1000 dilution of the primary 
antibody (either Phospho-IκBα (Ser32) (14D4) Rabbit mAb or IRF-3 (FL-425) 
Rabbit polyclonal IgG). After use, the primary antibody can be stored at -20
o
C 
and reused.   
 
2.7.2.2 Secondary Antibody Incubation  
 
Two washes of 15 minutes with 0.1% PBS-Tween were then performed to remove 
excess primary antibody, before the secondary antibody was added. The 
membrane can be cut at this stage, to separate the standards from the samples. A 
1:2000 dilution of polyclonal Swine anti-Rabbit Ig horseradish peroxidase (HRP) 
was added to the samples, whilst a 1:2000 dilution of streptavidin-HRP conjugate 
was added to the standards, and left to incubate for 45 – 60 minutes. The 
membrane was then washed with 0.1% PBS-Tween for 2 hours, changing the 
solution every 15 minutes, to ensure all excess antibody had been removed before 
visualising the bands using enhanced chemiluminescence.  
 
2.7.3 Enhanced Chemiluminescence  
 
The emission of light as a result of the dissipation of energy from a substance in 
an excited state, caused by a chemical reaction, is termed chemiluminescence. 
Enhanced chemiluminescence (ECL) involves the use of enhancers (such as 
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phenols) to increase the light output and extend the light emission duration. The 
principle of ECL western blotting can be seen in Figure 2.6.  
 
Detection of the bands was performed in a dark room, to avoid exposing the 
autoradiography film to light. Excess 0.1% PBS-Tween was drained from the 
membrane before placing it, protein side up, on a sheet of cling film in an X-ray 
cassette. An equal volume of ECL Reagent (Amersham) was mixed together (1ml 
of each per membrane), added to the membrane, and incubated for 1 minute. 
Excess reagent was dabbed off, the membrane was turned over (protein side 
down), and sealed like an envelope in the cling film, smoothing out any air 
bubbles. The wrapped film was then placed protein side up. A sheet of 
autoradiography film was placed on top of the membrane, the cassette was closed, 
and exposed for 2 minutes. The film was then developed immediately, and 
depending on the intensity and clarity of the bands seen, a new sheet of film could 
be exposed for a differing length of time.  
 
2.7.4 Stripping and Reprobing Membranes  
 
A membrane may be stripped of its bound primary and secondary antibodies, 
allowing it to be reprobed with different antibodies. To strip a membrane, 
stripping buffer was added (enough to cover the membrane), and incubated for 4 
minutes at 37
o
C in a shaker incubator. After washing at RT with 0.1% PBS-
Tween 3 times for 10 minutes each, the membrane was blocked for 60 minutes 
using 5% blocking reagent, and washed twice for 15 minutes with 0.1% PBS-
Tween. A different primary antibody can then be added, following the procedure 
above.  
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Figure 2.5: Principle of western blotting. The proteins are electrophoretically 
transferred from the SDS-PAGE gel onto the nitrocellulose membrane. The 
membrane is blocked, and primary and secondary antibodies are added, followed 
by the substrate, after which the proteins can be visualised using enhanced 
chemiluminescence [Komabiotech, URL].  
 
 
Figure 2.6: Principle of ECL western blotting. HRP catalyses the oxidation of 
luminal to its excited state, and it subsequently decays back to the ground state 
via a light emitting pathway [GE Healthcare Life Sciences, URL].  
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2.8 Immunoprecipitation  
 
Immunoprecipitation is a technique used to precipitate a protein out of a lysate 
using an antibody specific for that protein coupled with beads specific for the 
antibody. The technique can be used to isolate and concentrate a particular protein, 
as well as determine if dimerisation between two proteins has occurred. In this 
project, RIG-I, MDA5, or LGP2 antibodies were used to precipitate out their 
respective protein, and SDS-PAGE was then used to detect a different protein, i.e. 
precipitate out MDA5 and perform SDS-PAGE to detect LGP2. If bands appear, 
this concludes that MDA5 and LGP2 form dimers together.  
 
In TC, 1.5ml of cardiac cells were stimulated with 200µl CBV5 for 1, 2, 4, and 6 
hour time points, or left unstimulated (0 hour). 2 flasks were used per time point. 
At each time point, the medium (plus CBV5) was aspirated off, and the cells 
washed with 2ml PBS. 1ml lysis buffer was added, and the flasks were placed on 
a rocking table for over 2 hours, and vortexed every 30 minutes. The lysis buffer 
was then transferred to Eppendorfs and centrifuged at 13,000 rpm for 20 minutes 
at RT. The supernatant was transferred to new Eppendorfs, and 25µl resuspended 
Protein A Sepharose (PAS) beads 10%(w/v) was added. The Eppendorfs were then 
incubated on ice for over 1 hour, with each Eppendorf being flicked every 5-10 
minutes to resuspend the PAS beads.  
 
2.8.1 Pre-Clearing  
 
The PAS beads were added at this stage to pre-clear the lysate, before the 
antibody was added, to prevent non-specific binding of the antibody to unwanted 
proteins. After incubation on ice, the Eppendorfs were centrifuged at 13,000 rpm 
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for 5 minutes at RT. The pellet (pre-clear 1 = P1) was kept and stored in the fridge, 
and the supernatant was transferred to new Eppendorfs. 25µl PAS was then added 
to the supernatant, and again incubated on ice for over 1 hour, with each 
Eppendorf being flicked every 5-10 minutes. The Eppendorfs were then 
centrifuged at 13,000 rpm for 5 minutes at RT, the pellet (P2) kept and stored in 
the fridge, and the supernatant transferred to new Eppendorfs.  
 
2.8.2 Primary Antibody Incubation and Washing  
 
6µl of MDA5 (C-16) Goat pAb, RIG-I (C-15) Goat pAb, or LGP2 (DHX58) Goat 
pAb was added, and the Eppendorfs were incubated on ice for over 1 hour, with 
each Eppendorf being flicked every 5-10 minutes. 30µl PAS beads (or more if 
required) were added, and again the Eppendorfs were incubated on ice for over 1 
hour and flicked every 5-10 minutes. PAS beads have a high affinity for the Fc 
region of antibodies, so once the antibodies have bound their specific protein, they 
in turn bind to PAS. The Eppendorfs were then centrifuged at 13,000 rpm for 5 
minutes at RT, the pellet (sample = S) was kept, and the supernatant was 
transferred to new Eppendorfs (to allow a different antibody to be added).  
 
The pellets (P1, P2, and S) were then washed: 500µl lysis buffer was added to 
each Eppendorf, followed by being vortexed for 1 minute, centrifuged at 13,000 
rpm for 2 minutes at RT, and having their supernatant aspirated off. This was 
repeated four times. After the final centrifugation, 500µl lysis buffer was added to 
one Eppendorf, mixed, and the whole contents transferred to its duplicate 
Eppendorf (as there were 2 flasks per time point, resulting in 2 Eppendorfs per 
time point). An extra 100µl lysis buffer was added to the first Eppendorf, to 
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retrieve the last few beads of the pellet, and transferred to the duplicate Eppendorf. 
This results in one Eppendorf with all the contents from the 2 original flasks. The 
pellet was then dried using a rolled up piece of blue roll.  
 
2.8.3 SDS-PAGE  
 
The final stage involves running an SDS-PAGE and probing with a different 
antibody to the one bound to the beads, to determine if dimerisation has occurred. 
The method for the SDS-PAGE and western blot is described above, with the 
following exceptions. 50µl X2 SDS-PAGE Non-Reducing Sample Buffer was 
added to each Eppendorf, and incubated for 15 minutes at RT (rather than boiled). 
After incubation, the Eppendorfs were centrifuged at 13,000 rpm for 1 minute at 
RT before loading onto the gel. As a control, X2 SDS-PAGE Reducing Sample 
Buffer was added to samples, followed by boiling for 10 minutes. The procedure 
then continues exactly as described in section 2.7, using MDA5 (H-61) Rabbit 
pAb, RIG-I (H-300) Rabbit pAb, or LGP2 (H-159) Rabbit pAb as the primary 
antibody.  
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2.9 Confocal Microscopy  
 
Confocal microscopy is a technique used to visualise the interaction and location 
of different proteins within cells. A confocal microscope can create sharp images 
of specimens by using a spatial pinhole that excludes out-of-focus light in 
specimens which are thicker than the focal plane. This increases the micrograph 
contrast and enables reconstruction of three-dimensional images. A confocal 
microscope works by scanning one or more focused beams of light, usually from a 
laser or arc-discharge source, across the specimen to create illumination. The 
principle light pathways in confocal microscopy can be seen in Figure 2.7.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.7: Principle light pathways in confocal microscopy. The point of 
illumination is brought to focus by the objective lens, and laterally scanned using 
a scanning device under computer control. This is detected by a photomultiplier 
detector through a detector pinhole, and the output from the photomultiplier 
detector is built into an image and displayed by the computer [Nikon 
MicroscopyU, URL].  
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2.9.1 Slide Preparation  
 
In this project, cardiac cells were stimulated with CBV5 and the colocalisation of 
RIG-I or MDA5 with IPS-1 was investigated. Lab-Tek 8-well chamber slides 
were used, and 2.5 slides were used per stimulation. Five time points were used 
per stimulation: 0 hour (unstimulated), 1 hour, 2 hours, 4 hours, and 6 hours. Two 
wells were used per time point. The slides were divided up as shown in Figure 2.8.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.8: Layout of Lab-Tek 8-well chamber slides stimulated with CBV5 at 
different time points. Cells were grown to confluency and stimulated. After fixing, 
the cells were incubated with the primary antibody, washed, and incubated with 
the corresponding secondary antibody: Donkey Anti-Goat TRITC (red) for RIG-I 
and MDA5, and Swine Anti-Rabbit FITC (green) for IPS-1. TOPRO was used as a 
nuclear stain.  
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Count all cells 
within the five 
areas  
To prepare the slides, 300µl DMEM was added to each well. One flask of cells 
was trypsonised, 10,000 cells were added to each well, and the slides were 
incubated overnight, making sure that they did not reach 100% confluency before 
carrying on with the stimulations. To determine the Xµl of cells, the cells were 
counted using a haemocytometer, as explained in Figure 2.9.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.9: Layout of a haemocytometer. Divide the number of cells in the five 
areas by 5 to get the average, and multiply by 10
4
 to get cells / ml. The following 
equation was used to work out Xµl of cells: Number of cells counted / 10,000 cells 
= 1000µl of medium / Xµl [modified from WHO, URL].  
 
 
The medium was aspirated from each well, and the slides were stimulated with 
150µl DMEM and 10µl CBV5 and incubated at 37
o
C 5% CO2 for 1, 2, 4, or 6 
hours. All aspirations and additions to the wells were made from the same corner, 
to minimise damage to the cells. At each time point, the cells were fixed with 
300µl 4% PFA for 15 minutes, washed with 300µl PBS, and left in 300µl PBS 
until the whole slide was ready.  
 
Once ready, the 300µl PBS was aspirated off and 150µl PBS / BSA / Saponin / 
NaN3 was added to each well. 4µl primary antibody was added to each well (as 
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detailed in Figure 2.8), and incubated for 1 hour at RT. The primary antibodies 
used were: MDA5 (C-16) Goat pAb; RIG-I (C-15) Goat pAb; and MAVS (H-135) 
Rabbit pAb.  
 
The cells were then washed twice with 300µl PBS / BSA / Saponin / NaN3, and 
150µl PBS / BSA / Saponin / NaN3 was added to each well. 5µl secondary 
antibody (Donkey Anti-Goat TRITC (red) and Swine Anti-Rabbit FITC (green)) 
was added to each well and incubated for 45-60 minutes in the dark at RT. The 
cells were then washed twice with 300µl PBS / BSA / Saponin / NaN3, and 150µl 
PBS / BSA / Saponin / NaN3 was added to each well. 1µl TOPRO (a nuclear stain) 
was added to each well and incubated for 10 minutes. The cells were finally 
washed three times with 300µl PBS / BSA / Saponin / NaN3, and all the liquid 
was removed.  
 
The chambers and gasket were removed from the slide, and a few drops of 
SlowFade Gold Antifade Reagent were added to each well, and left for 10 minutes. 
This reagent suppresses photobleaching and preserves the signal of the 
fluorescently labelled secondary antibody. A coverslip was then placed over the 
wells and any air bubbles were gently pushed out from underneath them. Excess 
SlowFade Gold Antifade Reagent was removed using blue roll, and the coverslips 
were sealed down using a thin layer or two of clear nail varnish. Slides were then 
imaged on an LSM510 confocal microscope under a 63x / 1.4 Oil DIC objective, 
utilising the three fluorescent wavelengths of 488 (Argon – green), 543 (red), and 
633 (blue).  
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2.9.2 Confocal Image Analysis  
 
Once confocal images have been taken, the extent of colocalisation needs to be 
statistically determined. It is no longer sufficient to merely overlay the red and 
green images, and say that where yellow appears is where colocalisation has 
occurred. User bias can play a large role in determining the amount of yellow 
colour present, leading to false positives as a result of increasing the background 
values. An imbalance of red and green pixel ratios can lead to wildly varying 
results. To eliminate user bias and provide a quantitative value of the extent of 
colocalisation, the images are automatically thresholded and the interdependency 
of the red and green channels is measured. A correlation coefficient is used to 
calculate the interdependence of the two variables, which equates to the extent of 
colocalisation that may be occurring.  
 
2.9.2.1 LSM Image Browser and AxioVision LE 
 
LSM Image Browser software [free software available from Zeiss, URL] was 
used to adjust the contrast and brightness of the confocal images taken. This does 
not affect the statistical analysis of the images, as the ImageJ and JACoP software 
(detailed below) automatically thresholds images, removing user bias. When 
images are taken, they are saved as an LSM file, which is essentially an extension 
of the TIFF multiple image stack file format, containing instrument specific 
hardware settings metadata and a thumbnail image. Before they can be analysed 
using ImageJ and JACoP, they need to be converted to TIF files, using 
AxioVision LE [free software available from Zeiss, URL]. The steps involved are 
detailed below:  
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 Open AxioVision LE  
 Click on “Open Image” (Ctrl-I)  
 Select an image (located in the .mdb folder, as an .lsm file)  
 Image will appear in the main window  
 Click “File – Export” (Ctrl-6)  
 Choose “Save In” location, tick “Use color for channel images”, change 
File Type to TIF Tagged Image File, keep “Convert to 8 bit” and “Apply 
display mappings” ticked (can also tick “Burn-in annotations” as well if 
required)  
 Click on “Start”  
 The image will be saved in the location chosen as a TIF File  
 
2.9.2.2 ImageJ and JACoP  
 
Having converted the images to TIF files, they can then be analysed using ImageJ 
and JACoP. ImageJ software [free download from either MacBiophotonics, URL, 
or ImageJ, URL] is an image processing and analysis in Java piece of software 
used to analyse confocal images. JACoP (Just Another Colocalisation Plugin) 
[available from ImageJ Plugins, URL] then needs to be downloaded to the Plugins 
folder of ImageJ [Bolte and Cordelieres, 2006]. The steps performed to run the 
colocalisation analysis are detailed below:  
 
 Open MacBiophotonics ImageJ  
 Drag and drop a .TIF image onto the ImageJ bar, opening the image in 
ImageJ 
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 Click “Image – Color – Split Channels” to get three 8-bit split channels 
(Red, Green, Blue) in grey (the images should already be in 8-bit since 
they were exported from AxioVision; if not, need to convert each of the 
three images to 8-bit by clicking “Image – Type – 8-bit” for each one)  
 Click “Plugins – JACoP”, bringing up the JACoP window and 
automatically selecting the Red and Green image.  
 The images to analyse can be changed using the drop down menu for 
Image A and Image B  
 Under “Analysis to perform”, make sure Pearson’s coefficient, M1 & M2 
coefficients, Costes’ automatic threshold, Cytofluorogram, and Costes’ 
randomization are all checked. Van Steensel’s CCF, Li’s ICA, Objects 
based methods, and Overlap coeff., k1 & k2 are not required  
 Click on the Micro. tab, select Confocal rather than Wide-Field  
 If wanted, in the Costes’ rando tab, can change the Nb of random. rounds, 
depending on computing power (any value between 200-1000)  
 Click on Analyze to run the analysis  
 
Once the analysis has run, several windows pop up. The log is the most important 
window, as it provides all of the statistical data. It details which two images have 
been compared, Pearson’s coefficient, Mander’s Coefficients (original and 
threshold values), Costes’ randomisation based colocalisation, Costes’ automatic 
threshold values, and the Cytofluorogram’s parameters. The most important 
values to note are the r(obs), r(rand), and the p-value. These three values are 
required for each set of images taken, to statistically determine the extent of 
colocalisation between two images (i.e., between RIG-I and IPS-1).  
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2.9.2.3 Pearson’s Correlation Coefficient  
 
Pearson’s correlation coefficient (r(obs), also referred to as Rr) measures the 
covariance between the intensities of each channel in each pixel, and is not 
sensitive to background or colocalised pixel intensity. It has a linear regression 
range of -1 to 1, with -1 being total negative correlation (whereby no pixels 
overlap), 0 being a random correlation, and 1 being total positive correlation 
(where all the pixels overlap). Values of approximately 0.5 and above are 
considered reasonable Pearson’s coefficients. The values obtained can then be 
compared across multiple samples.  
 
2.9.2.4 Mander’s Overlap Coefficient  
 
Mander’s overlap coefficient is calculated from the Pearson’s coefficient. It is 
sensitive to background intensity (therefore images require thresholding), but is 
easier to interpret than Pearson’s coefficient, as it ranges from 0 (total negative 
correlation) to 1 (total positive correlation). Manders’ overlap coefficient is 
strongly influenced by the ratio of red:green pixels (ch1:ch2), so they need to be 
roughly 1:1 to use this method.  
 
2.9.2.5 Mander’s Colocalisation Coefficients  
 
Mander’s colocalisation coefficients (M1 and M2) show the extent that green 
pixels in one channel overlap red pixels in the other channel, and vice versa. Each 
value represents the percentage of the total pixels in each channel that overlap 
with pixels in the other channel. It is sensitive to background intensity, but not to 
overlapping pixel intensities (i.e., bright red – bright green is equivalent to faint 
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red – bright green). Values range from 0 to 1, with 1 representing 100% 
colocalisation.  
 
2.9.2.6 Costes’ Randomisation Method  
 
Costes’ randomisation method calculates the 
statistical significance of the Pearson’s 
correlation coefficient. It returns a significance 
(p-value) expressed as a percentage, which is 
inversely correlated to the probability of getting 
r(obs) by chance. A p-value of 1 indicates that 
there is a >95% certainty that colocalisation exists. 
Costes’ randomisation method is achieved by 
creating a random image (Figure 2.10) for both 
channels by shuffling pixel blocks, and calculating the r(obs) compared to one of 
the original images. This is repeated 200-1000 times (depending on value set) and 
averaged to obtain the r(rand), and this is then compared against the original r(obs) 
to obtain the p-value.  
 
2.9.2.7 Costes’ Threshold  
 
Costes’ Threshold is an algorithm designed to calculate the ‘perfect’ threshold, 
thereby eliminating user bias from the thresholding procedure. The limit values 
for each channel start at the maximum intensity, and are progressively 
decremented. The Pearson’s coefficient is calculated for each decrement until it 
reaches a value of 0, which equates to a random pixel correlation. At this point, 
the threshold has been reached for each image. 
Figure 2.10: Random 
image obtained using 
Costes’ randomisation 
method.  
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2.10 Plasmid DNA  
 
2.10.1 Plasmid DNA Preparation  
 
2.10.1.1 Transformation  
 
All procedures were performed with sterile tips and next to a bunsen burner, to 
ensure sterility. Agar plates containing Zeocin, a selection antibiotic, were first 
prepared, by adding 40µl Zeocin to 100ml agar. psiRNA-RIG-I (Invivogen) or 
psiRNA-MDA5 (Invivogen) plasmids (Figure 2.11) were then transformed into a 
competent Escherichia.coli strain (E.coli GT116). 5µl of the plasmid was added to 
100µl of E.coli GT116 and incubated on ice for 30 minutes. This was followed by 
heat shocking the tubes at 42
o
C for 45 seconds, then placing them back on ice for 
2 minutes. 500µl of Luria Broth (LB) was then added to each tube, and placed on 
a shaker incubator at 225 rpm at 37
o
C for 1 hour. 100µl of the transformed E.coli 
in LB was then added to a Zeocin agar plate, evenly spread until absorbed, and 
placed in an incubator at 37
o
C overnight to grow. The plasmids contain a Zeocin-
resistance gene, so only the E.coli that have taken up the plasmid will survive on 
the Zeocin agar plates.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.11: The psiRNA-h7SK GFPzeo plasmid from the human 7SK RNA 
polymerase III promoter. The plasmids contain the GFP:zeo fusion gene that 
allows for simple monitoring of transfection efficiency and selection in both E. 
coli and mammalian cells [Invivogen, URL].  
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After growing up the E.coli colonies, the transformed E.coli and plasmids were 
expanded. 25µl Zeocin was added to 25ml LB in bottles, and individual colonies 
were added to separate bottles, as well as being added to a reference plate, and 
incubated overnight in a shaker incubator at 225 rpm at 37
o
C.  
 
2.10.1.2 DNA Isolation  
 
The broths were centrifuged at 4000 rpm for 10 minutes, and the supernatant 
discarded. 400µl STET buffer was added, the samples vortexed, and transferred to 
sterile Eppendorfs. 10µl lysozyme (50mg/ml; damages bacterial cell walls) was 
added to each tube, immediately after which the tubes were boiled for 1 minute 
until the lids pop open. The samples were then placed on ice for 5 minutes, then 
centrifuged at 13,000 rpm for 30 minutes. The pellet was removed (by ’stabbing’ 
it with a sterile toothpick), and 5µl of RNAse A (20µg/ml; degrades RNA) was 
added and the samples incubated at 37
o
C - 42
o
C for 30 minutes. 400µl of phenol / 
chloroform / isoamyl alcohol (bottom layer) was then added, the samples vortexed, 
and centrifuged for 15 minutes at 13,000 rpm.  
 
The supernatant was transferred to a fresh sterile Eppendorf, and 400µl of 
chloroform / isoamyl alcohol was added, the samples vortexed, and centrifuged 
again for 15 minutes at 13,000 rpm. The supernatant was again transferred into 
new Eppendorfs. 20µl (1/20
th
) sodium acetate 2M pH 6.5 and 1ml (2.5x vol) of 
95% ethanol were added, mixed, and the Eppendorfs were then frozen at -80
o
C 
for at least 1 hour. Afterwards, the Eppendorfs (straight from the freezer) were 
centrifuged at 13,000 rpm for 20 minutes at RT. The excess supernatant was 
removed, the Eppendorfs were centrifuged at 13,000 rpm for a further minute, and 
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the remaining supernatant was removed. 80µl sterile water (ddH2O), or LAL 
water, was added to each Eppendorf, and the samples frozen at -20
o
C.  
 
2.10.1.3 Agarose Gel Electrophoresis  
 
To check the purity of the plasmid preparations, the samples were run on an 
agarose gel. A 1%w/v agarose gel was prepared (1g agarose in 100ml of 1X ELFO), 
and 10µl of the sample (with 5µl of ELFO Loading Buffer) was run on it at 100V 
for 45 minutes. A 1kb DNA ladder was run alongside the samples. Once run, the 
bands were observed using a Stratagene eagle eye UV imaging system.  
 
2.10.2 Silencing  
 
Silencing is a method used to downregulate or entirely suppress a particular gene 
via the introduction of antisense RNA, such as small interfering RNA (siRNA). 
Once transfected into a cell, siRNA binds to and cleaves specific messenger RNA 
and decreases its activity. In this project, psiRNA-hMDA5 (Invivogen) or 
psiRNA-hRIG-I (Invivogen) plasmids (Figure 2.11) were introduced into cells to 
knockdown (KD) MDA5 or RIG-I activity, respectively. psiRNA-hMDA5 is a 
psiRNA vector expressing short hairpin RNA (shRNA) targeting the human 
MDA5 gene, and psiRNA-hRIG-I is the same but targets the human RIG-I gene. 
This allows the other protein (RIG-I or MDA5) to be studied, to help determine 
which one is the primary detector of CBV5.  
 
The method takes 5 days to perform: the dishes are prepared on day 1; the plasmid 
DNA (containing the siRNA) is transfected into the cells on day 2; the medium is 
replaced with selection medium on day 3; SDS-PAGE and western blotting are 
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used to check the KD on day 4; and if the KD worked, the cells are stimulated and 
a CBA assay is performed on day 5.  
 
2.10.2.1 Day 1 – Cell Preparation  
 
On day 1, the dishes for each transfection were prepared. 9 dishes per transfection 
were required, to meet the following criteria: three time points per stimulation 
with CBV5 (3 dishes); duplicates (6 dishes); 2 dishes for the unstimulated (0 hour) 
time point (8 dishes); and 1 dish for control (9 dishes total). As both a RIG-I and 
MDA5 transfection were being performed, 9 dishes were required for each of 
them. In each dish, 500µl cardiac cells was added to 1.5ml DMEM, to ensure 50-
60% confluency by day 2.  
 
2.10.2.2 Day 2 – Transfection Reagent Preparation  
 
Using sterile Eppendorfs and tips, jetPRIME
TM
 Transfection Reagent was 
prepared on day 2 in the afternoon. For each dish, 1µl plasmid DNA (psiRNA-
hMDA5 or psiRNA-hRIG-I) was added to 100µl jetPRIME
TM
 Buffer and 2µl 
jetPRIME
TM
 Reagent. 1ml medium was removed from each dish, and the 103µl 
jetPRIME
TM
 Transfection Reagent and plasmid DNA was added and incubated at 
37
o
C 5% CO2 overnight.  
 
2.10.2.3 Day 3 – Switch to Selection Medium  
 
The DMEM of each dish was replaced with 2ml Zeocin-DMEM selection 
medium (200ml DMEM / FCS / NA + 200µl Zeocin) on the morning of day 3. 
This ensures that only cells that have taken up the plasmid DNA containing the 
Zeocin resistance gene (and therefore the siRNA) survive.  
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2.10.2.4 Day 4 – Check Knockdown  
 
On day 4, the KD of RIG-I and MDA5 was checked using SDS-PAGE and 
western blotting. If RIG-I siRNA (or MDA5 siRNA) was successfully transfected 
into the cells, it should KD the function of RIG-I (or MDA5), and the expression 
levels of RIG-I (or MDA5) obtained in transfected cells should be lower than the 
expression levels of RIG-I (or MDA5) in untransfected cells.  
 
2.10.2.5 Day 5 – Stimulation of Cells  
 
If the KD worked, then 1ml of cells was stimulated on day 5 with 100µl CBV5 for 
2 hours, 4 hours, or 6 hours, or left unstimulated (0 hour). At each time point, the 
supernatant was transferred to two screwtop Eppendorfs and frozen at -20
o
C. An 
IFN- flex set bead system assay was performed on the stored supernatant.  
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2.11 Cytometric Bead Array  
 
A cytometric bead array (CBA) human soluble protein flex set bead system 
(Becton Dickinson) was used to quantitatively measure IFN-β production in cells. 
The flex set bead system is a bead-based immunoassay capable of measuring 
soluble IFN-β in cell culture supernatant samples. The beads, of known size and 
fluorescence, are coated with a capture antibody specific for IFN-β. The detection 
reagent is a mixture of phycoerythrin (PE)-conjugated secondary antibodies, 
which provides a fluorescent signal in proportion to the amount of bound IFN-β. 
When the beads are incubated with cell supernatant, sandwich complexes (capture 
bead, IFN-β, and PE) are formed, and can be measured using flow cytometry.  
 
2.11.1 Assay Procedure  
 
The standards and detection reagents were prepared according to the BD CBA 
Human Soluble Protein Master Buffer Kit manual. 50µl of the tissue culture 
supernatant prepared previously was added to flow tubes, followed by the addition 
of 50µl of the IFN-β beads, mixed, and incubated for 1 hour at RT. 50µl of the PE 
detection reagent was then added and mixed, followed by a further 2 hour 
incubation at RT in the dark. 1ml of Wash Buffer was added to each tube, 
centrifuged at 200g for 5 minutes, and then the supernatant was carefully 
aspirated off and discarded. The bead pellets were resuspended in 300µl of Wash 
Buffer, and the samples were analysed using flow cytometry, with the data 
acquired being analysed using the FCAP Array software (Becton Dickinson).  
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Chapter 3 
RNA HELICASE INVOLVEMENT IN 
CBV5 INFECTION OF CARDIAC CELLS  
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3.1 Introduction  
 
The RLR family, consisting of the three known family members RIG-I, MDA5, 
and LGP2, are pattern recognition receptors which detect a range of different 
viruses. RIG-I (retinoic acid inducible gene-I) and MDA5 (melanoma 
differentiation-associated gene 5) are homologous cytoplasmic proteins 
containing an N-terminal region with two caspase activation and recruitment 
domains (CARDs), a central SF2 type DExD/H-box RNA helicase domain, and a 
C-terminal repressor domain (RD) [Takeuchi and Akira, 2007]. LGP2 (laboratory 
of genetics and physiology 2) harbours a DExD/H-box RNA helicase domain and 
a C-terminal RD, but lacks any CARDs [Yoneyama et al., 2005].  
 
Once a viral ligand has been detected and bound by RIG-I and MDA5, both signal 
downstream through their CARDs to activate IRF3/7 and NF-κB indirectly, via 
the protein intermediate IPS-1 (IFN-β promoter stimulator 1) [Kawai et al., 2005]. 
After interaction with RIG-I and MDA5, IPS-1 goes on to recruit and activate a 
variety of other proteins, including TRAF2, TRAF3, and TRAF6 [Xu et al., 2005; 
Oganesyan et al., 2006; Saha et al., 2006]. These TRAF proteins then signal 
further downstream to the IκB kinase (IKK) family members, to activate the 
transcription factors IRF3/7 and NF-κB, and initiate an immune response.  
 
RIG-I and MDA5 contribute to antiviral signalling in different ways depending on 
the virus involved [Kato et al., 2006; Loo et al., 2008]. Although a lot of research 
has gone into determining the precise pathogen associated molecular patterns 
(PAMPs) recognised by each RLR, the results are still far from conclusive.  
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RIG-I has been shown to detect a wide variety of different viruses and PAMPs, 
with uncapped 5’-triphosphate RNA (5’-pppRNA) found to be important for RIG-
I activation [Hornung et al., 2006]. Other motifs found to induce RIG-I-mediated 
IFN production include: double-stranded RNA [Yoneyama et al., 2004]; 5’-ppp 
single-stranded RNA [Pichlmair et al., 2006]; uridine and adenosine-rich 3’-
sequences in 5’-ppp ssRNA [Saito et al., 2008; Uzri and Gehrke, 2009]; short 
double-stranded blunt-end 5’-pppRNA [Schlee and Hartmann, 2010]; cleavage 
products produced by the host endonuclease RNase L during viral infection 
[Malathi et al., 2007]; and short dsRNA viral transcripts, less than 1kb in length 
[Kato et al., 2008]. There are also suggestions that negative sense virus genomic 
RNA, generated by viral replication, constitutes the major trigger for RIG-I, 
whilst the other types of RNA mentioned above do not substantially contribute to 
IFN induction [Rehwinkel et al., 2010].  
 
MDA5, on the other hand, has been shown to be critical for Picornaviridae 
detection, due to the VPg region at the 5’ end of the viral genome [Gitlin et al., 
2006; Kato et al., 2006; Pichlmair et al., 2006]. MDA5 has also been shown to be 
essential for Poly I:C-induced IFN production [Kato et al., 2006; Loo et al., 2008]. 
Whilst RIG-I is required for the detection of short dsRNA, MDA5 preferentially 
binds long dsRNA products (greater than 1-2kb in length) [Kato et al., 2008].  
 
Coxsackievirus B5 (CBV5), a member of the Picornaviridae family, belongs to 
the Enterovirus genus and the Human enterovirus B species. One of the most 
serious diseases caused by CBV5 is viral myocarditis, which can lead on to 
dilated cardiomyopathy (DCM). Viral myocarditis is an inflammatory disease of 
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the myocardium characterised by leukocyte infiltrate and necrosis of the myocytes 
[Bohn and Benson, 2002]. Some patients can develop chronic myocarditis, whilst 
myocardial destruction can lead on to DCM. DCM is characterised by dilation and 
impaired contraction of the left or both ventricles of the heart, and is the major 
reason for cardiac transplantation in Europe and the USA [Manolio et al., 1992]. 
Determining the primary detector of CBV5 in cardiac cells is therefore vital in 
developing treatments for CBV5 infection.  
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3.2 Results  
 
3.2.1 MDA5 and RIG-I Expression Levels  
 
Indirect immunofluorescence coupled with flow cytometry was used to 
investigate the expression levels of RIG-I and MDA5 in human cardiac cells in 
response to stimulation with purified CBV5, UV-CBV5 (UV-inactivated CBV5 
has the ability to bind to cellular receptors, but is unable to cause a productive 
infection), purified genomic CBV5 ssRNA, and Poly I:C. The stimuli were 
incubated at 1, 2, 4, and 6 hour time points (0 hour = unstimulated). Once 
stimulated, the cells were harvested, fixed and permeabilised. They were then 
incubated with Goat pAb antibodies against either MDA5 (Figure 3.1) or RIG-I 
(Figure 3.2), followed by incubation with FITC-conjugated secondary antibody.  
 
The expression levels of MDA5 (Figure 3.1) in response to Poly I:C stimulation 
increased, with a maximum increase at 2 hours. Furthermore, after CBV5 
stimulation, there is a marked increase in MDA5 expression after the first two 
hours, which tails off after 4 and 6 hours of infection. The UV-CBV5 stimulation 
showed no response in MDA5 expression levels. Likewise, stimulation with 
ssRNA resulted in no effect in MDA5 expression.  
 
The expression levels of RIG-I in human cardiac cells in response to the four 
different stimulations can be seen in Figure 3.2. The Poly I:C had no effect on the 
expression levels of RIG-I, and neither did the UV-CBV5. Likewise, ssRNA 
stimulation had little effect upon the expression levels of RIG-I. CBV5 
stimulation resulted in an initial strong response by RIG-I after 1 hour, which 
gradually decreased over the remaining hours. 
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Figure 3.1: Expression levels of MDA5 in human cardiac cells. Cardiac cells 
were stimulated with Poly I:C, CBV5 virions, UV-CBV5, or ssRNA, at 1, 2, 4, and 
6 hour time points (0hr = unstimulated), measured by intensity of fluorescence. 
Confluent cells were stimulated, harvested, fixed and permeabilised, followed by 
incubation with MDA5 Goat pAb primary antibody and pAb Rabbit anti-Goat 
FITC secondary antibody. Fluorescence was detected using a FACSCalibur (BD) 
counting 10,000 cells not gated. Isotype controls were performed, with values 
similar to unstimulated samples. Data show means ± SD and are representative of 
three independent experiments.  
 
Figure 3.2: Expression levels of RIG-I in human cardiac cells. Cardiac cells 
were  stimulated with Poly I:C, CBV5 virions, UV-CBV5, or ssRNA, at 1, 2, 4, and 
6 hour time points (0hr = unstimulated), measured by intensity of fluorescence. 
Confluent cells were stimulated, harvested, fixed and permeabilised, followed by 
incubation with RIG-I Goat pAb primary antibody and pAb Rabbit anti-Goat 
FITC secondary antibody. Fluorescence was detected using a FACSCalibur (BD) 
counting 10,000 cells not gated. Isotype controls were performed, with values 
similar to unstimulated samples. Data show means ± SD and are representative of 
three independent experiments. 
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3.2.2 Signalling Detection Upon Infection With CBV5  
 
RIG-I and MDA5, activated by ligand RNA, interact with IPS-1 via CARD-
CARD interactions, which induces the recruitment of downstream signalling 
molecules. This results in IκB being released from the NF-κB complex and 
getting phosphorylated, marking it for ubiquitination and degradation by 
proteosomes. The transcription factors NF-κB and IRF3 transcriptionally 
upregulate type I IFNs to mediate induction of the innate immune response. The 
detection of phospho-IκB therefore corresponds to NF-κB activation.  
 
Human cardiac cells were stimulated with Poly I:C, ssRNA, CBV5 virions, or 
UV-CBV5 at 1, 2, 4, and 6 hour time points, or left unstimulated (0 hour). 
Discontinuous SDS-PAGE combined with western blotting using Phospho-IκB 
mAb or IRF3 mAb was used to detect the presence of phospho-IκB (Figure 3.3) 
or IRF3 (Figure 3.4), respectively. The bands were visualised using enhanced 
chemiluminescence.  
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The blots for phospho-IκB detection in human cardiac cells stimulated with Poly 
I:C, ssRNA, CBV5 virions, or UV-CBV5 can be seen in Figure 3.3. Phospho-IκB 
was detected in the lysate of cardiac cells stimulated with Poly I:C at all time 
points. ssRNA induced a similar response, with a slightly weaker presence of 
phospho-IκB at the 6 hour time point. Interestingly, stimulation with CBV5 
resulted in a delayed phospho-IκB detection occurring from 2 hours onwards, with 
no phospho-IκB presence after 1 hour. Upon stimulation with UV-CBV5, 
phospho-IκB was detected at all time points, with the weakest presence occurring 
at the 6 hour time point.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3: Phospho-IκB detection. Human cardiac cells were stimulated with 
Poly I:C, ssRNA, CBV5 virions, or UV-CBV5 for 1, 2, 4, or 6 hour time points (0 
hr = unstimulated). Discontinuous SDS-PAGE followed by western blotting using 
Phospho-IκB Rabbit mAb  and a Swine Anti-Rabbit Ig HRP was used to detect the 
presence of phospho-IκB. The bands were visualised using the ECL procedure. 
Representative of three independent experiments.  
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As well as NF-κB, IRF3 is another indicator of MDA5 and RIG-I activation. 
Figure 3.4 shows IRF3 detection in human cardiac cells stimulated with Poly I:C, 
ssRNA, CBV5 virions, or UV-CBV5. IRF3 is being detected at all time points in 
response to Poly I:C, ssRNA, and UV-CBV5 stimulation. Again, CBV5 
stimulation results in IRF3 being detected after 2 hours, with no IRF3 present 
after 1 hour.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4: IRF3 detection. Human cardiac cells were stimulated with Poly I:C, 
ssRNA, CBV5 virions, or UV-CBV5 for 1, 2, 4, or 6 hour time points (0 hr = 
unstimulated). Discontinuous SDS-PAGE followed by western blotting using IRF3 
Rabbit pAb and a Swine Anti-Rabbit Ig HRP was used to detect the presence of 
IRF3. The bands were visualised using the ECL procedure. Representative of 
three independent experiments.  
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3.2.3. IFN-β Production  
 
Using a flow cytometric flex set bead system (Becton Dickinson), the IFN-β 
production in human cardiac cells stimulated with CBV5, ssRNA, or Poly I:C was 
measured, and can be seen in Figure 3.5. IFN-β is a type I IFN, which signals 
through the IFN-α/β receptor and the Jak-STAT pathway to drive interferon 
stimulated gene (ISG) expression and an innate immune response (Figure 1.17). 
In response to CBV5 stimulation, compared to the basal unstimulated level, IFN-β 
production is greatly upregulated after 2  hours (over 5 times greater; 300 pg/ml 
vs. 1600 pg/ml) and 4 hours (6 times greater; 300 pg/ml vs. 1800 pg/ml), but 
drops down slightly after 6 hours (only 2.5 times greater; 300 pg/ml vs 800 pg/ml). 
Stimulation with ssRNA and Poly I:C both had a similar, though much less 
pronounced, effect on IFN-β production. In both cases, IFN-β production was 
increased after 2 hours, and slowly drops down after 4 and 6 hours. 
 
Figure 3.5: IFN-β production in human cardiac cells. Confluent cardiac cells 
were stimulated with CBV5, ssRNA, or Poly I:C for 2, 4, or 6 hours, or left 
unstimulated, measured using a flow cytometric flex set bead system (Becton 
Dickinson). Data show means ± SD and are representative of three independent 
experiments.  
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3.2.4 Silencing of RIG-I and MDA5 
 
In order to verify the involvement of RIG-I and MDA5 in CBV5 innate immune 
recognition, RIG-I and MDA5 expression was knocked down using psiRNA-RIG-
I and psiRNA-MDA5. Reduction in expression was confirmed using SDS-PAGE 
and western blotting. The role of CBV5 and its capability of activating an innate 
immune response in RIG-I or MDA5 silenced cardiac cells was investigated.  
 
3.2.4.1: psiRNA Purification 
 
psiRNA-RIG-I and psiRNA-MDA5 were transformed into a competent E.coli 
strain (E.coli GT116), which was expanded and lysed. The plasmids were then 
purified from the lysate, concentrated and sterilised. To check the purity of the 
plasmid preparations, 10µl of the sample was run on a 1%w/v agarose gel at 100V 
for 45 minutes (Figure 3.6). 
 
Agarose gel analysis of the purified plasmid samples revealed plasmids 
illustrating a very high level of purity. 
 
Figure 3.6 Agarose gel of purified 
psiRNA-RIG-I and psiRNA-MDA5. 
The plasmids are approximately 
3000bp. The positions of the 1kb 
DNA ladder fragments are indicated 
on the right. The plasmid sample 
was run on a 1%w/v agarose gel for 
45 minutes at 100V. Bands were 
observed using a Stratagene eagle 
eye UV imaging system. 
Representative of two independent 
experiments. 
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3.2.4.2: RIG-I Silenced and MDA5 Silenced Cardiac Response to CBV5  
 
Cellular expression of RIG-I or MDA5 was reduced by transfecting cardiac cells 
with psiRNA-RIG-I or psiRNA-MDA5. A 70% reduction in MDA5 expression 
and an 80% reduction in RIG-I expression was achieved (Figure 3.7). Controls 
using TLR7 were also performed, to show that psiRNA-MDA5 and psiRNA-RIG-
I are specific and do not affect other genes. No TLR7 expression reduction was 
observed.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7. RIG-I, MDA5, and TLR7 expression after use of psiRNA. Lysates 
from cells transfected before and after with (A) psiRNA-MDA5 or (B) psiRNA-
RIG-I were separated by SDS-PAGE and transferred onto a nitrocellulose 
membrane. The membrane was probed for MDA5, RIG-I, or TLR7 using specific 
primary antibodies followed by the appropriate secondary antibody conjugated to 
HRP and imaged via enhanced chemiluminescence. The gels were analysed via 
densitometry using Quantity One 1-D analysis software from Biorad to calculate 
area and pixel value. Representative of three independent experiments.  
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Silenced cells were stimulated with CBV5 for 2, 4, and 6 hour time points (0 hour 
= unstimulated). The cell supernatant was collected post-stimulation for IFN- 
analysis using the IFN- flex set bead system. The release of IFN- was 
significantly decreased in cardiac cells with reduced RIG-I expression (Figure 
3.8), and even more decreased in cardiac cells with reduced MDA5 expression 
(Figure 3.9).  
 
 
 
 
 
 
 
 
Figure 3.8: IFN- expression in human cardiac cells. IFN- release from 
untransfected cardiac cells (green) and RIG-I silenced cardiac cells (light brown) 
in response to CBV5 stimulation at different time points. The cell supernatant was 
used for IFN- detection using a flow cytometric IFN- flex set bead system 
(Becton Dickinson). Data show means ± SD and are representative of three 
independent experiments.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.9: IFN- expression in human cardiac cells. IFN- release from 
untransfected cardiac cells (green) and MDA5 silenced cardiac cells (light brown) 
in response to CBV5 stimulation at different time points. The cell supernatant was 
used for IFN- detection using a flow cytometric IFN- flex set bead system 
(Becton Dickinson). Data show means ± SD and are representative of three 
independent experiments.  
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3.3 Conclusion  
 
To determine RIG-I and MDA5 involvement in cardiac cells in response to CBV5 
infection, the expression levels of both RLRs were measured, and phospho-IκB 
and IRF3 were detected, along with IFN-β production. Both RIG-I and MDA5 
expression levels increased within the first two hours of CBV5 infection, and 
dropped off slightly after 4 and 6 hours of infection. MDA5 expression was higher 
than RIG-I overall.  
 
The initial strong response by both RLRs, however, shows that both are involved 
in CBV5 sensing. Since the genomic ssRNA by itself failed to upregulate MDA5 
or RIG-I, this suggests that MDA5 and RIG-I sense the replicative intermediate 
dsRNA form that occurs during the viral replication cycle. The presence of 
phospho-IκB and IRF3 being detected in response to stimulation with ssRNA, as 
well as IFN-β production, is perhaps due to ssRNA detection by TLR7 or TLR8, 
both of which could trigger activation and cytokine secretion.  
 
CBV5 infection causes an intense cytokine secretion of IFN-β, similar to that seen 
during CBV3 infection [Wang et al., 2010; Hühn et al., 2010]. In response to 
RIG-I and MDA5 being silenced in cardiac cells and stimulated with purified 
CBV5, there was a decrease in IFN- production in cells with silenced RIG-I, and 
a more significant reduction in IFN- production when MDA5 was silenced. This 
indicates that both RLRs play a role in CBV5 detection; however, MDA5 might 
be more involved in viral sensing.  
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Both RLRs have increasingly been shown to interact with the same virus, 
indicating that they are not solely responsible for the detection of one type of virus. 
For example, both RIG-I and MDA5 appear to respond to reoviruses, WNV, and 
Dengue virus [Fredericksen and Gale, 2006], as well as measles virus [Ikegame et 
al., 2010]. Despite the fact that CBV5 is a picornavirus, RIG-I is still able to 
detect it. The VPg region at the 5’ end of the picornaviral genome is critical for 
MDA5 detection [Gitlin et al., 2006; Kato et al., 2006; Pichlmair et al., 2006], 
whereas RIG-I requires 5’pppRNA [Hornung et al., 2006]. In this case, because 
CBV5 has a VPg 5’ region rather than a 5’pppRNA, perhaps RIG-I is detecting a 
different part of the CBV5 RNA, or is being upregulated in a different manner.  
 
RIG-I has been shown to be degraded in cells infected with a variety of 
picornaviruses [Barral et al., 2009], and MDA5 is cleaved in poliovirus-infected 
cells [Barral et al., 2007], although CBV5 does not appear to have this effect. 
RIG-I also appears to be associated with the cytoskeleton [Mukherjee et al., 2009], 
and many viruses, including poliovirus and CBV3, cause massive reorganisation 
of the cytoskeleton. This alteration of the cytoskeleton could potentially act as a 
RIG-I-mediated sensor of infection [Coyne et al., 2007, Ju et al., 2007].  
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Chapter 4  
DETERMINING THE ROLE OF RIG-I 
AND MDA5 IN CBV5 SENSING USING 
HUH CELLS  
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4.1 Introduction  
 
RLRs were initially thought to recognise the same ligand, dsRNA, but it has since 
become apparent that RIG-I and MDA5 possess distinct virus specificities. It has 
been shown that they each recognise different viruses and different viral RNAs 
[Kato et al., 2006; Loo et al., 2008]. RIG-I recognises single-stranded RNA 
(ssRNA) containing a terminal 5’-triphosphate (ppp) [Pichlmair et al., 2006], as 
well as linear dsRNA no longer than 23 nucleotides in length [Kato et al., 2008]. 
MDA5 recognises long strands of dsRNA, but the mechanism by which this 
occurs is less clear [Kato et al., 2008].  
 
RIG-I recognises negative sense ssRNA viruses, including influenza virus, 
Newcastle disease virus, Sendai virus, and Hepatitis C virus, whilst positive sense 
ssRNA viruses, such as picornaviruses, and more specifically 
encephalomyocarditis virus and Coxsackievirus B3, have been shown to activate 
MDA5 [Kato et al., 2006; Loo et al., 2008; Wang et al., 2010].  
 
In order to determine the involvement of RIG-I in CBV5 recognition, Huh cells 
were used. The Huh (human hepatoma) cell lines are established from a 
hepatocellular carcinoma [Nakabayashi et al., 1982]. They possess a highly useful 
property for studying RIG-I, namely that Huh 7.5.1 cells have an inactivating 
mutation in RIG-I, which leads to a defect in IFN production.  
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4.2 Results  
 
4.2.1. Expression Levels in Huh 7.5 Cells  
 
Huh 7.5 cells were stimulated with Poly I:C, CBV5 virions, UV-CBV5, or ssRNA, 
at 1, 2, 4, and 6 hour time points, or left unstimulated (0 hour). MDA5 expression 
was measured by indirect immunofluorescence (Figure 4.1). In all cases, MDA5 
expression levels in these cells was low. Poly I:C, which is a known MDA5 
agonist, had little effect upon MDA5 expression levels, and neither did CBV5 and 
ssRNA.  
 
Figure 4.1: MDA5 expression in Huh 7.5 cells. Cells were stimulated with Poly 
I:C, CBV5 virions, UV-CBV5, or ssRNA, at 1, 2, 4, and 6 hour time points (0hr = 
unstimulated), measured by intensity of fluorescence. Confluent cells were 
stimulated, harvested, fixed and permeabilised, followed by incubation with 
MDA5 Goat pAb primary antibody and pAb Rabbit anti-Goat FITC secondary 
antibody. Fluorescence was detected using a FACSCalibur (Becton Dickinson) 
counting 5,000 cells not gated. Isotype controls were performed, with values 
similar to unstimulated samples. Data show means ± SD and are representative of 
three independent experiments.  
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The expression levels of RIG-I in response to the same stimulations were also 
tested (Figure 4.2). Poly I:C, UV-CBV5, and ssRNA stimulation had little effect 
on RIG-I expression levels. However, CBV5 induced RIG-I expression at all time 
points, with the greatest response occurring after 2 hour. 
 
 
Figure 4.2: RIG-I expression in Huh 7.5 cells. Expression levels of RIG-I in Huh 
7.5 cells stimulated with Poly I:C, CBV5 virions, UV-CBV5, or ssRNA, at 1, 2, 4, 
and 6 hour time points (0hr = unstimulated), measured by intensity of 
fluorescence. Confluent cells were stimulated, harvested, fixed and permeabilised, 
followed by incubation with RIG-I Goat pAb primary antibody and pAb Rabbit 
anti-Goat FITC secondary antibody. Fluorescence was detected using a 
FACSCalibur (Becton Dickinson) counting 5,000 cells not gated. Isotype controls 
were performed, with values similar to unstimulated samples. Data show means ± 
SD and are representative of three independent experiments.  
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4.2.2 Expression Levels in Huh 7.5.1 Cells  
 
The Huh 7.5.1 cells have a RIG-I mutation that results in its inactivation. They 
were therefore used to investigate the importance of MDA5 and in particular RIG-
I in CBV5 innate immune recognition. The expression levels of MDA5 in Huh 
7.5.1 cells in response to Poly I:C, CBV5 virions, UV-CBV5, or ssRNA 
stimulation at 1, 2, 4, and 6 hour time points were measured by indirect 
immunofluorescence (Figure 4.3). There was a very low MDA5 expression in 
unstimulated cells, and there was no response to Poly I:C, CBV5, UV-CBV5, or 
ssRNA, indicating that the minimal expression of MDA5 was not sufficient to 
detect viral stimuli. 
 
 
Figure 4.3: Expression levels of MDA5 in Huh 7.5.1 cells. Cells were stimulated 
with Poly I:C, CBV5 virions, UV-CBV5, or ssRNA, at 1, 2, 4, and 6 hour time 
points (0hr = unstimulated), measured by intensity of fluorescence. Confluent 
cells were stimulated, harvested, fixed and permeabilised, followed by incubation 
with MDA5 Goat pAb primary antibody and pAb Rabbit anti-Goat FITC 
secondary antibody. Fluorescence was detected using a FACSCalibur (Becton 
Dickinson) counting 5,000 cells not gated. Isotype controls were performed, with 
values similar to unstimulated samples. Data show means ± SD and are 
representative of three independent experiments.  
 
 
 
 
116 
 
The expression levels of RIG-I in Huh 7.5.1 cells was minimal, as expected 
(Figure 4.4). The different stimulations with Poly I:C, CBV5, UV-CBV5 and 
ssRNA had little effect upon RIG-I expression, although there was a very slight 
response to CBV5.  
 
 
Figure 4.4: Expression levels of RIG-I in Huh 7.5.1 cells. Cells stimulated with 
Poly I:C, CBV5 virions, UV-CBV5, or ssRNA, at 1, 2, 4, and 6 hour time points 
(0hr = unstimulated), measured by intensity of fluorescence. Confluent cells were 
stimulated, harvested, fixed and permeabilised, followed by incubation with RIG-I 
Goat pAb primary antibody and pAb Rabbit anti-Goat FITC secondary antibody. 
Fluorescence was detected using a FACSCalibur (Becton Dickinson) counting 
5,000 cells not gated. Isotype controls were performed, with values similar to 
unstimulated samples. Data show means ± SD and are representative of three 
independent experiments.  
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4.2.3 Phospho-IκB and IRF3 Detection in Huh 7.5 Cells  
 
Phospho-IκB detection corresponds with NF-κB activation, which, coupled with 
IRF3 detection, gives an indication of MDA5 and RIG-I activity in response to 
different stimulations. Figure 4.5 shows phospho-IκB detection in Huh 7.5 cells 
stimulated with Poly I:C, ssRNA, CBV5 virions, or UV-CBV5 for 1, 2, 4, or 6 
hour time points. In response to Poly I:C stimulation, phospho-IκB was detected 
after 1 hour, but from 2 hours onwards, very little phospho-IκB could be seen. 
ssRNA and UV-CBV5 both induced a similar response, with phospho-IκB being 
detected at all time points, but least so at 6 hours. CBV5 stimulation resulted in 
phospho-IκB being present at all time points, and most strongly after 6 hours.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5: Phospho-IκB detection in Huh 7.5 cells. Huh 7.5 cells were 
stimulated with Poly I:C, ssRNA, CBV5 virions, or UV-CBV5 for 1, 2, 4, or 6 hour 
time points (0 hr = unstimulated). Discontinuous SDS-PAGE followed by western 
blotting using Phospho-IκB Rabbit mAb and a Swine Anti-Rabbit Ig HRP 
secondary antibody was used to detect the presence of phospho-IκB. The bands 
were visualised using the ECL procedure. Representative of three independent 
experiments.  
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IRF3 detection in Huh 7.5 cells in response to the four stimulations can be seen in 
Figure 4.6. Overall, the extent of IRF3 detection was fairly minor. Similar to 
phospho-IκB detection, Poly I:C stimulation resulted in IRF3 being detected most 
strongly after 1 hour, but dropping off after that. CBV5 stimulation resulted in no 
IRF3 being present after 1 hour, with a gradual, though minimal increase in 
detection after 2, 4, and 6 hours. ssRNA stimulation resulted in minor IRF3 
detection, with the strongest presence occurring at 2 hours. Stimulation with UV-
CBV5 caused IRF3 to be detected over the first 4 hours, but no IRF3 present after 
6 hours.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6: IRF3 detection in Huh 7.5 cells. Huh 7.5 cells were stimulated with 
Poly I:C, ssRNA, CBV5 virions, or UV-CBV5 for 1, 2, 4, or 6 hour time points (0 
hr = unstimulated). Discontinuous SDS-PAGE followed by western blotting using 
IRF3 Rabbit pAb and a Swine Anti-Rabbit Ig HRP secondary antibody was used 
to detect the presence of IRF3. The bands were visualised using the ECL 
procedure. Representative of three independent experiments.  
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4.2.4 Phospho-IκB and IRF3 Detection in Huh 7.5.1 Cells  
 
To determine whether stimulations with CBV5, ssRNA, UV-CBV5 and Poly I:C 
can lead to an NF-κB-driven transcription response, or IRF3 activation, Huh 7.5.1 
cells were subject to stimulation for 1, 2, 4, and 6 hours, and the presence of 
phospho-IκB (Figure 4.7) or IRF3 (Figure 4.8) was investigated.  
 
In Figure 4.7, Poly I:C stimulation induced the greatest response, with phospho-
IκB present at all time points. Similarly, ssRNA stimulation resulted in phospho-
IκB being detected at all time points. Stimulation with CBV5 again resulted in 
phospho-IκB being detected at all time points. Phospho-IκB was detected at low 
levels at 1, 2, and 4 hour time points in response to UV-CBV5 stimulation, and 
very low levels after 6 hours.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7: Phospho-IκB detection in Huh 7.5.1 cells. Huh 7.5.1 cells were 
stimulated with Poly I:C, ssRNA, CBV5 virions, or UV-CBV5 for 1, 2, 4, or 6 hour 
time points (0 hr = unstimulated). Discontinuous SDS-PAGE followed by western 
blotting using Phospho-IκB Rabbit mAb and a Swine Anti-Rabbit Ig HRP 
secondary antibody was used to detect the presence of phospho-IκB. The bands 
were visualised using the ECL procedure. Representative of three independent 
experiments.  
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Figure 4.8 shows IRF3 detection in Huh 7.5.1 cells stimulated with the four 
different stimulations. IRF3 is detected at all time points in response to Poly I:C, 
and ssRNA. There is a minimal detection of IRF3 upon UV-CBV5 stimulation. 
However, stimulation with CBV5 results in IRF3 being detected at the 2 and 4 
hour time points, with no IRF3 present after 1 hour. The amount of IRF3 present 
decreases at the 6 hour time point, but is still detectable.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8: IRF3 detection in Huh 7.5.1 cells. Huh 7.5.1 cells were stimulated 
with Poly I:C, ssRNA, CBV5 virions, or UV-CBV5 for 1, 2, 4, or 6 hour time 
points (0 hr = unstimulated). Discontinuous SDS-PAGE followed by western 
blotting using IRF3 Rabbit pAb and a Swine Anti-Rabbit Ig HRP secondary 
antibody was used to detect the presence of IRF3. The bands were visualised 
using the ECL procedure. Representative of three independent experiments. 
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4.2.5 IFN-β Production 
 
IFN-β production in Huh 7.5 and Huh 7.5.1 cells stimulated with CBV5 was 
measured using a flow cytometric flex set bead system (Becton Dickinson), and 
can be seen in Figure 4.9 and Figure 4.10, respectively. IFN-β production is 
greater in Huh 7.5 cells than in Huh 7.5.1 cells, which is to be expected, as Huh 
7.5.1 cells have an inactivating mutation in RIG-I leading to a defect in IFN 
production. In both cases, the greatest response can be seen after 2 and 4 hours of 
stimulation with CBV5. At the 2 hour time point, Huh 7.5.1 cells have a near 70% 
reduction in IFN-β production compared to Huh 7.5 cells (1022 pg/ml vs. 1721 
pg/ml). After 4 hours, IFN-β production in Huh 7.5 cells is still over 50% greater 
than that seen in Huh 7.5.1 cells (1884 pg/ml compared to 1212 pg/ml). IFN-β 
production in Huh 7.5 cells after 6 hours of stimulation with CBV5 is less than 
half that seen at the 4 hour time point (903 pg/ml compared to 1884 pg/ml), but 
still over 25% greater than IFN-β production seen in Huh 7.5.1 cells (714 pg/ml).  
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Figure 4.9: IFN-β production in Huh 7.5 cells. Confluent cells were stimulated 
with CBV5 for 2, 4, or 6 hours, or left unstimulated. IFN-β was measured in the 
cell supernatant using a flow cytometric flex set bead system (Becton Dickinson). 
Data show means ± SD and are representative of three independent experiments.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.10: IFN-β production in Huh 7.5.1 cells. Confluent cells were 
stimulated with CBV5 for 2, 4, or 6 hours, or left unstimulated. IFN- was 
measured in the cell supernatant using a flow cytometric flex set  bead system 
(Becton Dickinson). Data show means ± SD and are representative of three 
independent experiments.  
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4.3 Conclusion  
 
The IFN-β production in Huh 7.5 cells and Huh 7.5.1 cells are the most significant 
results here. Huh 7.5.1 cells have an inactivating mutation in RIG-I that leads to a 
defect in IFN production. As less IFN-β production is seen in Huh 7.5.1 cells, this 
indicates that RIG-I plays a role in CBV5 detection. If detection was performed 
solely by MDA5, it would be expected that IFN-β production in both Huh 7.5 
cells and Huh 7.5.1 cells would remain the same, as the RIG-I mutation would 
have no effect, due to RIG-I not being involved. Because a decrease in IFN-β 
production is detected, RIG-I plays a role alongside MDA5 in sensing CBV5.  
 
In Huh 7.5 cells and Huh 7.5.1 cells, the expression levels of RIG-I become 
greater than those of MDA5 in response to CBV5 stimulations, again suggesting 
that RIG-I plays an important role in CBV5 sensing.  
 
Huh cells have been used in a variety of experiments to determine the role of 
RIG-I during infection. It has been shown that HSV-1 and adenovirus DNA 
induce IFN-β mRNA production when they are transfected into Huh 7 but not 
Huh 7.5.1 cells [Cheng et al., 2007], that RIG-I and MDA5 synergistically 
mediate an antiviral response to Dengue virus [Nasirudeen et al., 2011], and that 
RIG-I is essential for HCV detection in Huh 7 cells [Sumpter et al., 2005]. A 
meta-analysis of Huh cells has also been performed to reveal factors that influence 
susceptibility to HCV infection [MacPherson et al., 2011]. These all show the 
importance of Huh cells in the research of viruses.  
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Chapter 5  
RLR DIMERISATION  
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5.1 Introduction  
 
The RLR family, consisting of the three known family members RIG-I, MDA5, 
and LGP2, are pattern recognition receptors which detect a range of different 
viruses. RIG-I (retinoic acid inducible gene-I) and MDA5 (melanoma 
differentiation-associated gene 5) are homologous cytoplasmic proteins 
containing an N-terminal region with two caspase activation and recruitment 
domains (CARDs), a central SF2 type DExD/H-box RNA helicase domain, and a 
C-terminal repressor domain (RD) [Takeuchi and Akira, 2007]. LGP2 (laboratory 
of genetics and physiology 2) harbours a DExD/H-box RNA helicase domain and 
a C-terminal RD, but lacks any CARDs [Yoneyama et al., 2005].  
 
Once a viral ligand has been detected and bound by RIG-I and MDA5, both signal 
downstream through their CARDs to activate IRF3/7 and NF-κB indirectly, via 
the protein intermediate IPS-1 (IFN-β promoter stimulator 1) [Kawai et al., 2005]. 
After interaction with RIG-I and MDA5, IPS-1 goes on to recruit and activate a 
variety of other proteins, including TRAF2, TRAF3, and TRAF6 [Xu et al., 2005; 
Oganesyan et al., 2006; Saha et al., 2006]. These TRAF proteins then signal 
further downstream to the IκB kinase (IKK) family members, to activate the 
transcription factors IRF3/7 and NF-κB, and initiate an immune response.  
 
RIG-I, MDA5, and LGP2 have been proposed to homo- and heterodimerise upon 
viral ligand detection. This process involves the C-terminal RD, which is 
important for controlling RLR-mediated IFN responses. RIG-I has two states; an 
inactive (closed) one and an active (open) one. In the inactive state, the CARDs 
and the helicase domain are repressed by RD. Once a viral ligand binds to the RD, 
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a conformational change occurs, converting RIG-I to the active state. This results 
in the dimerisation of RIG-I and the initiation of downstream signalling via the 
CARDs. Without the RD, RIG-I constitutively activates downstream signalling, 
whilst overexpression of the RD inhibits the antiviral response [Cui et al., 2008]. 
The proposed model for 5’-triphosphate single-stranded RNA activation of RIG-I 
by ligand-induced dimer formation of RD can be seen in Figure 1.15.  
 
Dimerisation of the RLRs is essential for them to function correctly. LGP2 has 
been suggested as a negative regulator of the RIG-I- and MDA5-mediated 
antiviral response, as its overexpression inhibits virus-induced IRF3 and NF-κB 
activation [Rothenfusser et al., 2005; Saito et al., 2007; Komuro and Horvath, 
2006]. LGP2 has been proven to be a regulator for RIG-I- and MDA5-dependent 
signalling via its RD. Although it was previously thought that LGP2 inhibits 
dimerisation of RIG-I and its interaction with IPS-1, it has now been shown that 
LGP2 augments MDA5-dependent signalling [Pippig, et al., 2009].  
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5.2 Results  
 
To test whether RIG-I, MDA5, and LGP2 homo- or heterodimerise together, 
immunoprecipitation experiments were performed. Immunoprecipitation is a 
technique used to precipitate a protein out of a lysate using an antibody specific 
for that protein coupled with beads specific for the antibody. The technique can be 
used to isolate and concentrate a particular protein, as well as determine if 
dimerisation between two proteins has occurred. In this project, RIG-I, MDA5, or 
LGP2 antibodies were used to precipitate out their respective protein, and SDS-
PAGE was then used to detect a different protein, i.e. precipitate out MDA5 and 
perform SDS-PAGE to detect LGP2.  
 
Cardiac cells were stimulated with CBV5 for 1, 2, 4, and 6 hours, or left 
unstimulated (0 hour). At each time point, the cells were washed, lysis buffer was 
added for over 2 hours, followed by centrifugation and transferral of the 
supernatant to new Eppendorfs. The cell lysate was then pre-cleared twice in 
Protein A Sepharose (PAS) beads, to prevent non-specific binding of the antibody 
to unwanted proteins, followed by incubation with primary antibody and more 
PAS beads. PAS beads have a high affinity for the Fc region of antibodies, so 
once the antibodies have bound their specific protein, they in turn bind to PAS. 
After washing the resulting pellet in lysis buffer, the samples were analysed using 
SDS-PAGE and western blotting, using X2 SDS-PAGE Non-Reducing Sample 
Buffer.  
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5.2.1 MDA5 Homodimerisation  
 
Cardiac cells were stimulated with CBV5 for 1, 2, 4, or 6 hours, or left 
unstimulated, and an MDA5 Goat pAb was used to precipitate MDA5 out of the 
cell lysate. The western blot results after incubating with MDA5 Rabbit pAb and 
detecting using polyclonal Swine anti-Rabbit Ig HRP are shown in Figure 5.1. 
The MDA5 immunoprecipitation indicates that MDA5 is present as a dimer at all 
time points after stimulation with CBV5, signified by the thick bands at 
approximately 200 kDa. The amount of MDA5 present decreases slightly after 6 
hours, shown by the less intense band. A few MDA5 monomers can also been 
seen at the approximate 110 kDa mark. A boiled control using X2 SDS-PAGE 
Reducing Sample Buffer was performed to illustrate that reducing conditions 
disrupt protein structure.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1: Homodimerisation of MDA5. MDA5 homodimers and MDA5 
monomers can be seen at all time points. Cardiac cells were stimulated with 
CBV5 for 1, 2, 4, or 6 hours, or left unstimulated, and the cell lysate was pre-
cleared twice with PAS beads. Incubation with MDA5 Goat pAb and PAS beads 
followed, to precipitate MDA5 out of the lysate. The resulting pellets were washed 
in lysis buffer and analysed using SDS-PAGE (using X2 SDS-PAGE Non-
Reducing Sample Buffer) and western blotting with MDA5 Rabbit pAb primary 
antibody followed by polyclonal Swine anti-Rabbit Ig HRP. A boiled control using 
X2 SDS-PAGE Reducing Sample Buffer was also performed. Enhanced 
chemiluminescence was used to visualise the protein bands. kDa: kiloDalton. 
Representative of three independent experiments. 
MDA5 Dimers  ~200kDa 
MDA5 Monomers ~110kDa 
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5.2.2 RIG-I Homodimerisation 
 
Cardiac cells were stimulated with CBV5 for 1, 2, 4, or 6 hours, or left 
unstimulated, and a RIG-I Goat pAb was used to precipitate RIG-I out of the cell 
lysate. The western blot results after incubating with RIG-I Rabbit pAb and 
detecting using polyclonal Swine anti-Rabbit Ig HRP are shown in Figure 5.2. 
Similar to that seen by MDA5 in Figure 5.1, homodimerisation of RIG-I appears 
to occur at all time points after stimulation with CBV5. RIG-I even appears to be 
a dimer in unstimulated cells, which is not consistent with a study performed by 
Cui et al., 2008. A few RIG-I monomers can also be seen. A boiled control using 
X2 SDS-PAGE Reducing Sample Buffer was performed to illustrate that reducing 
conditions disrupt protein structure.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2: Homodimerisation of RIG-I. RIG-I dimers and a few RIG-I 
monomers can be seen at all time points. Cardiac cells were stimulated with 
CBV5 for 1, 2, 4, or 6 hours, or left unstimulated, and the cell lysate was pre-
cleared twice with PAS beads. Incubation with RIG-I Goat pAb and PAS beads 
followed, to precipitate RIG-I out of the lysate. The resulting pellets were washed 
in lysis buffer and analysed using SDS-PAGE (using X2 SDS-PAGE Non-
Reducing Sample Buffer) and western blotting with RIG-I Rabbit pAb primary 
antibody followed by polyclonal Swine anti-Rabbit Ig HRP. A boiled control using 
X2 SDS-PAGE Reducing Sample Buffer was also performed. Enhanced 
chemiluminescence was used to visualise the protein bands. kDa: kiloDalton. 
Representative of three independent experiments. 
RIG-I Dimers  ~200kDa 
RIG-I Monomers  ~110kDa 
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5.2.3 LGP2 Monomers 
 
Cardiac cells were stimulated with CBV5 for 1, 2, 4, or 6 hours, or left 
unstimulated, and a LGP2 Goat pAb was used to precipitate LGP2 out of the cell 
lysate. The western blot results after incubating with LGP2 Rabbit pAb and 
detecting using polyclonal Swine anti-Rabbit Ig HRP can be seen in Figure 5.3. 
At each time point, monomers of LGP2 are detected, indicated by the thick band 
located around the 60 kDa mark. A boiled control using X2 SDS-PAGE Reducing 
Sample Buffer was performed to illustrate that reducing conditions disrupt protein 
structure.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3: Monomers of LGP2. LGP2 monomers can be seen at all time points. 
Cardiac cells were stimulated with CBV5 for 1, 2, 4, or 6 hours, or left 
unstimulated, and the cell lysate was pre-cleared twice with PAS beads. 
Incubation with LGP2 Goat pAb and PAS beads followed, to precipitate LGP2 
out of the lysate. The resulting pellets were washed in lysis buffer and analysed 
using SDS-PAGE (using X2 SDS-PAGE Non-Reducing Sample Buffer) and 
western blotting with LGP2 Rabbit pAb primary antibody followed by polyclonal 
Swine anti-Rabbit Ig HRP. A boiled control using X2 SDS-PAGE Reducing 
Sample Buffer was also performed. Enhanced chemiluminescence was used to 
visualise the protein bands. kDa: kiloDalton. Representative of three independent 
experiments. 
 
LGP2 Monomers  ~60kDa 
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5.2.4 MDA5 – LGP2  
 
MDA5 Goat pAb was used to precipitate MDA5 out of the cell lysate, then 
western blotting was performed using a LGP2 Rabbit pAb followed by a 
polyclonal Swine anti-Rabbit Ig HRP (Figure 5.4). Very faint bands can be seen, 
possibly suggesting the presence of a small amount of LGP2. From this blot, it 
appears that LGP2 does not dimerise with MDA5 upon CBV5 stimulation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4: Association between MDA5 and LGP2. Minor MDA5-LGP2 
dimerisation occurs, and a few LGP2 monomers can be seen. Cardiac cells were 
stimulated with CBV5 for 1, 2, 4, or 6 hours, or left unstimulated, and the cell 
lysate was pre-cleared twice with PAS beads. Incubation with MDA5 Goat pAb 
and PAS beads followed, to precipitate MDA5 out of the lysate. The resulting 
pellets were washed in lysis buffer and analysed using SDS-PAGE (using X2 SDS-
PAGE Non-Reducing Sample Buffer) and western blotting with LGP2 Rabbit pAb 
primary antibody followed by polyclonal Swine anti-Rabbit Ig HRP. Enhanced 
chemiluminescence was used to visualise the protein bands. kDa: kiloDalton. 
Representative of three independent experiments. 
 
 
MDA5-LGP2 Dimers  ~170kDa 
LGP2 Monomers  ~60kDa 
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5.2.5 LGP2 – MDA5  
 
The association between LGP2 and MDA5 can be seen in Figure 5.5. LGP2 Goat 
pAb was used to precipitate LGP2 out of the cell lysate, then western blotting was 
performed using a MDA5 Rabbit pAb followed by a polyclonal Swine anti-Rabbit 
Ig HRP. Heterodimerisation between LGP2 and MDA5 appears to occur at all 
time points, indicated by the bands appearing near the 170 kDa mark. The bands 
around the 110 kDa mark imply that MDA5 monomers are also present. It seems 
that only a percentage of LGP2 is required to associate with MDA5, as MDA5 
appears much more prevalently as a monomer. Treatment with SDS could have 
disrupted the bond between LGP2 and MDA5, thereby allowing the detection of 
MDA5 monomers.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.5: Association between LGP2 and MDA5. MDA5 monomers can be 
seen at all time points, as can LGP2 – MDA5 heterodimers. Cardiac cells were 
stimulated with CBV5 for 1, 2, 4, or 6 hours, or left unstimulated, and the cell 
lysate was pre-cleared twice with PAS beads. Incubation with LGP2 Goat pAb 
and PAS beads followed, to precipitate LGP2 out of the lysate. The resulting 
pellets were washed in lysis buffer and analysed using SDS-PAGE (using X2 SDS-
PAGE Non-Reducing Sample Buffer) and western blotting with MDA5 Rabbit pAb 
primary antibody followed by polyclonal Swine anti-Rabbit Ig HRP. Enhanced 
chemiluminescence was used to visualise the protein bands. kDa: kiloDalton. 
Representative of three independent experiments. 
 
 
LGP2 – MDA5 Dimers ~170kDa 
MDA5 Monomers ~110kDa 
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5.2.6 RIG-I – LGP2  
 
RIG-I Goat pAb was used to precipitate RIG-I out of the cell lysate, then western 
blotting was performed using a LGP2 Rabbit pAb followed by a polyclonal Swine 
anti-Rabbit Ig HRP to determine the presence of LGP2 (Figure 5.6). Bands were 
located around the 60 kDa mark, suggesting that monomers of LGP2 were present, 
and thereby verifying that LGP2 does not heterodimerise with RIG-I. The SDS 
treatment could have broken the bond between RIG-I and LGP2, resulting in only 
LGP2 monomers being seen.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.6: Association between RIG-I and LGP2. LGP2 monomers can be seen 
at all time points. Cardiac cells were stimulated with CBV5 for 1, 2, 4, or 6 hours, 
or left unstimulated, and the cell lysate was pre-cleared twice with PAS beads. 
Incubation with RIG-I Goat pAb and PAS beads followed, to precipitate RIG-I out 
of the lysate. The resulting pellets were washed in lysis buffer and analysed using 
SDS-PAGE (using X2 SDS-PAGE Non-Reducing Sample Buffer) and western 
blotting with LGP2 Rabbit pAb primary antibody followed by polyclonal Swine 
anti-Rabbit Ig HRP. Enhanced chemiluminescence was used to visualise the 
protein bands. kDa: kiloDalton. Representative of three independent experiments. 
 
 
LGP2 Monomers  ~60kDa 
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5.2.7 LGP2 – RIG-I  
 
The association between LGP2 and RIG-I can be seen in Figure 5.7. LGP2 Goat 
pAb was used to precipitate LGP2 out of the cell lysate, then western blotting was 
performed using a RIG-I Rabbit pAb followed by a polyclonal Swine anti-Rabbit 
Ig HRP. Similar to Figure 5.5, heterodimerisation between LGP2 and RIG-I can 
be seen at all time points, indicated by the top bands near the 170 kDa mark. 
Monomers of RIG-I can also be seen, as indicated by the bands around the 110 
kDa mark, which could be caused by the treatment with SDS, disrupting the 
LGP2 – RIG-I dimers.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.7: Association between LGP2 and RIG-I. RIG-I monomers can be seen 
at all time points, as can LGP2 – RIG-I heterodimers. Cardiac cells were 
stimulated with CBV5 for 1, 2, 4, or 6 hours, or left unstimulated, and the cell 
lysate was pre-cleared twice with PAS beads. Incubation with LGP2 Goat pAb 
and PAS beads followed, to precipitate LGP2 out of the lysate. The resulting 
pellets were washed in lysis buffer and analysed using SDS-PAGE (using X2 SDS-
PAGE Non-Reducing Sample Buffer) and western blotting with RIG-I Rabbit pAb 
primary antibody followed by polyclonal Swine anti-Rabbit Ig HRP. Enhanced 
chemiluminescence was used to visualise the protein bands. kDa: kiloDalton. 
Representative of three independent experiments. 
 
 
LGP2 – RIG-I Dimers ~170kDa 
RIG-I Monomers ~110kDa 
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5.3 Conclusion  
 
The function and mechanism of LGP2 in innate immunity is still puzzling. So far, 
it is known that the LGP2 RD can regulate RIG-I- and MDA5-dependent 
signalling. This study aimed to determine whether the RLRs dimerise. It can be 
seen that RIG-I and MDA5 exist primarily as homodimers, but also as monomers, 
in cardiac cells, whilst LGP2 exists as a monomer. RIG-I and MDA5 can also 
heterodimerise with a percentage of LGP2.  
 
The perplexing question is that although heterodimers between LGP2 and RIG-I 
or MDA5 are present in the LGP2 immunoprecipitations, in the MDA5 or RIG-I 
immunoprecipitations, LGP2 presence is only detected as a monomer. These 
results could be due to the higher affinity of the LGP2 RD with the other RLRs, 
enabling it to bind and precipitate RIG-I or MDA5, whereas MDA5 or RIG-I have 
a lower affinity, and may therefore not be able to bind a detectable percentage of 
higher LGP2 aggregates.  
 
Overall, this study concludes that LGP2 and RIG-I or MDA5 associate in cardiac 
cells, and that there is a synergistic mechanism of RLR association for viral 
detection. Whether LGP2 is acting as a positive or negative regulator of RIG-I and 
MDA5 in response to CBV5 infection remains to be determined, although in the 
case of many picornaviruses, including EMCV, as well as other RNA viruses, 
LGP2 acts as a positive regulator of MDA5- and RIG-I-mediated viral recognition 
[Satoh et al., 2010].  
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Chapter 6  
IMAGING OF RLR INTERACTIONS  
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6.1 Introduction  
 
It is important to know the extent of colocalisation between RIG-I and MDA5 
with IPS-1 in response to viral infection, to determine when RIG-I and MDA5 are 
most active. The RLR family, consisting of the three known family members 
RIG-I, MDA5, and LGP2, are pattern recognition receptors that detect a range of 
different viruses. RIG-I (retinoic acid inducible gene-I) and MDA5 (melanoma 
differentiation-associated gene 5) are homologous cytoplasmic proteins 
containing an N-terminal region with two caspase activation and recruitment 
domains (CARDs), a central SF2 type DExD/H-box RNA helicase domain, and a 
C-terminal repressor domain (RD). LGP2 (laboratory of genetics and physiology 
2) harbours a DExD/H-box RNA helicase domain and a C-terminal RD, but lacks 
any CARDs.  
 
Once a viral ligand has been detected and bound by RIG-I and MDA5, both signal 
downstream through their CARDs to activate IRF3/7 and NF-κB indirectly, via 
the protein intermediate IPS-1 (IFN-β promoter stimulator 1). After interaction 
with RIG-I and MDA5, IPS-1 goes on to recruit and activate a variety of other 
proteins, including TRAF2, TRAF3, and TRAF6. These TRAF proteins then 
signal further downstream to the IκB kinase (IKK) family members, to activate 
the transcription factors IRF3/7 and NF-κB, and initiate an immune response. The 
CARD-CARD interaction between RIG-I and MDA5 with IPS-1 is an essential 
step in the antiviral process. If this interaction is disrupted, then the whole 
signalling cascade will fail to initiate.  
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6.2 Results  
 
Confocal microscopy was used to visualise the interaction and colocalisation 
between IPS-1 and MDA5 (Figure 6.1) and between IPS-1 and RIG-I (Figure 6.2) 
in human cardiac cells in response to CBV5 stimulation. The cells were incubated 
with two species of primary antibody: RIG-I and MDA5 were incubated with goat 
pAb; whilst IPS-1 was incubated with rabbit pAb. Using two different species of 
primary antibody allows for the use of different fluorescently-conjugated 
secondary antibodies, each specific for a particular species of primary antibody. 
RIG-I and MDA5 were incubated with Donkey anti-Goat TRITC (red) secondary 
antibody, whilst IPS-1 was incubated with Swine anti-Rabbit FITC (green) 
secondary antibody. This ensures that both MDA5 and RIG-I appear as red under 
the confocal microscope, whilst IPS-1 appears green. The nucleus was stained 
blue using TOPRO.  
 
Once the confocal images were taken, the extent of colocalisation needed to be 
statistically determined. This was achieved using a variety of different software, 
including LSM Image Browser, AxioVision LE, ImageJ, and JACoP. The ImageJ 
and JACoP pieces of software automatically threshold images, removing user bias 
and providing a quantitative value of the extent of colocalisation. The Pearson’s 
correlation coefficient, r(obs), measures the covariance between the intensities of 
each channel in each pixel, and is not sensitive to background or colocalised pixel 
intensity. It has a linear regression range of -1 to 1, with -1 being total negative 
correlation (whereby no pixels overlap), 0 being a random correlation, and 1 being 
total positive correlation (where all the pixels overlap). Values of approximately 
0.5 and above are considered reasonable Pearson’s coefficients.  
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In both cases, the greatest response to CBV5 can be seen within the first 2 hours 
of infection. RIG-I and MDA5 are both present in the cytoplasm only, and not in 
the nucleus, and this is clearly seen in all the images. The same goes for IPS-1, 
which is located on mitochondrial membranes within the cytoplasm.  
 
6.2.1 Colocalisation between IPS-1 and MDA5 
 
Figure 6.1 shows the colocalisation between IPS-1 and MDA5 in cardiac cells in 
response to CBV5 stimulation. In unstimulated cells (panel A), MDA5 and IPS-1 
activity are at a basal level, with a Pearson’s correlation coefficient, r(obs), of 
0.683. This shows that there is minimal colocalisation between IPS-1 and MDA5, 
but even when no viral infection is present, there is some colocalisation going on. 
Panel B depicts cells that have been incubated with CBV5 for 1 hour. There is an 
immediate antiviral response by MDA5, with the r(obs) increasing to 0.91, 
showing massive colocalisation between IPS-1 and MDA5. Such a high r(obs) 
value suggests that nearly all available MDA5 is linked with IPS-1, to ensure a 
rapid antiviral response. This response continues in panel C, in which cells have 
been incubated for 2 hours with CBV5. The r(obs) is 0.912, again showing 
extreme colocalisation between IPS-1 and MDA5.  
 
In cells stimulated with CBV5 for 4 hours (panel D), the colocalisation between 
MDA5 and IPS-1 is slightly decreased, with an r(obs) of 0.802. Although this is 
not as high as the r(obs) found after 1 hour and 2 hour CBV5 stimulations, the 
extent of colocalisation between IPS-1 and MDA5 is still greater than that found 
in cells left unstimulated (r(obs) of 0.802 compared to 0.683). After 6 hours of 
CBV5 stimulation (panel E), the extent of colocalisation increases slightly back 
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up to 0.877, which, although lower than the r(obs) found after 1 hour and 2 hour 
CBV5 stimulations, still shows extensive colocalisation between IPS-1 and 
MDA5.  
 
 
       Nucleus           IPS-1           MDA5           Merged 
r(obs)=0.683 
r(rand)=0.0±0.0030 
P-value=100% 
 
 
 
 
r(obs)=0.91 
r(rand)=0.0±0.0030 
P-value=100% 
 
 
 
 
r(obs)=0.912 
r(rand)=0.0±0.0030 
P-value=100% 
 
 
 
r(obs)=0.802 
r(rand)=0.0±0.0030 
P-value=100% 
 
 
 
 
r(obs)=0.877 
r(rand)=0.0±0.0030 
P-value=100% 
 
 
 
 
 
Figure 6.1: Colocalisation of IPS-1 and MDA5 in cardiac cells in response to 
CBV5 stimulation. Confluent cells were left unstimulated (A), or incubated with 
100µl CBV5 for 1 hour (B), 2 hours (C), 4 hours (D), or 6 hours (E). IPS-1 and 
MDA5 were labelled using indirect immunofluorescence with FITC and TRITC 
conjugated probes, respectively. TOPRO was used to stain the nucleus. The cells 
were imaged using a Carl Zeiss LSM510 confocal microscope. The merged 
images show extensive colocalisation between IPS-1 and MDA5, determined 
using ImageJ software. (Scale bar = 10µm). Representative cell samples shown.  
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6.2.2 Colocalisation between IPS-1 and RIG-I 
 
Figure 6.2 shows the colocalisation between IPS-1 and RIG-I in cardiac cells in 
response to CBV5 stimulation. The extent of colocalisation is very similar to that 
seen between IPS-1 and MDA5 in Figure 6.1. In unstimulated cells (panel A), the 
r(obs) is 0.567, showing a small amount of colocalisation between IPS-1 and RIG-
I. Maybe because RIG-I has been shown to associate with the cytoskeleton, this 
r(obs) is lower than that of MDA5 with IPS-1, although both values still show 
minor colocalisation. In panel B, showing cells stimulated for 1 hour with CBV5, 
the r(obs) is 0.877. RIG-I can be seen to colocalise strongly with IPS-1 to initiate 
an immune response, though the colocalisation is slightly lower than that of 
MDA5 and IPS-1 (r(obs) of 0.91). After 2 hours of stimulation with CBV5 (panel 
C), the colocalisation between IPS-1 and RIG-I increased to 0.918, equalling that 
seen by MDA5 and IPS-1. Both MDA5 and RIG-I are extensively bound to IPS-1 
during this stage of viral infection.  
 
In panel D, the RIG-I antiviral response to CBV5 stimulation after 4 hours 
decreases down to an r(obs) of 0.724. This effect is similar to that seen in the 
MDA5 response, although the MDA5 response appears to be slighter greater 
(r(obs) of 0.802 for MDA5 compared to 0.724 for RIG-I). The colocalisation 
between IPS-1 and RIG-I in response to 4 hour CBV5 infection is still greater 
than that seen in unstimulated cells (panel A). After 6 hours of CBV5 stimulation 
(panel E), the r(obs) increases back up to 0.896, again showing extensive 
colocalisation between IPS-1 and RIG-I. Interestingly, the colocalisation between 
IPS-1 and RIG-I at this stage of infection is slightly greater than that shown 
between IPS-1 and MDA5 (r(obs) of 0.896 versus 0.877), as well as that shown 
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between RIG-I and IPS-1 after 1 hour of CBV5 stimulation (r(obs) again of 0.896 
versus 0.877), suggesting RIG-I potentially plays a greater role later on during the 
infection.  
 
 
       Nucleus           IPS-1            RIG-I           Merged  
r(obs)=0.567 
r(rand)=0.0±0.0030 
P-value=100% 
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P-value=100% 
 
 
 
 
r(obs)=0.918 
r(rand)=0.0±0.0030 
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Figure 6.2: Colocalisation of IPS-1 and RIG-I in cardiac cells in response to 
CBV5 stimulation. Cells were left unstimulated (A), or incubated with 100µl 
CBV5 for 1 hour (B), 2 hours (C), 4 hours (D), or 6 hours (E). IPS-1 and RIG-I 
were labelled using indirect immunofluorescence with FITC and TRITC 
conjugated probes, respectively. TOPRO was used to stain the nucleus. The cells 
were imaged using a Carl Zeiss LSM510 confocal microscope. The merged 
images show extensive colocalisation between IPS-1 and RIG-I, determined using 
ImageJ software. (Scale bar = 10µm). Representative cell sampes shown.  
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6.3 Conclusion  
 
Both MDA5 and RIG-I show extensive colocalisation with IPS-1 in cardiac cells 
in response to CBV5 stimulation, determined using ImageJ software. The ImageJ 
and JACoP pieces of software remove user bias from images and provide a 
quantitative value of the extent of colocalisation. From the values obtained, it can 
be seen that the greatest response occurs within the first two hours of infection, 
drops down slightly in the fourth hour, but picks up again at six hours post-
infection. MDA5 shows marginally greater colocalisation with IPS-1 earlier on 
during CBV5 infection, whilst RIG-I appears to play a greater role later on during 
infection. Overall, both act synergistically with IPS-1 to initiate downstream 
signalling in response to CBV5 infection.  
 
The RLRs have been shown to interact with IPS-1 in response to various other 
viral infections. Influenza A virus infection in human primary macrophages 
results in the translocation of actin and RIG-I / IPS-1 signalling components to the 
mitochondria to initialise the production of type I IFNs and inflammatory 
cytokines [Ohman et al., 2009]. The RSV NS1 protein colocalises with IPS-1 
following infection, blocking RIG-I – IPS-1 signalling [Boyapalle et al., 2012]. In 
response to Rhinovirus infection in primary bronchial epithelial cells, TLR3, RIG-
I, and MDA5 coordinate together to elicit an antiviral response [Slater et al., 
2010].  
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Coxsackievirus B5 (CBV5), belonging to the Enterovirus genus and 
Picornaviridae family, consists of a non-enveloped icosahedral capsid enclosing a 
naked single-stranded, positive sense, polyadenylated RNA genome. CBV5 can 
cause a range of diseases, with the most serious including viral myocarditis 
(which can lead on to dilated cardiomyopathy, DCM), aseptic meningitis, and 
pancreatitis. Viral myocarditis is an inflammatory disease of the myocardium 
characterised by leukocyte infiltrate and necrosis of the myocytes [Bohn and 
Benson, 2002], and results in a high mortality rate in newborns. Myocardial 
destruction can lead on to DCM, characterised by dilation and impaired 
contraction of the left or both ventricles of the heart, and is the major reason for 
cardiac transplantation in Europe and the USA [Manolio et al., 1992].  
 
The immune system, consisting of two main branches of immunity (innate and 
acquired), defends the human body against invading pathogens. Innate immunity 
is the first line of defence against pathogens, and responds rapidly to invading 
microbes. It does this via pattern recognition receptors (PRRs) which can 
distinguish self from non-self, and recognise certain microbial components, 
termed pathogen-associated molecular patterns (PAMPs), to initiate an 
appropriate immune response. Recognition of PAMPs by PRRs leads to the rapid 
activation of latent transcription factors (such as NF-κB and IRF3) to stimulate the 
expression of antimicrobial genes and the production of type I interferons (IFN) 
[Akira and Takeuchi, 2007].  
 
The Toll-like receptors (TLRs) are an important class of PPRs. The 13 currently 
known members within the TLR family recognise a wide range of different 
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PAMPs, and initiate appropriate downstream signalling (via two different 
pathways: the MyD88-dependent pathway; and the MyD88-independent (TRIF-
dependent) pathway) to activate the innate and adaptive immune response. Several 
TLRs are important for the recognition of different viruses, including TLR2, 
TLR3, TLR4, TLR7/8, and TLR9.  
 
Along with the TLRs, several new TLR-independent PRRs have been discovered, 
including the retinoic acid inducible gene-I (RIG-I)-like receptor (RLR) family. 
There are three known members: RIG-I [Yoneyama et al., 2004], melanoma 
differentiation-associated gene 5 (MDA5) [Kang et al., 2002], and laboratory of 
genetics and physiology 2 (LGP2) [Rotherfusser et al., 2005]. The RLRs detect 
cytoplasmic viral RNA during viral replication, and preferentially recognise 
different viruses. RIG-I has been shown to detect a number of both positive and 
negative stranded viruses, as well as several different viral PAMPs, whilst MDA5 
has been shown to be critical for Picornaviridae detection, including CBV3. 
Despite the wealth of research on hunting the RLR ligands, the precise PAMPs 
recognised by each RLR are, as yet, still undetermined.  
 
In this regard, this project aimed to enhance the current knowledge on whether the 
RNA helicase RIG-I or MDA5 is the primary detector of CBV5. To determine 
this, the extent of RIG-I and MDA5 involvement in CBV5 infection of cardiac 
cells was investigated. As one of the leading causes of viral myocarditis is CBV5, 
work was performed upon cardiac cells. To further elucidate the role of RIG-I and 
MDA5 in CBV5 sensing, Huh cells were used, as Huh 7.5.1 cells have an 
inactivating RIG-I mutation that leads to a defect in IFN production. RIG-I has 
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been proposed to dimerise in response to viral ligands, so whether dimerisation 
between RIG-I, MDA5, and LGP2 occurred after CBV5 infection was observed 
using immunoprecipitation experiments. Finally, the interaction and colocalisation 
between RIG-I and MDA5 with IPS-1 (an adaptor protein essential for 
downstream signalling) was examined using confocal microscopy.  
 
Understanding whether RIG-I or MDA5 is the primary detector of CBV5 will 
help in the development of novel therapeutic approaches for not only viral 
myocarditis, but for other diseases caused by CBV5 as well.  
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7.1 RNA Helicase Involvement in CBV5 Infection of Cardiac Cells  
 
To determine RIG-I and MDA5 involvement in human cardiac cells in response to 
CBV5 infection, a number of different experiments were performed. To start off 
with, indirect immunofluorescence coupled with flow cytometry was used to 
investigate the expression levels of RIG-I and MDA5 in human cardiac cells in 
response to stimulation with purified CBV5, UV-CBV5, purified genomic CBV5 
ssRNA, and Poly I:C.  
 
Neither MDA5 nor RIG-I showed any response to stimulation with UV-CBV5, 
which is to be expected. UV-inactivation destroys the viral RNA, whilst leaving 
the capsid intact. This allows CBV5 to maintain its ability to bind to cellular 
receptors, but its viral RNA is unable to cause a productive infection. As both 
MDA5 and RIG-I are located within the cytoplasm, if the viral RNA is inactivated, 
they will not be upregulated. Poly I:C, a synthetic dsRNA analogue, has been 
shown to induce MDA5 expression [Kato et al., 2006; Loo et al., 2008], and 
results here confirm that, with only MDA5 expression levels being upregulated in 
response to Poly I:C stimulation.  
 
Both RIG-I and MDA5 expression levels increased within the first two hours of 
CBV5 infection, and dropped off slightly after 4 and 6 hours of infection. The 
overall response by MDA5 was higher than that of RIG-I, suggesting that MDA5 
is the primary detector of CBV5, but the fact that RIG-I expression levels also 
increased indicates that RIG-I plays a role in CBV5 sensing too. Since the 
genomic ssRNA by itself failed to upregulate either MDA5 or RIG-I, this suggests 
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that these RLRs sense the replicative intermediate dsRNA form that occurs during 
the viral replication cycle.  
 
Following on from showing that both RIG-I and MDA5 expression levels are 
upregulated in response to CBV5 stimulation, discontinuous SDS-PAGE 
combined with western blotting was performed to detect the presence of phospho-
IκB and IRF3. The detection of phospho-IκB corresponds to NF-κB activation, as 
RIG-I and MDA5, once activated by ligand RNA, interact with IPS-1 via CARD-
CARD interactions, inducing the recruitment of downstream signalling molecules. 
This results in IκB being released from the NF-κB complex and getting 
phosphorylated, marking it for ubiquitination and degradation by proteosomes 
[Karin and Ben-Neriah, 2000]. The transcription factors NF-κB and IRF3 
transcriptionally upregulate type I IFNs to mediate induction of the innate 
immune response.  
 
The same four stimulations (Poly I:C, ssRNA, CBV5, and UV-CBV5) and time 
points (0, 1, 2, 4, and 6 hours) were used as before, and both phospho-IκB and 
IRF3 were found to be present in all cases. Interestingly, ssRNA stimulation 
resulted in phospho-IκB and IRF3 being detected, which is perhaps due to ssRNA 
detection by TLR7 or TLR8, both of which could trigger activation [Triantafilou 
et al., 2005a]. The presence of phospho-IκB and IRF3 in response to Poly I:C 
stimulation is likely due to MDA5 being upregulated, and the same is true for 
stimulation with CBV5.  
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Using a flow cytometric flex set bead system (Becton Dickinson), the IFN-β 
production in human cardiac cells stimulated with CBV5, ssRNA, or Poly I:C was 
measured. IFN-β is a type I IFN, which, once upregulated by IRF3 and NF-κB, 
signals through the IFN-α/β receptor and the Jak-STAT pathway to drive 
interferon stimulated gene (ISG) expression and an innate immune response [Lei 
et al., 2009; Yoneyama and Fujita, 2009]. IFN-β was upregulated in response to 
all three stimulations, though most greatly by CBV5, and the greatest response 
occurred after 2 and 4 hours of stimulation, and dropped down after 6 hours. This 
result shows that CBV5 infection causes an intense cytokine secretion of IFN-β, 
similar to that seen during CBV3 infection [Wang et al., 2009; Hühn et al., 2010]. 
Even though MDA5 and RIG-I expression levels are not upregulated in response 
to ssRNA, IFN-β production occurs, again suggesting that TLR7 or TLR8 are 
detecting the purified genomic CBV5 ssRNA and initiating cytokine secretion.  
 
Finally, in order to verify the involvement of RIG-I and MDA5 in CBV5 innate 
immune recognition in human cardiac cells, RIG-I and MDA5 expression was 
knocked down using psiRNA-RIG-I and psiRNA-MDA5 plasmids, and IFN-β 
production was measured. In response to RIG-I and MDA5 being silenced in 
cardiac cells and stimulated with purified CBV5, there was a decrease in IFN-β 
production in cells with silenced RIG-I, and a more significant reduction in IFN-β 
production when MDA5 was silenced.  
 
Overall, in human cardiac cells, both RLRs play a role in CBV5 detection. 
However, MDA5 appears to be more involved in viral sensing than RIG-I.  
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7.2 Determining the Role of RIG-I and MDA5 in CBV5 Sensing Using Huh 
Cells  
 
In order to more fully determine the involvement of RIG-I in CBV5 recognition, 
Huh cells were used. Established from a hepatocellular carcinoma, the Huh cell 
line possesses a highly useful property for studying RIG-I, specifically that Huh 
7.5.1 cells have an inactivating mutation in RIG-I, which leads to a defect in IFN 
production. The same set of experiments that were performed on the cardiac cells 
were performed on Huh 7.5 (wild type) cells and Huh 7.5.1 cells, namely: 
determining the expression levels of MDA5 and RIG-I; detecting phospho-IκB 
and IRF3; and determining IFN β production.  
 
The expression levels of both RIG-I and MDA5 in response to Poly I:C, CBV5, 
UV-CBV5, and ssRNA stimulation at various time points was minimal in both 
Huh 7.5 cells and Huh 7.5.1 cells in all cases, with the one exception of CBV5 
stimulation in Huh 7.5 resulting in the upregulation of RIG-I expression. This 
suggests that RIG-I plays an important role in CBV5 sensing. Phospho-IκB and 
IRF3 detection in Huh cells in response to the four different stimulations is similar 
to that seen in cardiac cells, with the same conclusions drawn.  
 
The IFN-β production in Huh 7.5 cells and Huh 7.5.1 cells are the most significant 
results here. Huh 7.5.1 cells have an inactivating mutation in RIG-I that leads to a 
defect in IFN production. As less IFN-β production is seen in Huh 7.5.1 cells, this 
indicates that RIG-I plays a role in CBV5 detection. If detection was performed 
solely by MDA5, it would be expected that IFN-β production in both Huh 7.5 
cells and Huh 7.5.1 cells would remain the same, as the RIG-I mutation would 
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have no effect, due to RIG-I not being involved. Because a decrease in IFN-β 
production is detected, RIG-I plays a role alongside MDA5 in sensing CBV5.  
 
Experimenting on Huh cells alongside human cardiac cells, it can be seen that 
RIG-I does indeed have a role to play within CBV5 infection, together with 
MDA5.  
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7.3 RLR Dimerisation  
 
As well as RIG-I and MDA5, the RLR family also contains LGP2. The exact 
function and mechanism of LGP2 in innate immunity is still undetermined, 
although it has been proven to be a regulator for RIG-I- and MDA5-dependent 
signalling, via its repressor domain (RD). The RD of RIG-I has been shown to be 
important for controlling RLR-mediated IFN responses. Once a viral ligand binds 
the RD, a conformational change occurs, converting RIG-I from a closed inactive 
state to an open active state, resulting in the dimerisation of RIG-I and the 
initiation of downstream signalling via the CARDs [Cui et al., 2008].  
 
Dimerisation of the RLRs is essential for them to function correctly. LGP2 has 
been suggested as a negative regulator of the RIG-I- and MDA5-mediated 
antiviral response, as its overexpression inhibits virus-induced IRF3 and NF-κB 
activation. One possible explanation for this is that LGP2 sequesters dsRNA away 
from RIG-I and MDA5, thereby preventing activation of the antiviral signal 
[Rothenfusser et al., 2005]. A second model is that LGP2, via its RD, inhibits 
dimerisation of RIG-I and its interaction with IPS-1 [Saito et al., 2007], whilst a 
third possibility is that LGP2 competes with IKKε for recruitment to IPS-1 
[Komuro and Horvath, 2006]. However, in vivo data suggests that LGP2 can act 
as a positive regulator of RIG-I- and MDA5-mediated antiviral responses, via its 
ATPase domain [Venkataraman et al., 2007; Satoh et al., 2010].  
 
This study aimed to determine whether the RLRs dimerise in response to CBV5 
infection, using immunoprecipitation experiments. Immunoprecipitation is a 
technique used to precipitate a protein out of a lysate using an antibody specific 
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for that protein coupled with beads specific for the antibody. RIG-I, MDA5, or 
LGP2 antibodies were used to precipitate out their respective protein, and SDS-
PAGE and western blotting were then used to detect a different protein. The 
results presented here show that RIG-I and MDA5 exist mainly as homodimers, 
but also as monomers, in human cardiac cells, and in addition, they can 
heterodimerise with a percentage of LGP2.  
 
However, the puzzling question is that although heterodimers between LGP2 and 
RIG-I or MDA5 are present in the LGP2 immunoprecipitations, in the MDA5 or 
RIG-I immunoprecipitations, LGP2 presence is only detected as a monomer. This 
could be due to the higher affinity of the LGP2 RD with the other RLRs, enabling 
it to bind and precipitate RIG-I or MDA5, whereas MDA5 or RIG-I have a lower 
affinity, and may therefore not be able to bind a detectable percentage of higher 
LGP2 aggregates.  
 
Overall, these immunoprecipitation experiments conclude that LGP2 and RIG-I or 
MDA5 associate in cardiac cells, and that there is a synergistic mechanism of 
RLR association for viral detection.  
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7.4 Imaging of RLR Interactions  
 
Confocal microscopy was used to visualise the interaction and colocalisation 
between IPS-1 and MDA5 and between IPS-1 and RIG-I in human cardiac cells in 
response to CBV5 stimulation, to determine when RIG-I and MDA5 are most 
active. RIG-I and MDA5 are both present in the cytoplasm only, and IPS-1 is 
located on mitochondrial membranes within the cytoplasm, and not in the nucleus, 
and this is clearly seen in all the images.  
 
In order to remove user bias from images and provide a quantitative value of the 
extent of colocalisation, the ImageJ and JACoP pieces of software were used 
[Bolte and Cordelieres, 2006]. The Pearson’s correlation coefficient, r(obs), 
measures the covariance between the intensities of each channel in each pixel, and 
is not sensitive to background or colocalised pixel intensity. It has a linear 
regression range of -1 to 1, with -1 being total negative correlation (whereby no 
pixels overlap), 0 being a random correlation, and 1 being total positive 
correlation (where all the pixels overlap). Values of approximately 0.5 and above 
are considered reasonable Pearson’s coefficients.  
 
Results presented here indicate that both MDA5 and RIG-I show extensive 
colocalisation with IPS-1, especially within the first two hours of infection. 
MDA5 showed marginally greater colocalisation with IPS-1 earlier on during 
CBV5 infection, whilst RIG-I appeared to play a greater role later on during 
infection. Both had very high Pearson’s coefficient values after CBV5 stimulation, 
indicating that once CBV5 has been detected, MDA5 and RIG-I bind, via CARD-
CARD interactions, with IPS-I. The interaction between MDA5 and IPS-1 is 
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marginally greater than that seen between RIG-I and IPS-1, once more confirming 
that MDA5 is most likely the primary detector of CBV5, with RIG-I playing a 
role too.  
 
Overall, both MDA5 and RIG-I act synergistically with IPS-1 to initiate 
downstream signalling in response to CBV5 infection.  
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7.5 Conclusion  
 
CBV5 can cause a range of diseases, with the most serious being viral myocarditis 
(which can lead on to DCM), aseptic meningitis, and pancreatitis. DCM is the 
major reason for cardiac transplantation in Europe and the USA, and thus the 
study of CBV5, and how it is detected by the immune system, is of great 
importance.  
 
The RNA helicases RIG-I and MDA5 are both involved in the sensing of a variety 
of different viruses and viral PAMPs. Previous literature has suggested that 
MDA5 is the sole detector of Picornaviridae, of which CBV5 is a member. 
Results presented here suggest that both MDA5 and RIG-I act synergistically to 
detect CBV5 and initiate a downstream immune response, although MDA5 
appears to be the marginally stronger sensor. The expression levels of both are 
upregulated in response to CBV5 infection in human cardiac cells, with MDA5 
expression levels being slightly greater than RIG-I. However, in Huh cells, RIG-I 
expression levels are greater than those of MDA5, indicating that it plays a role in 
CBV5 sensing.  
 
The presence of phospho-IκB (corresponding to NF-κB activation) and IRF3 is 
detected in both cardiac cells and Huh cells in response to CBV5. In response to 
ssRNA stimulation, RIG-I and MDA5 expression levels remained low, but 
phospho-IκB and IRF3 were detected, showing that other PRRs, such as TLR7 or 
TLR8, are playing a role. IFN-β production is also greatly upregulated in response 
to CBV5 infection. In Huh 7.5.1 cells, which contain an inactivating mutation in 
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RIG-I that leads to a defect in IFN production, IFN-β production is reduced, 
showing that RIG-I plays a role in CBV5 detection, alongside MDA5.  
 
RIG-I and MDA5 have both been shown to colocalise with the adaptor protein 
IPS-1 in response to CBV5 infection, again indicating the synergistic response by 
the two RLRs. The third RLR, LGP2, plays a role in the sensing of CBV5 too. 
Both RIG-I and MDA5 form dimers in the cytoplasm, with LGP2 remaining a 
monomer. In response to CBV5 stimulation, LGP2 can heterodimerise with RIG-I 
and MDA5, potentially upregulating or downregulating their activity. These 
heterodimers between LGP2 and RIG-I or MDA5 are present in the LGP2 
immunoprecipitations, but in the MDA5 or RIG-I immunoprecipitations, LGP2 
presence is only detected as a monomer. Determining the extent of affinity of the 
LGP2 RD with the other RLRs, and the MDA5 or RIG-I RD with LGP2, could 
help solve this puzzle.  
 
This study has proven that RIG-I plays a greater role in CBV5 sensing than 
previously thought, and that both MDA5 and RIG-I act synergistically to initiate 
an innate immune response upon recognition of CBV5. The recent discovery that 
RIG-I signals to the inflammasome in an IPS-1-independent manner [Poeck et al., 
2010] also opens up new possibilities for developing therapeutic targets against 
CBV5. Inflammasomes are caspase-1 activating multiprotein complexes which 
assemble in the cytoplasm [Martinon et al., 2009]. Activated caspase-1 cleaves 
the proforms of the interleukin-1b cytokine family members, leading to their 
activation and secretion, and initiation of the inflammatory response.  
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In conclusion, the RLRs play a vital role in the innate immune recognition of 
CBV5. Other PRRs, including the TLRs and the inflammasome, may also 
contribute to the innate immune response against CBV5, but further 
experimentation is needed to elucidate this. The true wonder of the human body’s 
immune system is gradually revealing itself to scientists, who must continue to 
use every tool at their disposal to combat the ultimate predators: viruses.  
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Appendix 
 
 
 
X10 PBS (500ml)  
 50g NaCl  
 1.25g KCl  
 7.2g Na2HPO4  
 1.25g KH2PO4  
 400ml distilled water (dH2O) 
 pH 7.2  
 Top up to 500ml with dH2O  
 
For PBS-Tween, add 10ml Tween-20 (rinse tip in buffer).  
 
X1 PBS (500ml)  
 50ml x10 PBS  
 450ml dH2O  
 
X2 PBS (500ml)  
 100ml x10 PBS  
 400ml dH2O  
 
X1 PBS / 0.02%(w/v) BSA / 0.02%(w/v) Saponin / 0.02%(w/v) Sodium Azide 
(NaN3) (500ml)  
 0.02% = 0.02g in 100ml 
 In 500ml need 0.1g  
 0.1g of each added to 500ml x1 PBS  
 
10% SDS (100ml)  
 10.0g SDS  
 In 100ml dH2O  
 Mix on a heater / stirrer  
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4% Paraformaldehyde (4% PFA) (200ml)  
 Add 8.0g PFA powder to approx. 80ml of dH2O in a glass beaker.  
 Heat to 60oC in a fume hood on a heater / stirrer  
 Add a few drops of 1M NaOH to help dissolve, whilst still on a heater / 
stirrer  
 When the solid has completely dissolved, top up to 100ml with dH2O, let 
the solution cool to room temperature, add 100ml of x2 PBS  
 
0.5M Tris pH 6.8 (250ml)  
 60.5g in 1000ml (M = Mass / M.wt therefore 0.5 = Mass / 121 therefore 
Mass = 60.5)  
 15.1g Tris in 250ml dH2O  
 pH to 6.8 with concentrated HCl  
 
X2 SDS-PAGE Reducing Sample Buffer (approx. 40ml)  
 20ml 0.5M Tris pH 6.8  
 16ml 10% SDS  
 10.0g Glycerol  
 4ml 14.3M β-mercaptoethanol  
 Small spatula with a bit of Bromophenol Blue  
 Stir with spatula till mixed, transfer to bottle  
 
Phenol / Chloroform / Isoamyl Alcohol  
 In fume hood, in a 500ml sterile glass bottle  
  Add 100ml Phenol + 100ml Chloroform / Isoamyl Alcohol + 100ml dH2O  
 Leave to settle  
 Place in fridge  
 
Stripping Buffer (200ml)  
  1.4ml β-Mercaptoethanol (100mM) 
 40ml 10% SDS (=2% in 200ml)  
 1.52g Tris HCl pH6.7 (62.5mM)  
 Top up to 200ml with PBS-T  
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Immunoprecipitation Solutions  
 
X2 SDS-PAGE Non-Reducing Sample Buffer (approx. 40ml)  
 10ml 0.5M Tris pH 6.8  
 8ml 10% SDS  
 5.0g Glycerol  
 Small spatula with a bit of Bromophenol Blue  
 Stir with spatula till mixed, transfer to bottle 
 
Net Buffer pH8 (100ml)  
 6.056g 500mM TrisHCl 
 8.768g 1.5M NaCl  
 1.86g 50mM EDTA  
 Make up to 100ml with dH2O  
 
10mM Iodoacetamide (50ml)  
 92.5mg (0.0925g)  
 In 50ml dH2O  
 
10% w/v NP-40 (50ml)  
 5g NP-40  
 In 50ml dH2O  
 
PMSF Stock (100ml)  
 1.74g PMSF  
 In 100ml Ethanol  
 
Protein A Sepharose (PAS) Beads (10%(w/v))  
 0.1g in 1ml Lysis Buffer  
 Incubate >1 hour, to allow beads to ‘swell’  
 Resuspend PAS by gently pipetting before each use  
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Lysis Buffer (50ml)  
 5ml NET Buffer  
 500µl Iodoacetamide  
 5ml NP-40  
 25µl PMSF  
 20µl Protease Tablets (mixture)  
 Make up to 50ml with dH2O  
 
DNA Isolation Solutions 
 
STET Buffer (100ml)  
 8g Sucrose  
 500µl Triton  
 10ml EDTA (500mM) pH 8 (adjust with HCl)  
 1ml Tris pH 8 (1M) (adjust with HCl)  
 Make up to 100ml with dH2O 
 
1M Tris (100ml)  
 12.1g Tris  
 In 100ml dH2O  
 pH to 8 with HCl  
 
500mM EDTA (=0.5M EDTA) (100ml)  
 37.22g EDTA  
 In 200ml dH2O  
 pH to 8 with HCl  
 
Sucrose Gradient Buffers  
 
60% / 30% / 10% in PBS  
 60g / 30g / 10g Sucrose (powder) into 3 separate conical flasks  
 Top each up to 100ml with PBS  
 Fridge  
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SDS-PAGE / Western Blot Solutions  
 
1.5M Tris-HCl pH 8.8 (500ml)  
 90.85g Tris  
 In 500ml dH2O  
 pH to 8.8 with conc. HCl  
 
X2 Transfer Buffer (1000ml)  
 4.88g Tris  
 20ml 10% SDS  
 400ml Isopropanol (= Propan-2-ol)  
 Make up to 1000ml with dH2O 
 pH to 8.3 with Acetic Acid  
 To get X1 TB  split into 2 beakers, add 500ml dH2O to each  
 
Running Buffer (500ml)   
 50ml x10 Running Buffer  
 450ml dH2O  
 
 [Tris-Glycine pH 8.8]  25mM Tris, 192mM glycine, 0.1% SDS 
 For 10x running buffer:  
 288g glycine 
 60.4g tris base  
 20g SDS  
 1800ml dH2O  
 
PBS-Tween (2000ml)  
 200ml x10 PBS into a 1000ml bottle  
 Top up to 1000ml with dH2O  
 Add 2ml PBS-Tween20, dropping the tips into the bottle  
 Mix (shake)  
 Decant 500ml into a new bottle, top both up with 500ml dH2O = 2 x 
1000ml bottles of PBS-T  
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10% Resolving Gel (for 2 gels)  
 4.02ml dH2O  
 2.5ml 1.5M Tris-HCl pH 8.8  
 100µl 10% SDS  
 3.33ml Acrylamide/Bis   
 To Polymerise, add:  
o 50µl 10% APS  
o 10µl TEMED  
 
4% Stacking Gel (for 2 gels)  
 6.1ml dH2O  
 2.5ml 0.5M Tris-HCl pH 6.8  
 100µl 10% SDS  
 1.3ml Acrylamide/Bis  
 To Polymerise, add:  
o 50µl 10% APS  
o 20µl TEMED  
 
Blocking Reagent (40ml)  
 2g Milk Powder  
 40ml PBS-T  
 
Agarose Gel Electrophoresis Solutions  
 
50X ELFO (2M Tris, 50mM EDTA) (1000ml)  
 242g Tris base  
 100ml EDTA (0.5M)  
 pH 7.7 with Acetic acid  
 Make up to 1000ml with dH2O  
 
1X ELFO (1000ml)  
 20ml 50X ELFO in 1000ml dH2O  
 
 
 
210 
 
ELFO Loading Buffer (200ml)  
 100ml Glycerol  
 20ml 50X ELFO  
 80ml dH2O  
 A few mg of Bromophenol Blue  
 
 
